Method and apparatus for manufacturing an implant

Information

  • Patent Grant
  • 10159498
  • Patent Number
    10,159,498
  • Date Filed
    Monday, June 15, 2015
    9 years ago
  • Date Issued
    Tuesday, December 25, 2018
    5 years ago
Abstract
An orthopedic device includes a femoral implant having a non-custom internal bone engagement surface. The femoral implant includes at least nine parameters adjusted preoperatively to correspond to a specific patient. The parameters can include patient-specific lengths, such as, for example, medial and lateral condyle widths and notch height, and patient-specific medial and lateral angles.
Description
INTRODUCTION

The present teachings provide an implant customized for a specific patient based on a plurality of parameters identified during a preoperative planning stage.


SUMMARY

The present teachings provide an orthopedic device that includes a femoral implant having a non-custom internal bone engagement surface. The femoral implant further includes at least nine parameters adjusted preoperatively to correspond to a specific patient. In one embodiment, the femoral implant includes three patient-specific lengths, three patient specific medial angles and three patient specific lateral angles, wherein the lengths and medial and lateral angles are selected preoperatively based on a three-dimensional image of an anatomy of a patient to match the anatomy of the patient.


The present teachings provide an orthopedic device manufacturing method. In one embodiment, the method includes preparing a three-dimensional image of a patient's joint, selecting a non-custom implant closely matching the joint, and modifying at least six angles of the implant to be patient-specific. In another embodiment, the method includes preparing a three-dimensional image of a patient's joint, selecting a non-custom femoral implant closely matching the joint, and modifying at least three lengths and six angles of the femoral implant to be patient-specific.


Further areas of applicability of the present teachings will become apparent from the description provided hereinafter. It should be understood that the description and specific examples are intended for purposes of illustration only and are not intended to limit the scope of the present teachings.





BRIEF DESCRIPTION OF THE DRAWINGS

The present teachings will become more fully understood from the detailed description and the accompanying drawings, wherein:



FIG. 1 is a flowchart of an implant manufacturing method according to the present teachings;



FIG. 1A is a flowchart of an implant manufacturing method according to the present teachings;



FIG. 1B is a flowchart of an implant manufacturing method according to the present teachings;



FIG. 1C is a surgical kit according to the present teachings;



FIG. 1D is a patient-specific alignment guide according to the present teachings;



FIG. 1E is a patient-specific alignment guide according to the present teachings;



FIG. 2 is a diagram illustrating a computer interface for an implant manufacturing method according to the present teachings;



FIG. 3 is perspective view of a generic casting of an implant according to the present teachings;



FIG. 4 is a posterior view of a generic casting according to the present teachings;



FIG. 4A is a posterior view of a generic casting including a plurality of additional modifiable features according to the present teachings;



FIG. 5 is a plan view of a generic casting according to the present teachings;



FIG. 5A is a plan view of a generic casting including a plurality of additional modifiable features according to the present teachings;



FIG. 5B is a distal view of a three-dimensional image of the patient's distal femur showing planned resection planes according to the present teachings;



FIG. 5C is a anterior view of a three-dimensional image of the patient's distal femur showing planned resection planes according to the present teachings;



FIG. 6 is a flow chart for an osteophyte/protrusion removal control method according to the present teachings;



FIG. 7 is a representative image of a patent's anatomy showing osteophyte/protrusion control tools for modifying the image;



FIGS. 8 and 9 are representative images of a patent's anatomy showing exemplary osteophyte/protrusion locations;



FIG. 10 is a representative image of a patent's anatomy showing representative depth control selections for surgeon manipulation;



FIGS. 11 and 12 are representative images of a patent's anatomy after osteophyte/protrusion removal with exemplary implants attached thereon;



FIGS. 13A and 13B illustrate a flowchart of a method of implant and guide design;



FIG. 14 is a schematic view of hardware and a user; and



FIG. 15 is a plan view of a display of a device.





DESCRIPTION OF VARIOUS ASPECTS

The following description is merely exemplary in nature and is in no way intended to limit the present teachings, applications, or uses. For example, although some of the present teachings are illustrated for a knee implant, the present teachings can be used for any orthopedic implant.


The present teachings provide a manufacturing method that integrates patient's anatomic and medical information with interactive participation by a surgeon to select and manufacture an implant and, optionally, related surgical instruments, for a particular patient from generally three options: a custom made implant specific to the patient, an implant that is only partially custom-made or a semi-custom implant, and a standard off-the shelf implant. Similarly, off-the-shelf, custom-made, or semi-custom-made instrumentation (e.g. alignment guides, drill guides, cutting guides or other instruments) can be selected and manufactured, as recommended by the surgeon, for the surgical procedure. All the implant components, alignment guides, and other disposable instruments can be included in a package provided to a surgeon for a specific patient.


Referring to FIG. 1, an exemplary flowchart of an interactive implant manufacturing method according to the present teachings is illustrated. The portion of the patient's anatomy related to the orthopedic procedure and the implant is characterized and detailed at 100. The characterization can be performed with various imaging methods capable of obtaining a representation of the affected anatomy, including, for example, soft and hard tissues. The tissues can include bone, bone joints with or without cartilage, ligaments, or other soft tissue. The imaging methods can include, for example, MRI, CT, ultrasound, radiography or X-ray, cameras and other devices.


The image information for the patient can be obtained at a medical facility or a doctor's office and can be sent to the manufacturer in an electronic and/or digital form contained. The image information can be stored on a physical medium, such as a CD, DVD, flash memory device (e.g. memory stick, compact flash, secure digital card), or other storage device. The information may alternatively, or in addition, be transmitted electronically with the Internet or worldwide web using appropriate transfer protocols. Also, electronic transmissions can include e-mail or other digital transmission to any appropriate type of computer device, smart phone, PDA or other devices in which electronic information can be transmitted.


Appropriate handheld devices (used as illustrated in FIG. 13), can include handheld mobile device or portable communication devices, such as the iPhone® handheld mobile device sold by Apple Inc., a corporation of California, USA; the LG Shine® handheld mobile device sold by LG Corp. a corporation of REPUBLIC OF KOREA; or the Blackberry Bold® handheld mobile device sold by Research In Motion Limited a corporation of CANADA. The handheld device can be those that are held in the palm of a hand of a user, such as a surgeon (see FIG. 14). The surgeon can then enter data with a stylus, keyboard, touch screen, etc. The handheld device can use local area networks, cell phone networks, or other data transmission systems to communicate with a main memory and processor of a service provider (see FIG. 14).


Appropriate handheld devices can provide access to electronic communication or file transfer protocols, such as internet or electronic mail, to transfer or access information files. The handheld devices can have installed programs that can be used to manipulate the information files, as discussed herein. Alternatively, or in addition thereto, the handheld devices can access servers that process data files while receiving input through the handheld devices and displaying images to the surgeon or user via the handheld device. In certain instances, the handheld device may only be a client that does not process and edit a data file of the pre-operative plan.


With continued reference to FIG. 1, at 110, the information collected at 100 can be used to create a three-dimensional model or image of the bone or joint with or without associated soft tissue or related anatomy using commercially available computer modeling software from various vendors or developers, such as, for example, from Materialise USA, Ann Arbor, Mich. The three-dimensional model of the patient's anatomy can be viewed on a computer display or other electronic screen and can also reproduced as a hard copy on film or other medium and viewed by direct or indirect or backlight illumination. The model can be sized for viewing on any appropriate screen size and may be cropped, rotated, etc. as selected by the individual (e.g. the surgeon) viewing the screen.


At 120, soft tissue associated with the affected anatomy can be modified, or removed or repaired, to restore alignment of the joint, for example, or to remove torn or diseased tissue, or to cut or repair ligaments, or to provide natural or artificial ligament grafts. Soft tissue information can be optionally used as an additional design parameter or input for the implant design, at 125. For example, a custom or patient-specific bearing articulation of a knee joint can be designed based on the kinematic profile and the soft tissue/ligament information available for a particular patient. Further, kinematic information for the patient can be obtained by an actual gait analysis of the patient, and can also be obtained by computer modeling software that uses the MRI images of the patient's joints and associated ligaments, muscle or other soft tissue to derive kinematic analysis of the patient and corresponding recommendations for soft tissue modification, such as releasing a ligament, for example. Such software is commercially available from LifeModeler, Inc., of San Clemente, Calif.


At 130, a preliminary pre-operative plan of the surgical procedure can be prepared for surgeon or other medical user or technician review, including the planning of various bone resections, sizes and types of implants, and various geometric requirements including relevant dimensions, such as height, width, orientation of particular features, etc. The preliminary pre-operative surgical plan can include a recommendation of particular implants and associated instruments to be used in the surgical procedure, as discussed below. The preliminary pre-operative surgical plan can be in the form of digital images that can be viewed interactively using a computer modeling software, such as the software referenced above. The preliminary pre-operative plan and any further changes or a finalized pre-operative plan can be a plan devised to obtain a healthy or as close to healthy anatomical orientation after an operative procedure. The healthy anatomy can be based on natural or pre-injury anatomy or mechanically correct or efficient anatomical orientation.


At 140, the preliminary pre-operative surgical plan can be submitted to the surgeon (or other user) for review, either electronically or by land mail, and either in digital or hard copy form, as discussed above in connection with transmitting imaging information. In particular, the surgeon can review the resection planes shown in image of the patient's anatomy, make changes in the location, size and orientation of the resection planes and, generally, work interactively until the pre-operative plan from 130 is surgeon-approved. Specifically, the surgeon may approve the image of the patient's anatomy showing corresponding resection planes. As shown in FIGS. 7 and 8, the patient's anatomy 510, as represented in the image, can be, for example, a distal femur with approved resection planes including medial and lateral anterior chamfer planes 513, medial and lateral anterior cut planes 511, medial and lateral posterior chamfer planes 512 and medial and lateral posterior cut planes 514. Following the surgeon's approval of the anatomy and the resection planes at 140, the surgeon is provided with the opportunity to remove one or more osteophytes/protrusions from the image of the patient's anatomy 510 at surgeon-selected locations and depths at 500 (See FIG. 6). Removal of such protrusions and smoothening of the joint surface that receives the implant can parallel the intra-operative joint preparation by the surgeon and improve the actual fit of a surgeon-selected implant, whether patient-specific, semi-custom, or off the shelf.


An automated osteophyte/protrusion removal control module 500 can be incorporated in the planning stage of the manufacturing method illustrated in FIG. 1. The automated osteophyte/protrusion removal control module 500 can be provided as a separate pre-operative planning module, as shown in FIG. 6, or it can be incorporated and/or fully integrated with the manufacturing method illustrated in FIG. 1.


Certain parts of the bone, including various bone bumps, protrusions, growths and osteophytes can be generally removed from the three-dimensional reconstruction of a patient's anatomy before designing a patient-specific implant or semi-custom implant, or before selecting an off the shelf implant. The automated osteophyte/protrusion removal control module can replace a time-consuming and potentially less accurate manual modification of the three-dimensional image to remove such bone growths or osteophytes by an experienced image or CAD technician. The automated osteophyte/protrusion removal control module 500 can provide more accurate and faster removal of such bone irregularities, which can vary in shape, location and size from patient to patient. It will be appreciated that the osteophyte/protrusion removal control module 500 can be used for smoothing out a bone surface by removing any type of bone protrusion, including bumps, irregularities and osteophytes. According to the present teachings, osteophytes are illustrated as exemplary, but not exclusive, candidates for complete or partial removal.


Referring to FIG. 6, the osteophyte/protrusion removal control module 500 can start 502 with an input of the three-dimensional image of the patient's anatomy 510 including resection planes, as shown in FIGS. 7-9, after review and approval of the resection planes by the surgeon (or other user, including other professionals or technicians) at 140 of FIG. 1. In the exemplary illustration of FIG. 7, the image of the patient's anatomy 510 can be analyzed to identify osteophyte/protrusion locations 530 (at 504 of FIG. 6) by determining tissue or bone overhang protruding past outer edges 532 of the various resection planes, such as the resection planes illustrated at 511, 513, 512 and 514 in FIGS. 7-9. If such osteophyte/protrusions 530 extend beyond the edges of the resection planes in the direction of the planned or anticipated implant location, the osteophyte/protrusions 530 can interfere with implant fitting.


Referring to FIGS. 6, 7 and 10, in addition to identifying the location of osteophytes/protrusions 530, the osteophyte/protrusion removal control module 500 can provide visual control for the surgeon to select the aggressiveness of osteophyte/protrusion removal, or the degree of smoothening and/or flattening of the corresponding joint anatomy. Specifically, by fine-tuning the osteophyte/protrusion locations, at 506 of FIG. 6, the surgeon can control the depth of the osteophyte/protrusion removal in a continuous or discrete manner. In one aspect, a landmark location 540 for each osteophyte/protrusion 530 can be identified and pegged for measuring from and initiating a continuous series of constant or variable depth contours 542 to aid the surgeon in selecting the depth of osteophyte/protrusion removal. The depth contours can be automatically generated by the computer software that generates a three-dimensional model or image of the anatomy, such as the software commercially available, for example, from Materialise USA, Ann Arbor, Mich. The landmark location 540 can be a location of lowest possible depth in the vicinity of the identified osteophyte/protrusion, a minimum, or a valley location, as shown in FIG. 10. Although the depth contours 542 are shown as discrete in FIG. 10, it will be appreciated that a continuous removal control can be provided, such that the surgeon can exercise unlimited choices of depth contours for removal. The depth contours 542 can represent curved smoothed-out surfaces under the original osteophyte/protrusion 530 and can be exposed after an overlying area is shaved or peeled in the image of the patient's anatomy 510 by the operation of graphical or visual removal tools provided on the image of the patient's anatomy 510. The surgeon or other user can manipulate the graphical removal tools with a user interface, such as a mouse, touch screen, joystick, slide pad, or other user interface.


Referring to FIG. 7, various visual removal tools can be provided for on-screen manipulation and control by the surgeon, at 508 of FIG. 6. For example, a removal tool corresponding to each edge of a resection plane can be provided and used to visually/graphically remove a portion of an osteophyte/protrusion associated with a particular edge 532. In FIG. 7, four such exemplary removal tools 520a, 520b, 520c, 520d (collectively referenced as 520) are shown, each removal tool associated with an edge of a resection plane, such as lateral and medial chamfer plane and lateral and medial cut plane. Although the removal tools 520 are illustrated as straight sliders in FIG. 7, the amount removed follows a depth contour 542, as illustrated in FIG. 10. The removal tools 520 can include a visual indicator 525 that can provide information to the surgeon in the form of a number on a scale indicative of the depth of aggressiveness of osteophyte/protrusion removal. In another aspect, the indicator 525 can provide visual information in terms of variable color in shades gradually changing from minimum depth removal (green, for example) to maximum depth removal (red, for example).


After the surgeon completes the osteophyte/protrusion removal, the surgeon can manipulate and superimpose implant images in relation to the modified patient's anatomy 510. In FIGS. 11 and 12, exemplary images of a resected femur 510 and tibia 515 referenced relatively to a mechanical axis 522 are illustrated. The femur image illustrates the patient's anatomy 510 after the osteophytes/protrusions 530 shown in FIGS. 8 and 9 have been removed and a femoral implant/component 560 is placed on the resulting smoothed out surface that follows one of the depth contours 542 shown in FIG. 9.


Referring to FIGS. 1, 1A, and 1B, based on the preliminary pre-operative surgical plan and the patient information, the surgeon can make a recommendation regarding the design of the implant at 150, and any desired associated alignment guides at 160. At 150, the surgeon can recommend a method of designing an implant. Specifically, the surgeon can select one of the following three options: a first option of a custom or patient-specific implant at 170 or a second option of a semi-custom made implant at 180, or a third option of a standard or off-the-shelf implant at 190. The surgeon can also include recommendations and preferences for various custom and non-custom instruments to be used in the procedure at the surgeon review at 140, as well as at the selection and design of implant at 150 and selection and design of alignment guides 160. It will be appreciated that, based on the surgeon's recommendation at 140, the preliminary pre-operative surgical plan can be modified at 130, including all the surgeon's preferences regarding anatomy modification (osteophyte removal, resection planes, etc.), implant design, alignment guide design and selection of various tools and instruments, and then resubmitted to the surgeon for approval.


A custom-made implant is a patient-specific, one of a kind implant specifically made for a particular patient, and consequently there is no inventory associated with such implant. Standard or off-the-shelf-implants are available and stocked in a number of sizes, typically six or more, and a number of configurations or types, including bilateral or unilateral implants, constrained, semi-constrained, mobile, etc. Because of the variety of sizes and configurations that are kept in stock to accommodate different patients, a large inventory of standard implants is created, and several molds for each type and size of implant may be used. As described below in detail, semi-custom implants provide an intermediate solution between custom-made and off-the-shelf implants. Semi-custom implants reduce the size of inventory and molds required for production, while allowing some degree of patient-specific customization.


Custom or patient-specific implants, when approved by surgeon at 170 for a specific patient, can be manufactured for the patient by rapid prototyping methods, such as stereolithography or other similar methods, or by CNC milling, or other automated or computer-controlled machining, or by robotic methods, at 250. Manufacturing can take place at a manufacturing center or facility in situ or at remote or off-site location. It will be understood that in situ manufacturing is used as a short hand for a manufacturing site of the original equipment manufacturer (OEM), but can be physically located at a different facility of the OEM. Off-site or remote manufacturing will be understood to refer to facilities operated by other manufacturers who are contracted by the OEM for manufacturing all or some of the implants, components or parts for the surgical procedure.


Off-the-shelf implants, when approved by the surgeon a 190, can be manufactured by standard casting methods from bar stock or other stock material at 200, then shaped to a final shape and size by grinding or milling at 210, polished at 220, and then cleaned/passivated at 230. Such off-the-shelf implants can be part of an existing inventory, or mass-produced, or produced by just-in-time agile manufacturing methods.


Semi-custom implants, when approved by the surgeon at 180, can be made from a generic casting at 240, as described below, or by modifying existing standard implant designs to match various features or parameters based on the anatomy of the patient, as described in co-pending patent application entitled Patient-Modified Implant and Associated Method, Ser. No. 12/103,834, filed on Apr. 16, 2008, the disclosure of which is incorporated by reference herein. After the generic casting is modified for certain parameters of a patient, it can be processed at aspects 210-230 to a passivated form. Patient-specific parameters can include parameters relating to the size of the implant, including height, width, various articulation parameters or angles, etc., as discussed in specific example below in reference to FIGS. 3-5.


The surgeon's review of the surgical plan at 140 may further include, at 160, a request for one or more patient-specific alignment guides to be used with the implant. Patient-specific alignment guides are described in co-pending patent application Ser. No. 11/756,057, filed on May 31, 2007, Ser. No. 11/971,390, filed on Jan. 9, 2008, Ser. No. 12/025,414, filed on Feb. 4, 2008, and Ser. No. 12/039,849 filed on Feb. 29, 2008. The alignment guides can be manufactured at 260 with by rapid prototyping methods, such as stereolithography or other similar methods or by CNC milling, or other automated or computer-controlled machining or robotic methods, and cleaned at 270. The alignment guides, the implants and optionally other disposable instruments (at 272) can be packaged and sterilized at 280, and forwarded to the surgeon or the surgeon's medical facility for implantation at 290.


The methods described in connection with FIGS. 1A and 1B can be modified to incorporate additional features, as illustrated in FIG. 1C. The additional features can include a preparation of a surgeon kit 1000 at 276 and optionally a tracking procedure in which tracking tags are added at 278 to the various parts that are included in the surgeon kit 1000. The tracking procedure can be incorporated in the manufacturing, cleaning, sterilizing, assembling and boxing the various components up to implantation and can be maintained, for example through the procedures at 260, 270, 230, 272, 274, 276, 280, and 290, as shown in FIG. 1B. The surgeon kit 1000 and can be tracked during assembling/stocking the surgeon kit 1000 with the various components, and the tagged components can be tracked from manufacture to implant procedure.


Referring to FIGS. 1B-1E, a surgeon kit 1000 can be generated at 276. The surgeon kit 1000 can be designed and assembled during the process described above in FIGS. 1A, 1B and 1C and during the manufacturing of the patient-specific alignment guides and implants. The surgeon kit 1000 can be assembled based on surgeon preferences and can include a set of implants, such as, for example, a femoral implant 1050, a bearing 1052 and a tibial implant 1054, for an exemplary knee replacement procedure, or other implant components depending on the surgical procedure and the surgeon's preference. The implants can be patient-specific, of semi-custom or standard off-the-self as described above. In addition to or instead of the implants, surgeon-selected alignment guides (at 160, 165 and 260), other disposable instruments (at 274) and other reusable instrument (at 274) selected according to the surgeon's preferences can be included in the surgical kit 1000. In one embodiment, the surgeon kit can include only instruments, such as, for example, alignment guides and other tools, designed to be disposable.


In the exemplary illustration of FIG. 1C, a surgeon kit 1000 for a knee procedure is shown to include a femoral alignment guide 1010, a tibial alignment guide 1018, a femoral drill guide 1012, a tibial drill guide 1020, a femoral distal cutting block 1014, a tibial cutting block 1030, a four-in-one femoral cutting block 1016, a tibial template 1022 with alignment rod 1024. The alignment guides are single-use and disposable. The various drill guides and cutting blocks can be re-sterilazable and reusable, although disposable drill guides, cutting blocks and other tools can also be designed. Additionally, a set of trochar pins 1032 and a set of spring drill pins 1034 can be included. Depending on the surgeon's preferences, various surgical blades 1036 can be added and additional medical products, such as, for example, bone cement 1038, or other medical supplies or biologics 1040.


Referring to FIGS. 1B-1E, a tracking system can be incorporated with the surgeon kit 1000. Tracking tags 1110 can be added at 278 optionally to the alignment guides, the implants and/or the entire surgeon kit 1000. The tracking tags 1110 can be simple barcode tags, or other scan readable tags or radio frequency identification (RFID). The tags 1110 can be added to individual instruments or on the entire surgical kit 1000, outside the box. The tracking tags can include patient-specific information and/or surgeon information, such as, for example, patient's name, age, gender, procedure to be performed, surgeon's name; clinic or hospital location, etc.


The tracking tags 1110 can be removable. For example, the tracking tags 1110 can be attached with removable glue sticks or frangible attachments. In one embodiment, the tracking tags 1110 can be incorporated in a frangible extension 1102 of an alignment guide 1100, as illustrated in FIGS. 1D-1E. The exemplary alignment guide 1100 can include a body 1120 having a patient-specific engagement surface 1126 for engaging a complementary surface of the corresponding anatomy of the patient and one or more alignment formations 1122 defining guiding bores 1124 for guiding alignment or drill pins or other instruments. The extension 1102 can be prepared or incorporated during the manufacturing process, for example, during the layering process of a rapid prototyping method, and can include a pocket 1104 in which a tracking tag 1110 is inserted, as part of the layering process. Layering can continue and cover the tracking tag 1110. In another embodiment, the extension 1102 can be a blank of larger dimensions from which the pocket 1104 is machined for the tracking tag 1110. The tracking tag 1110 can be removed or broken off by the surgeon. Tracking of the patient-specific (and surgeon) information can be provided for the entire manufacturing procedure from start to finish, i.e., from the manufacturing of the tracked components to assembling the surgeon kit 100 to the implant procedure at the operating theater or site.


Referring to FIG. 2, a computer interface 400 to a computer program for the management of the manufacturing method is illustrated diagrammatically. An orthopedic system manager 402 can be in the form of software or other computer program associated with the original equipment manufacturer. The orthopedic system manager 402 can be accessible locally via dedicated computer machines or computer terminal directly communicated with software either by hard wire or wirelessly. The orthopedic system manager 402 can also be accessible remote remotely via the Internet or other remote communication portals using any electronic or other devices that can connect to the Internet or other web-based network, or other similar communication networks, including cable, satellite and telephone-based networks.


The system manager 402 can provide access to patient file information, including lists of all current patients at 403, and surgery dates, surgeons, and approval status of the surgical plan for each patient, at 404. Each patient file can include personal and medical information of the patient, such as, for example, weight, height, gender, age, lifestyle, pertinent medical records and medical history, as well as information on patient assessment that includes physical and kinematic evaluation pertaining to the orthopedic procedure at 406, and soft and hard tissue analysis at 408, including information provided at aspects 120 and 125 of FIG. 1, as discussed above. Imaging center information for patient scans, as discussed in relation to aspects 100 and 110 of FIG. 1, can added or modified at 410, and an imaging center for each specific patient can be specified at 412. Surgeon profiles, including surgeon preferences regarding anatomic axes alignment or implant and instrument preferences that can be taken into account when preparing the preliminary pre-operative plan discussed at aspect 130 of FIG. 1, can be created and edited at 414. Information and selection of manufacturing centers can be accessed at 416 for manufacturing the implants and or alignment guides as discussed in relation to aspects 260, 250, 240, and 210-230 of FIG. 1. The preliminary pre-operative surgical plan for each patient can be provided at 418, as discussed above at 140 in reference to FIG. 1, and e-mailed or otherwise communicated to the patient's surgeon at 420.


As discussed above at aspects 150 to 190 of FIG. 1, one implant option includes manufacturing semi-custom implants by generic casting. Illustrative examples of generic casting of a semi-custom femoral implant/component are shown in FIGS. 3-5. A generic casting 300 of the implant is a casting that is more specialized than ordinary bar stock, from which any size of implant can be made, but less specialized than the off-the-shelf implants that are available in a particular number of sizes, typically six-to ten sizes and are finished from specific castings of those sizes. The generic casting can be made in a size and shape that can accommodate a range of variable features for the implant, and at the same time can be machined to multiple sizes, such as three or four smaller sizes. In contrast, off-the-shelf implants require a mold or casting for each offered size, and a larger inventory of available sizes for each implant component. The generic casting can generally include geometric features which are size/shape and/or patient-independent or universal, and also features that are size/shape or patient-specific, as discussed in the examples below. More particularly, the generic casting can include at least one geometric feature that will remain unchanged for any patient or universal feature, and at least one geometric feature that can be specifically customized for and is specific to a particular patient. Additionally, generic castings can be provided in the same sizes as off-the-shelf components, although generic castings can have different shapes than off-the-shelf components.


Referring to FIGS. 4 and 5, an exemplary generic casting 300 of a femoral implant is illustrated. In this example, the generic casting 300 can have an anterior flange 302 of medial-lateral width W, and/or a height H and/or other geometric dimensions to accommodate multiple sizes of femoral implants. For example, multiple sizes of left-sided implants 304a, 304b, and various sizes of right-sided implants 306a, 306b can be formed by a single generic casting. In addition to multiple sizes, multiple shapes can be made from a single generic casting. Appropriate markings or indentations or score lines for cutting to size can be provided, such as height markings 330, for example. The implant for a particular patient can be formed from the generic casting 300 by selecting particular features, such as the width W or height H, or other geometric features for a particular patient and machining the generic casting 300 to provide the size, dimension or shape, or combinations thereof for that particular geometric feature.


Referring to FIG. 5, the generic casting 300 does not include a patella track feature, but provides an area in which a custom patella track 308 can be machined at a custom angle or custom shape for each specific patient. The generic casting 300 can also include additional material in the intercondylar notch area 310 to allow for custom machining of the intercondylar notch area 310 to accommodate various types of articulation or constraint in relation to a tibial implant, such cams or intercondylar boxes, and other contact areas for articulation with the tibial implant in accordance with a kinematic plan for the joint of the specific patient. Custom shapes of various other portions of the implants can also be prepared fro the generic castings. Separate molds for posterior stabilized and cruciate retaining articulations can be made, each mold capable of accommodating multiple sizes of the corresponding implant type. For example, the intercondylar notch area 310 can be machined for line or area contact with the articular surfaces of a tibial implant of various degrees of flexion. Exemplary articulations are disclosed in commonly assigned U.S. Pat. Nos. 6,589,283, 6,413,279, and 6,165,223, and in co-pending U.S. patent application Ser. No. 10/840,765 filed on May 6, 2004, all of which are incorporated herein by reference. Various markings 332 corresponding to different sizes can be provided.


Referring to FIG. 3, the generic casting 300 can include at least one patient-independent or universal feature, such as, for example, universal cement wells 312 or other universal features. Such universal features can be used with any internal geometry 314, which can be machined into the generic casting 300 to accommodate the appropriate shape and/or size for a specific patient.


Referring to FIGS. 3, 4A, 5A, 5B and 5C, a semi-custom implant (304a, 304b, 306a, 306b) can also be generated from a generic casting 300 by customizing a plurality of features based on the patient's anatomy during the pre-operative planning stage in addition to or instead of the parameters discussed above. The generic casting 300 can include a standard, non-custom articulation surfaces for the medial and lateral condyles and an internal bone engagement surface 300a for engaging the resected femur and including five internal planes 511a, 513a, 517a, 512a and 514a (FIG. 3) corresponding to anterior cut plane 511′, anterior chamfer plane 513′, distal cut plane 517′, posterior chamfer plane 512′ and posterior cut plane 514′ (FIGS. 5B and 5C). The internal bone engagement surface 300a and corresponding internal planes of the generic casting 300 can correspond to standard, i.e., non-custom, sizes for the femoral implant. By selecting a relatively large number of parameters corresponding to the patient's anatomy, as captured in the three-dimensional image of the corresponding joint portion of the patient, the semi-custom implant can be made to correspond to the patient's anatomy as closely as desired while retaining the internal geometry corresponding to the resection planes in the sagittal view. More specifically, in an exemplary embodiment, at least nine parameters of the implant can be patient-specific, including three lengths and six angles, as discussed below in reference to the preoperative plan for the specific patient and the various planned resection planes.


In an exemplary embodiment of the preoperative plan, an image of the patient's anatomy, i.e. the distal femur 510′ of the patient indicating the planned cut planes is illustrated in FIGS. 5B and 5C. FIG. 5B represents a distal view of the three-dimensional image of the distal femur 510′, as reconstructed by MRI, CT or other scans. The planned resections indicated on the image include medial and lateral sides of a posterior chamfer plane 512′, of a distal cut plane 517′, and of an anterior chamfer plane 513′. The most anterior point of the intercondylar notch is indicated by a tangent line at 907. FIG. 5C represents an anterior view of the three-dimensional image of the distal femur 510′, and illustrates the distal cut plane 517′, anterior chamfer plane 513′, and an anterior cut plane 511′. The straight edges of the various cut planes are indicated as follows in reference to FIG. 5C: posterior distal edge 950 is the posterior edge of the distal cut plane 517′; anterior distal edge 952 is the anterior edge of distal cut plane 517′; distal anterior edge 954 is the distal edge of the anterior cut plane 511′; and proximal anterior edge 956 is the proximal edge of the anterior cut plane 511′. FIG. 5B also illustrates the posterior distal edge 950, the anterior distal edge 952, and the distal anterior edge 954.


A representative, but not exhaustive list of patient-specific parameters that can be selected at the preoperative stage for incorporation into the implant design after a particular size implant has been selected is indicated in FIGS. 4A and 5A-C.


Specifically, a central plane 800 perpendicular to the epicondylar axis 801 of the distal femur 510′ can be identified through the center of and orthogonal to the medial-lateral width W of the generic casting 300. The central plane 800 can be used as a reference plane for the bone cuts and the various patient-specific parameters to be used in modeling the semi-custom implant. The specified parameters can include, for example, three distances/lengths of the implant and six angles of the implant, each of which can be modified pre-operatively to be patient-specific such that they correspond to conform to the particular patient's anatomy. It will be appreciated that a lesser or greater number of parameters or different parameters can be use to customize and optimize the implant for the patient. The following exemplary parameters are illustrated in FIGS. 4A and 5A-C: medial condyle width 802, lateral condyle width 804, notch height 806, first, second and third medial angles 808, 810, 812; and first, second and third lateral angles 814, 816, 818.


In particular, and referring to FIGS. 5B and 5C, the medial condyle width 802 is defined as the distance between the central plane 800 and the farthest medial point/tangent line 902 (but not part of an osteophyte) on the posterior distal edge 950. The lateral condyle width 804 is defined as distance between the central plane 800 and the farthest lateral point/tangent 904 on the posterior distal edge 950 (but not part of an osteophyte). The notch height 806 defined as the distance along the central plane 800 from the posterior cut plane 514′ at edge 906 to the most anterior point/tangent line 907 on the notch (but not part of an osteophyte). The first medial angle 808 is defined as the angle between the central plane 800 and the line 908 connecting the medial-most points on the posterior distal edge 950 and the anterior distal edge 952. The second medial angle 810 is defined as the angle between the central plane 800 and the line 910 connecting the medial-most points on the anterior distal edge 952 and the distal anterior edge 954. The third medial angle 812 is defined as the angle between the central plane 800 and the line 912 connecting the medial-most points on the distal anterior edge 954 and the proximal anterior edge 956. The first lateral angle 814 is defined as the angle between the central plane 800 and the line 914 connecting the lateral-most points on the posterior distal edge 950 and the anterior distal edge 952. The second lateral angle 816 is defined as the angle between the central plane 800 and the line 916 connecting the lateral-most points on the anterior distal edge 952 and the distal anterior edge 954. The third lateral angle 818 defined as the angle between the central plane 800 and the line 918 connecting the lateral-most points on the distal anterior edge 954 and the proximal anterior edge 956.


Referring to FIG. 1A, when the above parameters 800, 802, 804, 806, 808, 810, 812, 814, 816, 818 are identified in the pre-operative planning stage, an image of a semi-custom implant customized with these parameters can be displayed at 135 for review and comparison with the image of the patient's anatomy. The values of the parameters 800, 802, 804, 806, 808, 810, 812, 814, 816, 818 can be adjusted, as desired, and the implant with the adjusted or finalized parameters can selected at 137 and forwarded to the surgeon for review at 140 together with the preoperative plan which includes surgeon's preferences of implants, guides and other instruments, as described above in connection with FIG. 1. The preoperative planning procedure can proceed as discussed above.


As discussed above, each semi-custom implant has an internal bone engagement geometry including five planes 511a, 513a, 517a, 512a and 514a corresponding to the resection planes and at least nine patient-specific parameters, including the three lengths and six angles described above.


It will be appreciated from the above discussion that generic casting can greatly reduce inventory, machining costs and investment in mold tooling, while at the same time accommodating sizes and geometric features specific to a patient. Specifically, each implant type can be formed from a generic casting that can accommodate multiple AP sizes corresponding to medial-lateral widths, such as four sizes, for example. For implants that are available in eight sizes, generic casting can reduce inventory by a half, using two molds total for eight sizes. Further, additional reductions in inventory can be obtained by combining right and left side implants into a single generic casting, as discussed above in relation to FIG. 4. Thus, generic castings reduce side-specific castings and also allow for various custom shapes and features.


The process can then be followed as illustrated in FIGS. 13A and 13B as discussed above in relation to FIG. 1. The blocks in FIGS. 13A and 13B that are illustrated with the same reference numerals as in FIG. 1, but augmented with a prime are not discussed in further detail, but are discussed above in FIG. 1 and include substantially similar processes. In addition to the various applications discussed above, input from a surgeon or other appropriate user can be provided with a handheld device, as discussed above. As illustrated in FIGS. 13A and B, a handheld device can be used by the surgeon to review the pre-operative plan at 140′. It will be understood, however, that the process for providing a selected implant and tools can be similar to that discussed above, for example, with reference to FIG. 1


With reference to FIG. 14, a schematic diagram illustrating main or exemplary hardware components for the process illustrated in FIG. 13A and 13B is illustrated. The pre-operative plan or preliminary pre-operative plan from block 130 and 130′ can be developed or produced by a service provider 700. The service provider 700 can own, operate, manage, or the like a main processor 702 and a main memory 704. The main processor and main memory 702, 704 can be at the service provider 700, in communication with the service provider 700, or otherwise controlled, maintained, or used by the service provider 700. Further, the main processor and main memory 702, 704 can be incorporated into a single server system. Regardless, the main processor 702 can process or execute a program, such as a program to develop the pre-operative plan, accept inputs from the surgeon, and augment or generate the final pre-operative plan. In addition, the main processor 702 can also be used to design and output the implant and alignment guide in blocks 150, 150′, and 160, 160′.


As discussed above, and further herein, the pre-operative plan can be delivered or accessed by the surgeon via notification or surgeon access in block 600′, 602′. The access or delivery of the pre-op plan can be via an internet or worldwide web connection 706 that uses a first communication method 708 from the service provider 700 and a second communication method 710 to a handheld device 712. It will be understood that the first and second communication method 708, 710 can be wired or wireless and can both be the same. Alternatively, or in addition to an internet connection a cell or mobile phone connection system 714, such as a tower, cell phone, antenna, can be provided. A first communication line 716 can transmit a communication through the mobile phone connection system 714. It will be understood that the service provider can communicate directly with the mobile phone connection system 714 via connection 716 or through an indirect connection 716′, such as an internet connection. A second communication line 718 can be used by a surgeon 720 with the handheld device 712. Again, it will be understood, that the first and second communication system 716, 716′, and 718 can be wired or wireless and can be the same or different. In addition, an intermediate system, such as a laptop or desktop computer 722 can be in communication with a system, such as the internet 706 via a first communication system 724 and the handheld device 712 can be interconnected with the computer 722 via a second communication system 726. Again, the first and second communication system 724, 726 can be the same or different and be wired or wireless.


With further reference to FIGS. 13A, 13B, and 14, the pre-operative plan from block 130′ can be delivered to a surgeon or accessed by a surgeon in any appropriate manner, such as via the internet 706 or cell communication 714. The pre-operative plan can be the preliminary pre-operative plan as discussed above. The pre-operative plan can include or be saved as a data file, in the main memory 704 associated with the main processor 702 of the service provider 700, of an appropriate type including image data, patient data, resection area data, etc. The pre-operative plan can be generated and stored by the service provider 700. The service provider 700 can be any appropriate service, such as an implant and/or guide manufacturer or specification producer. A specification producer can be a service that provides specifications for an implant or guide to a manufacturer for production.


The service provider 700 can notify the surgeon 720 or user that the preliminary pre-operative plan is ready for review in block 600′. The notification that the pre-operative plan is prepared can be performed in any appropriate manner. For example, an electronic mail notification can be sent to the surgeon 720, a text message can be sent to the surgeon 720, a telephone call can be made to the surgeon 720 via landline or a wireless connection, as illustrated in FIG. 14. Regardless, the surgeon can be notified that the pre-operative plan is ready for review in block 600 through the use of the mobile device 712.


Once the surgeon 720 is notified that the pre-operative plan is ready for review, the surgeon 720 can access the pre-operative plan in block 602′. The surgeon can access the pre-operative plan in one or a plurality of ways in block 140′. For example, the surgeon 720 can download the pre-operative plan to the handheld device in block 604′. Alternatively, or in addition thereto, the surgeon 720 can access the main processor/memory 702, 704 to review the pre-operative plan in the main memory 704 in block 606′ with the handheld device 712. It will be further understood that the surgeon 720 may also access the plan with the computer or terminal 722 by downloading the pre-operative plan data file to the computer 722 on which appropriate software is installed to access the pre operative plan. The surgeon 720 may also view a printout of the pre-operative plan for manipulating or commenting on the pre-operative plan, or any other appropriate manner.


If the surgeon 720 downloads the file to the handheld device 712, the file can be downloaded to the handheld device 712 using any appropriate transfer protocol or communication system, as illustrated in FIG. 14. For example, the handheld device 712 can be connected to the computer 722 through an appropriate communications cable or protocol 726, such as Bluetooth®, a wireless communication protocol or a Universal Serial Bus (USB) cable. Once the file is downloaded to the handheld device 712, a program on the handheld device 712 can execute or read the file and display images for the surgeon 720. The surgeon 720 can then review the plan in block 140′. For example, as illustrated in FIG. 7, a view of a bone to be resected can be displayed along with the slider bars 520 for allowing editing or augmentation of the pre-operative plan by the surgeon.


The view of the images, including the slider bars 520, can be augmented for the handheld device 712. For example, a cropped and zoomed image may only include a portion of the bone or region to be cut or resected for viewing by the surgeon. For example, as illustrated in FIG. 15, the handheld device 712 can include a view screen 740 that displays an image of the bone to be resected, but only includes a portion thereof, such as a lateral portion of a distal femur. The zoomed and cropped image can include fewer than all of the slide bars 520, such as only the slide bars 520c and 520d. The slide bars 520c and 520d can be illustrated and accessed by the surgeon to change data in the file for creation of appropriate instruments and implants for the specific patient or for augmentation of semi-custom or selection of an off-the-shelf instrument and implant.


The surgeon 720 can access or change the pre-operative plan file using the slide bars 520c and 520d through any appropriate access or manipulation process. For example, the screen 740 of the handheld device 712 can be a touch screen. Accordingly, the surgeon 720 can touch the screen with a finger or stylus to move the slider or marker portion 525 on the slider bars 520c and 520d. Alternatively, or in addition thereto, a trackball or other pointer device 742 can be provided to access and move the slider bars 520c and 520d. It will be understood that the handheld device 712 can have any appropriate input devices, such as an external or connected input devices, that can be mapped for appropriate command inputs into the system for augmenting the pre-operative plan file. The changes, if made by the surgeon, can then be saved to the pre-operative plan file to generate an edited pre-operative plan file.


If the surgeon 720, after review of the pre-operative plan in block 140′, finds the plan to be unacceptable in block 620′, the NO path 622′ can be followed for the surgeon 720 to edit the plan in block 624′. The surgeon 720 can edit the plan in block 624 in any appropriate manner, such as by moving the slider bars 520c and 520d, or any other appropriate slider bars. Alternatively, the surgeon 720 can edit the pre-operative plan in any appropriate manner, including those discussed above. Moreover, the surgeon 720 can input changes into the pre-operative plan using any appropriate input portion, such as touching the screen 740. It will be understood, that the pre-operative plan file that is downloaded to the handheld device 712 can then be saved with the edits as the edited pre-operative plan and transmitted to the service provider 700 for appropriate edits to be re-reviewed or finalized, as discussed above. It will be understood, however, that the handheld device 712, which can include the appropriate program, can save the file in the appropriate format and transmit it back to the service provider 700.


Alternatively, or in addition to downloading the pre-operative plan file, the handheld device 712 can access the pre-operative plan which is stored in the main storage 704 associated with the service provider in block 606 and separate from the handheld device 712. If the handheld device 712 accesses the pre-operative plan on the main processor, memory 702, 704, the handheld device 712 need only display an image representing a portion of the file on the display screen 740. That is, the pre-operative plan and any edits or processing made to the pre-operative plan can be done solely or substantially by the main processor 702 that executes a program to manipulate and display the file. The main processor 702 and the main memory 704 need not be physically near or connected to the handheld device 712.


The handheld device 712 can be provided to display the image, such as an image of the bone for resection, for the surgeon 720. Therefore, the handheld device 712 may not be required to process the pre-operative plan file from the service provider 700, but only be provided to display the pre-operative plan file and receive and transmit input from the surgeon 720. Accordingly, even if the pre-operative plan is accessed from the service provider in block 606, the slide bars 520c and 520d can be displayed on the display 742 of the handheld device 712 for input by the surgeon 720. The inputs, however, can be directly transmitted to the main processor 702 for processing augmentation or editing of the file. This is in addition or alternative to augmenting or editing the file that has been downloaded to the handheld device 712 for re-transmission of the edited pre-operative plan to the service provider 700.


By only or substantially accessing the pre-operative plan file from the main processor/memory 702, 704 data transmission can be minimized from the main memory 704 or provider 700 to the handheld device 712 of the surgeon 720. Decreased data transmission can provide increased speed and decreased data usage costs or bottlenecks in a system. In addition, the handheld device 712 can be provided or include limited memory and processing capabilities when the pre-operative plan file is only accessed with the handheld 712 and only small amounts of information are transferred, for example, regarding slide bar location and smaller portions of an image file. Accordingly, it can be provided, that a complete or pre-operative plan is transmitted to the handheld device 712, processed completely on the handheld device 712, edited on the handheld device 712, saved and re-transmitted back to the service provider 700 or the handheld device 712 can only access the pre-operative plan file saved at the main memory 702 and transmit edits to the server.


Data transmission and processing can also be reduced by limiting or cropping the pre-operative plan data file. For example, as illustrated in FIG. 15, only a lateral and distal portion of the bone is illustrated on the display device or display screen 740 of the handheld device 712. It will be understood that an image file or image information can include the entire bone or other data saved in the image file. Accordingly, the image file can be cropped at the server or at the provider and only a portion of the image file transmitted to the handheld device 712. This can be done repeatedly for different portions of the image data to allow for smaller file packet size or file size for transmission to the handheld device 712. The cropping and compression of the data file can be done in substantially real-time by the server for a substantially seamless viewing and manipulation by the surgeon.


Even if the surgeon 720 accesses the data file on the main memory 704, the surgeon 720 can review the pre-operative plan block 140′, as discussed above, and make a determination of whether the pre-operative plan is acceptable in block 620′. As discussed above, if the pre-operative plan is not acceptable, the NO path 622′ can be followed to allow for surgeon edits in block 624′.


Further, regardless of the method of review of the pre-operative plan in block 140′, the pre-operative plan can be determined to be acceptable in block 620′ and follow the YES path 626′. When following the YES path 626′, the implant can be designed and an alignment guide can be designed in blocks 150′ and 160′.


The foregoing discussion discloses and describes merely exemplary arrangements of the present teachings. Furthermore, the mixing and matching of features, elements and/or functions between various embodiments is expressly contemplated herein, so that one of ordinary skill in the art would appreciate from this disclosure that features, elements and/or functions of one embodiment may be incorporated into another embodiment as appropriate, unless described otherwise above. Moreover, many modifications may be made to adapt a particular situation or material to the teachings of the invention without departing from the essential scope thereof. One skilled in the art will readily recognize from such discussion, and from the accompanying drawings and claims, that various changes, modifications and variations can be made therein without departing from the spirit and scope of the present teachings as defined in the following claims.

Claims
  • 1. An orthopedic device comprising: a femoral implant having a central plane and an internal bone engagement surface that includes an anterior planar surface, an anterior chamfer surface, a distal planar surface, a posterior chamfer surface, and a posterior planar surface, wherein the internal bone engagement surface is standardized so as to be independent of an anatomy of a specific patient's joint and is one of a series of predetermined size increments for the femoral implant, each of the series of predetermined size increments varying by a set distance from others, the femoral implant further including a medial condyle width, a lateral condyle width, a notch height located between the medial and lateral condyles and three medial angles and three lateral angles, each of the medial condyle width, the lateral condyle width, the notch height, the three medial angles and the three lateral angles are configured to be patient-specific based on an image of the specific patient's joint, wherein the medial condyle width, the lateral condyle width, the notch height, the three medial angles and the three lateral angles are designed using computer modeling to have a shape dependent upon an anatomy of the specific patient, and wherein one of the three medial angles is defined by: an angle between the central plane and a line connecting medial-most points on an anterior edge of the distal planar surface and on a posterior edge of the distal planar surface,an angle between the central plane and a line connecting medial-most points on a distal edge of the anterior chamfer surface and the anterior edge of the distal planar surface, oran angle between the central plane and a line connecting medial-most points on the distal edge of the anterior chamfer surface and a proximal edge of the anterior planar surface.
  • 2. The orthopedic device of claim 1, further comprising a surgical kit including the femoral implant and a patient-specific alignment guide.
  • 3. The orthopedic device of claim 2, wherein the surgical kit includes reusable instruments.
  • 4. The orthopedic device of claim 2, wherein the surgical kit includes a drill guide and a cutting block.
  • 5. The orthopedic device of claim 2, wherein the surgical kit includes a tracking tag.
  • 6. The orthopedic device of claim 2, wherein the patient-specific alignment guide includes a removable tracking tag.
  • 7. An orthopedic device comprising: a femoral implant having a central plane and an internal engagement surface that includes an anterior planar surface, an anterior chamfer surface, a distal planar surface, a posterior chamfer surface, and a posterior planar surface, wherein the internal bone engagement surface is standardized so as to be independent of an anatomy of a specific patient's joint and is one of a series of predetermined size increments for the femoral implant, each of the series of predetermined size increments varying by a set distance from others, the femoral implant further including three patient-specific lengths including a medial condyle width, a lateral condyle width, and a notch height located between the medial and lateral condyles, three patient specific medial angles and three patient-specific lateral angles, wherein each of the medial condyle width, the lateral condyle width, the notch height, the three medial angles and the three lateral angles are configured to be patient-specific based on an image of the specific patient's joint, wherein the medial condyle width, the lateral condyle width, the notch height, the three medial angles and the three lateral angles are designed using computer modeling to have a shape dependent upon an anatomy of the specific patient, and wherein one of the three lateral angles is defined by: an angle between the central plane and a line connecting lateral-most points on the anterior edge of the distal planar surface and on the posterior edge of the distal planar surface,an angle between the central plane and a line connecting lateral-most points on the distal edge of the anterior chamfer surface and the anterior edge of the distal planar surface, oran angle between the central plane and a line connecting lateral-most points on the distal edge of the anterior chamfer surface and the proximal edge of the anterior planar surface.
  • 8. The orthopedic device of claim 7, further comprising a surgical kit including the femoral implant and a patient-specific alignment guide including a removable tracking tag.
  • 9. The orthopedic device of claim 7, further comprising a disposable instrument kit including only disposable instruments.
  • 10. The orthopedic device of claim 9, wherein the instrument kit includes disposable patient-specific alignment guides.
  • 11. An orthopedic device, comprising: a semi-custom femoral implant having a central plane, and including a bone engagement surface that is standardized so as to be independent of an anatomy of a specific patient's joint and is one of a series of predetermined size increments for the femoral implant, each of the series of predetermined size increments varying by a set distance from others and an articulating surface,wherein the non-patient-specific bone engagement surface includes an anterior planar surface, an anterior chamfer surface, a distal planar surface, a posterior chamfer surface, and a posterior planar surface;the articulating surface includes a medial condyle and a lateral condyle separated by a notch, the notch being located along the central plane; andthe articulating surface includes plurality of patient-specific features configured to be patient-specific based on an image of the specific patient's joint and designed using computer modeling to have a shape dependent upon an anatomy of the specific patient including:a medial condyle width;a lateral condyle width;a notch height defined by a distance between the posterior planar surface and the most anterior point of the notch;a first medial angle defined by an angle between the central plane and a line connecting medial-most points on an anterior edge of the distal planar surface and on a posterior edge of the distal planar surface;a second medial angle defined by an angle between the central plane and a line connecting medial-most points on a distal edge of the anterior chamfer surface and the anterior edge of the distal planar surface;a third medial angle defined by an angle between the central plane and a line connecting medial-most points on the distal edge of the anterior chamfer surface and a proximal edge of the anterior planar surface;a first lateral angle defined by an angle between the central plane and a line connecting lateral-most points on the anterior edge of the distal planar surface and on the posterior edge of the distal planar surface;a second lateral angle defined by an angle between the central plane and a line connecting lateral-most points on the distal edge of the anterior chamfer surface and the anterior edge of the distal planar surface;a third lateral angle defined by an angle between the central plane and a line connecting lateral-most points on the distal edge of the anterior chamfer surface and the proximal edge of the anterior planar surface.
  • 12. The orthopedic device of claim 11, further comprising a surgical kit including the femoral implant and a patient-specific alignment guide.
  • 13. The orthopedic device of claim 12, wherein the surgical kit includes reusable instruments.
  • 14. The orthopedic device of claim 12, wherein the surgical kit includes a drill guide and a cutting block.
  • 15. The orthopedic device of claim 12, wherein the surgical kit includes a tracking tag.
  • 16. The orthopedic device of claim 12, wherein the patient-specific alignment guide includes a removable tracking tag.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 13/766,419 filed on Feb. 13, 2013, which is a divisional of U.S. application Ser. No. 12/872,663 filed on Aug. 31, 2012, now U.S. Pat. No. 8,407,067 issued on Mar. 26, 2013, which claims the benefit of U.S. Provisional Application No. 61/310,752 filed on Mar. 5, 2010. The disclosures of all the above applications are incorporated herein by reference.

US Referenced Citations (1602)
Number Name Date Kind
1480285 Moore Jan 1924 A
1763730 Lackum Jun 1930 A
1959615 Derrah May 1934 A
2181746 Siebrandt Nov 1939 A
2407845 Nemeyer Sep 1946 A
2416228 Sheppard Feb 1947 A
2433815 Nicephore Dec 1947 A
2455655 Carroll Dec 1948 A
2618913 Plancon et al. Nov 1952 A
2702550 Rowe Feb 1955 A
2724326 Long Nov 1955 A
2910978 Urist Nov 1959 A
2955530 Nilo Oct 1960 A
3048522 Valley Aug 1962 A
3229006 Egon Jan 1966 A
3229372 Quashnock et al. Jan 1966 A
3330611 Heifetz Jul 1967 A
3514791 Sparks Jun 1970 A
3554197 Dobbie Jan 1971 A
3624747 McKnight et al. Nov 1971 A
3631596 Glaus Jan 1972 A
3678934 Warfield et al. Jul 1972 A
3698017 Scales et al. Oct 1972 A
3703036 Karubian Nov 1972 A
3774244 Walker Nov 1973 A
3783873 Jacobs Jan 1974 A
3807393 McDonald Apr 1974 A
3811449 Gravlee et al. May 1974 A
3840904 Tronzo Oct 1974 A
3869731 Waugh et al. Mar 1975 A
3903549 Deyerle Sep 1975 A
3905105 Tuke Sep 1975 A
3905374 Winter Sep 1975 A
3911923 Yoon Oct 1975 A
3913585 Wolvek Oct 1975 A
3920022 Pastor Nov 1975 A
3941127 Froning Mar 1976 A
3967625 Yoon et al. Jul 1976 A
3975858 Much Aug 1976 A
3989049 Yoon Nov 1976 A
3991426 Flom et al. Nov 1976 A
3994287 Turp et al. Nov 1976 A
4053953 Flom et al. Oct 1977 A
4055862 Farling Nov 1977 A
4081866 Upshaw et al. Apr 1978 A
4085466 Goodfellow et al. Apr 1978 A
4085743 Yoon Apr 1978 A
4103680 Yoon Aug 1978 A
4246895 Rehder Jan 1981 A
4299224 Noiles Nov 1981 A
4304178 Haberle Dec 1981 A
4306866 Weissman Dec 1981 A
4311145 Esty et al. Jan 1982 A
4324006 Charnley Apr 1982 A
4344193 Kenny Aug 1982 A
4349018 Chamber Sep 1982 A
4373709 Whitt et al. Feb 1983 A
4374523 Yoon Feb 1983 A
4385404 Sully et al. May 1983 A
4386609 Mongeon Jun 1983 A
4400833 Kurland Aug 1983 A
4421112 Mains et al. Dec 1983 A
4428571 Sugarman Jan 1984 A
4436684 White Mar 1984 A
D273895 Kenna et al. May 1984 S
D274091 Kenna May 1984 S
4453421 Umano Jun 1984 A
4457306 Borzone Jul 1984 A
4475549 Oh Oct 1984 A
4501269 Bagby Feb 1985 A
4506393 Murphy Mar 1985 A
4509518 Mcgarry et al. Apr 1985 A
4516276 Mittelmeier May 1985 A
4524766 Petersen Jun 1985 A
4528980 Kenna Jul 1985 A
4534365 Bonetta et al. Aug 1985 A
4535773 Yoon Aug 1985 A
4545375 Cline Oct 1985 A
4554686 Baker Nov 1985 A
4562598 Kranz Jan 1986 A
4565191 Slocum Jan 1986 A
4565192 Shapiro Jan 1986 A
4567886 Petersen Feb 1986 A
4574794 Cooke et al. Mar 1986 A
4619391 Sharkany et al. Oct 1986 A
4619658 Pappas et al. Oct 1986 A
4621630 Kenna Nov 1986 A
4624254 Mcgarry et al. Nov 1986 A
4632111 Roche Dec 1986 A
4633862 Petersen Jan 1987 A
4641648 Shapiro Feb 1987 A
4642120 Nevo et al. Feb 1987 A
4646729 Kenna et al. Mar 1987 A
4662372 Sharkany et al. May 1987 A
4663720 Duret et al. May 1987 A
4678470 Nashef et al. Jul 1987 A
4682598 Beraha Jul 1987 A
4685460 Thornton Aug 1987 A
4689984 Kellner Sep 1987 A
4695283 Aldinger Sep 1987 A
4696292 Heiple Sep 1987 A
4703751 Pohl Nov 1987 A
4704686 Aldinger Nov 1987 A
4706660 Petersen Nov 1987 A
4711233 Brown Dec 1987 A
4715860 Amstutz et al. Dec 1987 A
4718413 Johnson Jan 1988 A
4718916 Morscher Jan 1988 A
4719907 Banko et al. Jan 1988 A
4721104 Kaufman et al. Jan 1988 A
4722330 Russell et al. Feb 1988 A
4739751 Sapega et al. Apr 1988 A
4759350 Dunn et al. Jul 1988 A
4778474 Homsy Oct 1988 A
4794854 Swaim Jan 1989 A
4800874 David et al. Jan 1989 A
4817602 Beraha Apr 1989 A
4821213 Cline et al. Apr 1989 A
4822365 Walker et al. Apr 1989 A
4834757 Brantigan May 1989 A
4838891 Branemark et al. Jun 1989 A
4841975 Woolson Jun 1989 A
4846161 Roger Jul 1989 A
4863472 Tormala et al. Sep 1989 A
4871975 Nawata et al. Oct 1989 A
4888022 Huebsch Dec 1989 A
4892545 Day et al. Jan 1990 A
4893619 Dale et al. Jan 1990 A
4896663 Vandewalls Jan 1990 A
4907577 Wu Mar 1990 A
4911721 Andergaten Mar 1990 A
4927422 Engelhardt May 1990 A
4935023 Whiteside et al. Jun 1990 A
4936852 Kent et al. Jun 1990 A
4936862 Walker et al. Jun 1990 A
4950296 McIntyre Aug 1990 A
4952213 Bowman et al. Aug 1990 A
4959066 Dunn et al. Sep 1990 A
4961740 Ray et al. Oct 1990 A
4961954 Goldberg et al. Oct 1990 A
4964865 Burkhead et al. Oct 1990 A
4976737 Leake Dec 1990 A
4979949 Matsen, III et al. Dec 1990 A
4979957 hodorek Dec 1990 A
4985037 Petersen Jan 1991 A
4985038 Lyell Jan 1991 A
4994064 Aboczky Feb 1991 A
5002579 Copf et al. Mar 1991 A
5006121 Hafeli Apr 1991 A
5007912 Albrektsson et al. Apr 1991 A
5007936 Woolson Apr 1991 A
5015247 Michelson May 1991 A
5019105 Wiley May 1991 A
5030219 Matsen, III et al. Jul 1991 A
5030221 Buechel et al. Jul 1991 A
5032132 Matsen, III et al. Jul 1991 A
5035700 Kenna Jul 1991 A
5037424 Aboczsky Aug 1991 A
5041117 Engelhardt Aug 1991 A
5053037 Lackey Oct 1991 A
5053039 Hofmann et al. Oct 1991 A
5056351 Stiver et al. Oct 1991 A
5060678 Bauman et al. Oct 1991 A
5061270 Aboczky Oct 1991 A
5061286 Lyle Oct 1991 A
5062843 Mahony, III Nov 1991 A
5073373 O'Leary et al. Dec 1991 A
5082670 Gage et al. Jan 1992 A
5084050 Draenert Jan 1992 A
5086401 Glassman et al. Feb 1992 A
5092869 Waldron Mar 1992 A
5098383 Hemmy et al. Mar 1992 A
5098436 Ferrante et al. Mar 1992 A
5098437 Kashuba et al. Mar 1992 A
5099859 Bell Mar 1992 A
5100689 Goldberg et al. Mar 1992 A
5101720 Bianchi Apr 1992 A
5108425 Hwang Apr 1992 A
5108441 Mcdowell Apr 1992 A
5111987 Moeinzadeh et al. May 1992 A
5122144 Bert et al. Jun 1992 A
5123906 Kelman Jun 1992 A
5123927 Duncan et al. Jun 1992 A
5129908 Petersen Jul 1992 A
5129909 Sutherland Jul 1992 A
5133760 Petersen et al. Jul 1992 A
5140777 Ushiyama et al. Aug 1992 A
5141512 Farmer et al. Aug 1992 A
5147365 Whitlock et al. Sep 1992 A
5150304 Berchem et al. Sep 1992 A
5152744 Krause et al. Oct 1992 A
5152778 Bales, Jr. et al. Oct 1992 A
5154717 Matsen, III et al. Oct 1992 A
5162506 Hadden Nov 1992 A
5163949 Bonutti Nov 1992 A
5170800 Smith et al. Dec 1992 A
5171243 Kashuba et al. Dec 1992 A
5171244 Caspari et al. Dec 1992 A
5171276 Caspari et al. Dec 1992 A
5174300 Bales et al. Dec 1992 A
5176684 Ferrante et al. Jan 1993 A
5176702 Bales et al. Jan 1993 A
5176711 Grimes Jan 1993 A
5178622 Lehner, II Jan 1993 A
5183053 Yeh Feb 1993 A
5183464 Dubrul et al. Feb 1993 A
5186178 Yeh Feb 1993 A
5192327 Brantigan Mar 1993 A
5194066 Van Zile Mar 1993 A
5197968 Clement Mar 1993 A
5197971 Bonutti Mar 1993 A
5197987 Koch et al. Mar 1993 A
5204106 Schepers et al. Apr 1993 A
5207680 Dietz et al. May 1993 A
5207692 Kraus et al. May 1993 A
5217463 Mikhail Jun 1993 A
5222984 Forte Jun 1993 A
5228459 Caspari et al. Jul 1993 A
5234433 Bert et al. Aug 1993 A
5242448 Pettine et al. Sep 1993 A
5246444 Schreiber Sep 1993 A
5253506 Davis et al. Oct 1993 A
5258004 Bales et al. Nov 1993 A
5258032 Bertin Nov 1993 A
5261915 Durlacher et al. Nov 1993 A
5263498 Caspari et al. Nov 1993 A
5263987 Shah Nov 1993 A
5269785 Bonutti Dec 1993 A
5273524 Fox et al. Dec 1993 A
5274565 Reuben Dec 1993 A
D343247 Walen Jan 1994 S
5275166 Vaitekunas et al. Jan 1994 A
5275603 Ferrante et al. Jan 1994 A
5282802 Mahony, III Feb 1994 A
5282803 Lackey Feb 1994 A
5285773 Bonutti et al. Feb 1994 A
5293878 Bales et al. Mar 1994 A
5295994 Bonutti Mar 1994 A
5299288 Glassman et al. Mar 1994 A
5300077 Howell Apr 1994 A
5304181 Caspari et al. Apr 1994 A
5306285 Miller et al. Apr 1994 A
5308349 Mikhail May 1994 A
5314482 Goodfellow et al. May 1994 A
5320529 Pompa Jun 1994 A
5320625 Bertin Jun 1994 A
5322505 Krause et al. Jun 1994 A
5323697 Schrock Jun 1994 A
5329845 Bichel Jul 1994 A
5342366 Whiteside et al. Aug 1994 A
5342367 Ferrante et al. Aug 1994 A
5342368 Petersen Aug 1994 A
5344423 Dietz et al. Sep 1994 A
5344458 Bonutti Sep 1994 A
5348541 Bonutti Sep 1994 A
5360446 Kennedy Nov 1994 A
5364402 Mumme et al. Nov 1994 A
5368599 Hirsch et al. Nov 1994 A
5368858 Hunziker Nov 1994 A
5370692 Fink et al. Dec 1994 A
5370699 Hood et al. Dec 1994 A
5379133 Kirk Jan 1995 A
5382249 Fletcher et al. Jan 1995 A
5383937 Mikhail Jan 1995 A
5390683 Pisharodi Feb 1995 A
5395376 Caspari et al. Mar 1995 A
5405395 Coates Apr 1995 A
5408409 Glassman et al. Apr 1995 A
D358647 Cohen et al. May 1995 S
5411521 Putnam et al. May 1995 A
5415662 Ferrante et al. May 1995 A
5417694 Marik et al. May 1995 A
5423827 Mumme et al. Jun 1995 A
5425355 Kulick Jun 1995 A
5425745 Green et al. Jun 1995 A
5438263 Dworkin et al. Aug 1995 A
5440496 Andersson et al. Aug 1995 A
5443475 Auerbach et al. Aug 1995 A
5445639 Kuslich et al. Aug 1995 A
5445642 McNulty et al. Aug 1995 A
5448489 Reuben Sep 1995 A
5449360 Schreiber Sep 1995 A
5452407 Crook Sep 1995 A
5454365 Bonutti Oct 1995 A
5454815 Geisser et al. Oct 1995 A
5454816 Ashby Oct 1995 A
5456268 Bonutti Oct 1995 A
5462550 Dietz et al. Oct 1995 A
5472415 King et al. Dec 1995 A
5474559 Bertin et al. Dec 1995 A
5484095 Green et al. Jan 1996 A
5486178 Hodge Jan 1996 A
5490854 Fisher et al. Feb 1996 A
5496324 Barnes Mar 1996 A
5497933 Defonzo et al. Mar 1996 A
5507763 Petersen et al. Apr 1996 A
5507833 Bohn Apr 1996 A
5514139 Goldstein et al. May 1996 A
5514143 Bonutti et al. May 1996 A
5514519 Neckers May 1996 A
5520692 Ferrante May 1996 A
5520694 Dance et al. May 1996 A
5520695 Luckman May 1996 A
5522897 King et al. Jun 1996 A
5527317 Ashby et al. Jun 1996 A
5539649 Walsh et al. Jul 1996 A
5540695 Levy Jul 1996 A
5545222 Bonutti Aug 1996 A
5546720 Labruzza Aug 1996 A
5549683 Bonutti Aug 1996 A
5549688 Ries Aug 1996 A
5554169 Green et al. Sep 1996 A
5554190 Draenert Sep 1996 A
5560096 Stephens Oct 1996 A
5560728 Mcfadden Oct 1996 A
5562675 Mcnulty et al. Oct 1996 A
5569163 Francis et al. Oct 1996 A
5569261 Marik et al. Oct 1996 A
5570700 Vogeler Nov 1996 A
5571110 Matsen, III et al. Nov 1996 A
5571111 Aboczky Nov 1996 A
5578037 Sanders et al. Nov 1996 A
5578039 Vendrely et al. Nov 1996 A
5586558 Riley Dec 1996 A
5593411 Stalcup et al. Jan 1997 A
5593448 Dong Jan 1997 A
5595703 Swaelens et al. Jan 1997 A
5597379 Haines et al. Jan 1997 A
5601565 Huebner Feb 1997 A
5607431 Dudasik et al. Mar 1997 A
5608052 Zmitek et al. Mar 1997 A
5609603 Linden Mar 1997 A
5611802 Samuelson et al. Mar 1997 A
5613969 Jenkins, Jr. Mar 1997 A
5616147 Gadelius Apr 1997 A
5620448 Puddu Apr 1997 A
5624444 Wixon et al. Apr 1997 A
5624463 Stone et al. Apr 1997 A
5632745 Schwartz May 1997 A
5634927 Houston et al. Jun 1997 A
5641323 Caldarise Jun 1997 A
5643272 Haines et al. Jul 1997 A
5649946 Bramlet Jul 1997 A
5649947 Auerbach et al. Jul 1997 A
5653714 Dietz et al. Aug 1997 A
5658294 Sederholm Aug 1997 A
5659947 Eilers et al. Aug 1997 A
5662656 White Sep 1997 A
5662710 Bonutti Sep 1997 A
5667069 Williams, Jr. Sep 1997 A
5667511 Vendrely et al. Sep 1997 A
5667512 Johnson Sep 1997 A
5667520 Bonutti Sep 1997 A
5671018 Ohara et al. Sep 1997 A
D385163 Hutchins et al. Oct 1997 S
5676668 McCue et al. Oct 1997 A
5677107 Neckers Oct 1997 A
5681316 DeOrio et al. Oct 1997 A
5681354 Eckhoff Oct 1997 A
5682886 Delp et al. Nov 1997 A
5683398 Carls et al. Nov 1997 A
5683469 Johnson et al. Nov 1997 A
5688279 McNulty et al. Nov 1997 A
5688280 Booth, Jr. et al. Nov 1997 A
5690635 Matsen, III et al. Nov 1997 A
5694693 Hutchins et al. Dec 1997 A
5697933 Gundlapalli et al. Dec 1997 A
5702447 Walch et al. Dec 1997 A
5702460 Carls et al. Dec 1997 A
5702464 Lackey et al. Dec 1997 A
5702475 Zahedi Dec 1997 A
5704941 Jacober et al. Jan 1998 A
5707350 Krause et al. Jan 1998 A
5709689 Ferrante et al. Jan 1998 A
5712543 Sjostrom Jan 1998 A
5716360 Baldwin et al. Feb 1998 A
5718708 Webb Feb 1998 A
5720752 Elliott et al. Feb 1998 A
5722978 Jenkins, Jr. Mar 1998 A
5723331 Tubo et al. Mar 1998 A
5725376 Poirier Mar 1998 A
5725593 Caracciolo Mar 1998 A
5728128 Crickenberger et al. Mar 1998 A
5733292 Gustilo et al. Mar 1998 A
5735277 Schuster Apr 1998 A
5745834 Bampton et al. Apr 1998 A
5748767 Raab May 1998 A
5749875 Puddu May 1998 A
5749876 Duvillier et al. May 1998 A
5755731 Grinberg May 1998 A
5755791 Whitson et al. May 1998 A
5755803 Haines et al. May 1998 A
5762125 Mastrorio Jun 1998 A
5766251 Koshino et al. Jun 1998 A
5768134 Swaelens et al. Jun 1998 A
5769092 Williamson, Jr. Jun 1998 A
5769855 Bertin et al. Jun 1998 A
5769899 Schwartz et al. Jun 1998 A
5772594 Barrick Jun 1998 A
5776200 Johnson Jul 1998 A
5786217 Tubo et al. Jul 1998 A
5788700 Morawa et al. Aug 1998 A
5792143 Samuelson et al. Aug 1998 A
5798924 Eufinger et al. Aug 1998 A
5799055 Peshkin et al. Aug 1998 A
5810827 Haines et al. Sep 1998 A
5810831 D'Antonio Sep 1998 A
5817097 Howard et al. Oct 1998 A
5817109 Mcgarry et al. Oct 1998 A
5824083 Draenert Oct 1998 A
5835619 Morimoto et al. Nov 1998 A
5842477 Naughton et al. Dec 1998 A
5846931 Hattersley et al. Dec 1998 A
5860980 Axelson, Jr. et al. Jan 1999 A
5860981 Bertin et al. Jan 1999 A
5866415 Villeneuve Feb 1999 A
5871018 Delp et al. Feb 1999 A
5871493 Sjostrom et al. Feb 1999 A
5876456 Sederholm et al. Mar 1999 A
5879354 Haines et al. Mar 1999 A
5879398 Swarts et al. Mar 1999 A
5879402 Lawes et al. Mar 1999 A
5879404 Bateman et al. Mar 1999 A
5880976 DiGioia, III et al. Mar 1999 A
5885297 Matsen, III Mar 1999 A
5885298 Herrington et al. Mar 1999 A
5888219 Bonutti Mar 1999 A
5895389 Schenk et al. Apr 1999 A
5899907 Johnson May 1999 A
5899914 Zirps et al. May 1999 A
5901060 Schall et al. May 1999 A
5908424 Bertin et al. Jun 1999 A
5911723 Ashby et al. Jun 1999 A
5911724 Wehrli Jun 1999 A
5913874 Berns et al. Jun 1999 A
5916219 Matsuno et al. Jun 1999 A
5921988 Legrand Jul 1999 A
5921990 Webb Jul 1999 A
5925049 Gustilo et al. Jul 1999 A
5925077 Williamson et al. Jul 1999 A
5942370 Neckers Aug 1999 A
5961499 Bonutti et al. Oct 1999 A
5967777 Klein et al. Oct 1999 A
5976149 Masini Nov 1999 A
5980526 Johnson et al. Nov 1999 A
5997566 Tobin Dec 1999 A
6007537 Burkinshaw et al. Dec 1999 A
6008433 Stone Dec 1999 A
6012456 Schuerch Jan 2000 A
6013081 Burkinshaw et al. Jan 2000 A
6015419 Strome et al. Jan 2000 A
6019767 Howell Feb 2000 A
6022350 Ganem Feb 2000 A
6024746 Katz Feb 2000 A
6033415 Mittelstadt et al. Mar 2000 A
6042612 Voydeville Mar 2000 A
6056754 Haines et al. May 2000 A
6056756 Eng et al. May 2000 A
6059789 Dinger et al. May 2000 A
6059817 Bonutti et al. May 2000 A
6059831 Braslow et al. May 2000 A
6059833 Doets May 2000 A
6063095 Wang et al. May 2000 A
6066175 Henderson et al. May 2000 A
6077270 Katz Jun 2000 A
6077287 Taylor et al. Jun 2000 A
6086593 Bonutti Jul 2000 A
6090122 Sjostrom et al. Jul 2000 A
6096043 Techiera et al. Aug 2000 A
6099531 Bonutti Aug 2000 A
6099532 Florea Aug 2000 A
6102850 Wang et al. Aug 2000 A
6106529 Techiera Aug 2000 A
6118845 Simon et al. Sep 2000 A
6120509 Wheeler Sep 2000 A
6120510 Albrektsson et al. Sep 2000 A
6120544 Grundei et al. Sep 2000 A
6126690 Ateshian et al. Oct 2000 A
6126692 Robie et al. Oct 2000 A
6132469 Schroeder Oct 2000 A
6132472 Bonutti Oct 2000 A
6136033 Suemer Oct 2000 A
6156069 Amstutz Dec 2000 A
6156070 Incavo et al. Dec 2000 A
6159217 Robie et al. Dec 2000 A
6159246 Mendes et al. Dec 2000 A
6161080 Aouni-Ateshian et al. Dec 2000 A
6162257 Gustilo et al. Dec 2000 A
6165223 Metzger et al. Dec 2000 A
6171340 Mcdowell et al. Jan 2001 B1
6174321 Webb Jan 2001 B1
6185315 Schmucker et al. Feb 2001 B1
6187010 Masini Feb 2001 B1
6187023 Bonutti Feb 2001 B1
6195158 Cadell et al. Feb 2001 B1
6195615 Lysen Feb 2001 B1
6197064 Haines et al. Mar 2001 B1
6198794 Peshkin et al. Mar 2001 B1
6203546 MacMahon Mar 2001 B1
6205411 DiGioia, III et al. Mar 2001 B1
6206927 Fell et al. Mar 2001 B1
6210445 Zawadzki Apr 2001 B1
6211976 Popovich et al. Apr 2001 B1
6214051 Badorf et al. Apr 2001 B1
6228121 Khalili May 2001 B1
6238435 Meulink et al. May 2001 B1
6254604 Howell Jul 2001 B1
6258097 Cook et al. Jul 2001 B1
6258127 Schmotzer Jul 2001 B1
6264698 Lawes et al. Jul 2001 B1
6270529 Terrill-Grisoni et al. Aug 2001 B1
6273891 Masini Aug 2001 B1
6277136 Bonutti et al. Aug 2001 B1
6290703 Ganem Sep 2001 B1
6290704 Burkinshaw et al. Sep 2001 B1
6290727 Otto et al. Sep 2001 B1
6293971 Nelson et al. Sep 2001 B1
6301495 Gueziec et al. Oct 2001 B1
6302913 Ripamonti et al. Oct 2001 B1
6310269 Friese et al. Oct 2001 B1
6312258 Ashman Nov 2001 B1
6312473 Oshida Nov 2001 B1
6319285 Chamier et al. Nov 2001 B1
6322728 Brodkin et al. Nov 2001 B1
6325806 Fox Dec 2001 B1
6325829 Schmotzer Dec 2001 B1
6327491 Franklin et al. Dec 2001 B1
6328572 Higashida et al. Dec 2001 B1
6338737 Toledano Jan 2002 B1
6338738 Bellotti et al. Jan 2002 B1
6343987 Hayama et al. Feb 2002 B2
6354011 Albrecht Mar 2002 B1
6358266 Bonutti Mar 2002 B1
6361506 Saenger et al. Mar 2002 B1
6361563 Terrill-Grisoni et al. Mar 2002 B2
6361565 Bonutti Mar 2002 B1
6379299 Borodulin et al. Apr 2002 B1
6379388 Ensign et al. Apr 2002 B1
6383228 Schmotzer May 2002 B1
6391040 Christoudias May 2002 B1
6391251 Keicher et al. May 2002 B1
6395005 Lovell May 2002 B1
6406495 Schoch Jun 2002 B1
6409722 Hoey et al. Jun 2002 B1
6413279 Metzger et al. Jul 2002 B1
6416553 White et al. Jul 2002 B1
6423063 Bonutti Jul 2002 B1
6423068 Reisberg et al. Jul 2002 B1
6424332 Powell Jul 2002 B1
6427698 Yoon Aug 2002 B1
6428541 Boyd et al. Aug 2002 B1
6431743 Mizutani et al. Aug 2002 B1
D462767 Meyer et al. Sep 2002 S
6458135 Harwin et al. Oct 2002 B1
6459948 Ateshian et al. Oct 2002 B1
6463351 Clynch Oct 2002 B1
6468280 Saenger et al. Oct 2002 B1
6468289 Bonutti Oct 2002 B1
6475243 Sheldon et al. Nov 2002 B1
6478799 Williamson Nov 2002 B1
6482209 Engh et al. Nov 2002 B1
6482236 Habecker Nov 2002 B2
6488715 Pope et al. Dec 2002 B1
6500181 Portney Dec 2002 B1
6503255 Albrektsson et al. Jan 2003 B1
6503267 Bonutti et al. Jan 2003 B2
6508980 Sachs et al. Jan 2003 B1
6510334 Schuster et al. Jan 2003 B1
6514259 Picard et al. Feb 2003 B2
6517583 Pope et al. Feb 2003 B1
6519998 Ertl et al. Feb 2003 B2
6520964 Tallarida et al. Feb 2003 B2
6533737 Brosseau et al. Mar 2003 B1
6547823 Scarborough et al. Apr 2003 B2
6551325 Neubauer et al. Apr 2003 B2
6554837 Hauri et al. Apr 2003 B1
6554838 McGovern et al. Apr 2003 B2
6556008 Thesen Apr 2003 B2
6558391 Axelson, Jr. et al. May 2003 B2
6558428 Park May 2003 B2
6562073 Foley May 2003 B2
6564085 Meaney et al. May 2003 B2
6567681 Lindequist May 2003 B1
6575980 Robie et al. Jun 2003 B1
6575982 Bonutti Jun 2003 B1
6589283 Metzger et al. Jul 2003 B1
6591581 Schmieding Jul 2003 B2
6602259 Masini Aug 2003 B1
6605293 Giordano et al. Aug 2003 B1
6610067 Tallarida et al. Aug 2003 B2
6620181 Bonutti Sep 2003 B1
6622567 Hamel et al. Sep 2003 B1
6629999 Serafin, Jr. Oct 2003 B1
6632225 Sanford et al. Oct 2003 B2
6635073 Bonutti Oct 2003 B2
6641617 Merrill et al. Nov 2003 B1
6673077 Katz Jan 2004 B1
6676662 Bagga et al. Jan 2004 B1
6676892 Das et al. Jan 2004 B2
6682566 Draenert Jan 2004 B2
6682567 Schroeder Jan 2004 B1
6695848 Haines Feb 2004 B2
6696073 Boyce et al. Feb 2004 B2
6697664 Kienzle, III et al. Feb 2004 B2
6699289 Iannotti et al. Mar 2004 B2
6701174 Krause et al. Mar 2004 B1
6702821 Bonutti Mar 2004 B2
6709462 Hanssen Mar 2004 B2
6711431 Sarin et al. Mar 2004 B2
6711432 Krause et al. Mar 2004 B1
6712856 Carignan et al. Mar 2004 B1
6716249 Hyde Apr 2004 B2
6725077 Balloni et al. Apr 2004 B1
6738657 Franklin et al. May 2004 B1
6740092 Lombardo et al. May 2004 B2
6743235 Subba Rao Jun 2004 B2
6749638 Saladino Jun 2004 B1
6750653 Zou et al. Jun 2004 B1
6770078 Bonutti Aug 2004 B2
6772026 Bradbury et al. Aug 2004 B2
6780190 Maroney Aug 2004 B2
6786930 Biscup Sep 2004 B2
6799066 Steines et al. Sep 2004 B2
6823871 Schmieding Nov 2004 B2
6827723 Carson Dec 2004 B2
6887247 Couture et al. May 2005 B1
6905514 Carignan et al. Jun 2005 B2
6916324 Sanford et al. Jul 2005 B2
6923817 Carson et al. Aug 2005 B2
6923831 Fell et al. Aug 2005 B2
6932842 Litschko et al. Aug 2005 B1
6942475 Ensign et al. Sep 2005 B2
6944518 Roose Sep 2005 B2
6945976 Ball et al. Sep 2005 B2
6953480 Mears et al. Oct 2005 B2
6960216 Kolb et al. Nov 2005 B2
6966932 Schroeder Nov 2005 B1
6975755 Baumberg Dec 2005 B1
6979299 Peabody et al. Dec 2005 B2
6990220 Ellis et al. Jan 2006 B2
6993406 Cesarano, III et al. Jan 2006 B1
7001385 Bonutti Feb 2006 B2
7022141 Dwyer et al. Apr 2006 B2
7029477 Grimm Apr 2006 B2
7029479 Tallarida et al. Apr 2006 B2
7042222 Zheng et al. May 2006 B2
7048741 Swanson May 2006 B2
7050877 Iseki et al. May 2006 B2
7060074 Rosa et al. Jun 2006 B2
7074241 McKinnon Jul 2006 B2
RE39301 Bertin Sep 2006 E
7104995 Crofford Sep 2006 B2
7104997 Lionberger et al. Sep 2006 B2
7105026 Johnson et al. Sep 2006 B2
7115131 Engh et al. Oct 2006 B2
7121832 Hsieh et al. Oct 2006 B2
7141053 Rosa et al. Nov 2006 B2
D533664 Buttler et al. Dec 2006 S
7169185 Sidebotham Jan 2007 B2
7172599 Steffensmeier et al. Feb 2007 B2
7174282 Hollister et al. Feb 2007 B2
7176466 Rousso et al. Feb 2007 B2
7184814 Lang et al. Feb 2007 B2
7198628 Ondrla et al. Apr 2007 B2
7218232 DiSilvestro et al. May 2007 B2
7220264 Hershberger May 2007 B1
7239908 Alexander et al. Jul 2007 B1
7241315 Evans Jul 2007 B2
7255702 Serra et al. Aug 2007 B2
7258701 Aram et al. Aug 2007 B2
7261719 Twomey et al. Aug 2007 B1
7275218 Petrella et al. Sep 2007 B2
7282054 Steffensmeier et al. Oct 2007 B2
7291117 Boecker et al. Nov 2007 B2
7291177 Gibbs Nov 2007 B2
7294133 Zink et al. Nov 2007 B2
7297164 Johnson et al. Nov 2007 B2
7309339 Cusick et al. Dec 2007 B2
7333013 Berger Feb 2008 B2
7335207 Smith Feb 2008 B1
7335231 McLean Feb 2008 B2
7371260 Malinin May 2008 B2
7383164 Aram et al. Jun 2008 B2
7385498 Dobosz Jun 2008 B2
7388972 Kitson Jun 2008 B2
7390327 Collazo et al. Jun 2008 B2
7392076 Moctezuma de La Barrera Jun 2008 B2
7419492 Yoon et al. Sep 2008 B2
7427200 Noble Sep 2008 B2
7427272 Richard et al. Sep 2008 B2
7465320 Kito et al. Dec 2008 B1
7468075 Lang et al. Dec 2008 B2
7474223 Nycz et al. Jan 2009 B2
7488324 Metzger et al. Feb 2009 B1
7488325 Qian Feb 2009 B2
7494510 Zweymuller Feb 2009 B2
7517365 Carignan et al. Apr 2009 B2
7519540 Mayaud Apr 2009 B2
7527631 Maroney et al. May 2009 B2
7534263 Burdulis, Jr. et al. May 2009 B2
7537664 O'Neill et al. May 2009 B2
7542791 Mire et al. Jun 2009 B2
7559931 Stone Jul 2009 B2
7575602 Amirouche et al. Aug 2009 B2
7578851 Dong et al. Aug 2009 B2
7582091 Duncan et al. Sep 2009 B2
7591821 Kelman Sep 2009 B2
7601155 Petersen Oct 2009 B2
7603192 Martin et al. Oct 2009 B2
7604639 Swanson Oct 2009 B2
7611516 Maroney Nov 2009 B2
7618451 Berez et al. Nov 2009 B2
7621915 Frederick et al. Nov 2009 B2
7625409 Saltzman et al. Dec 2009 B2
7646161 Albu-Schaffer et al. Jan 2010 B2
7651501 Penenberg et al. Jan 2010 B2
7670345 Plassky et al. Mar 2010 B2
7674100 Hayes-Pankhurst et al. Mar 2010 B2
7682398 Croxton et al. Mar 2010 B2
7695477 Creger et al. Apr 2010 B2
7695521 Ely et al. Apr 2010 B2
7699847 Sheldon et al. Apr 2010 B2
7702380 Dean Apr 2010 B1
7704253 Bastian et al. Apr 2010 B2
7723395 Ringeisen et al. May 2010 B2
7747305 Dean et al. Jun 2010 B2
D622854 Otto et al. Aug 2010 S
7780672 Metzger et al. Aug 2010 B2
7780740 Steinberg Aug 2010 B2
7789885 Metzger Sep 2010 B2
7794466 Merchant et al. Sep 2010 B2
7794467 McGinley et al. Sep 2010 B2
7794504 Case Sep 2010 B2
7806896 Bonutti Oct 2010 B1
7809184 Neubauer et al. Oct 2010 B2
7819925 King et al. Oct 2010 B2
7828806 Graf et al. Nov 2010 B2
7833245 Kees et al. Nov 2010 B2
7837040 Ward et al. Nov 2010 B2
7837690 Metzger Nov 2010 B2
7846382 Strand et al. Dec 2010 B2
7850698 Straszheim-Morley et al. Dec 2010 B2
7854737 Daniels et al. Dec 2010 B2
7879109 Borden et al. Feb 2011 B2
7892261 Bonutti Feb 2011 B2
7896921 Smith et al. Mar 2011 B2
7926363 Miller et al. Apr 2011 B2
7935119 Ammann et al. May 2011 B2
7935150 Carignan et al. May 2011 B2
7938861 King et al. May 2011 B2
7959637 Fox et al. Jun 2011 B2
7962196 Tuma Jun 2011 B2
7963968 Dees, Jr. Jun 2011 B2
7967823 Ammann et al. Jun 2011 B2
7967868 White et al. Jun 2011 B2
7974677 Mire et al. Jul 2011 B2
7981158 Fitz et al. Jul 2011 B2
7988736 May et al. Aug 2011 B2
7993353 Rossner et al. Aug 2011 B2
8062301 Ammann et al. Nov 2011 B2
8066708 Lang et al. Nov 2011 B2
8070752 Metzger et al. Dec 2011 B2
8083745 Lang et al. Dec 2011 B2
8083746 Novak Dec 2011 B2
8083749 Taber Dec 2011 B2
8086336 Christensen Dec 2011 B2
8092465 Metzger et al. Jan 2012 B2
8105330 Fitz et al. Jan 2012 B2
8122582 Burdulis, Jr. et al. Feb 2012 B2
8133230 Stevens et al. Mar 2012 B2
8133234 Meridew et al. Mar 2012 B2
8137406 Novak et al. Mar 2012 B2
8147861 Jones et al. Apr 2012 B2
8160345 Pavlovskaia et al. Apr 2012 B2
8167823 Nycz et al. May 2012 B2
8167951 Ammann et al. May 2012 B2
8170641 Belcher May 2012 B2
8172850 Mcminn May 2012 B2
8182489 Horacek May 2012 B2
8192441 Collazo Jun 2012 B2
8192495 Simpson et al. Jun 2012 B2
8200355 Lee et al. Jun 2012 B2
8211112 Novak et al. Jul 2012 B2
8221430 Park et al. Jul 2012 B2
8241292 Collazo Aug 2012 B2
8241293 Stone et al. Aug 2012 B2
8246680 Betz et al. Aug 2012 B2
8260589 Kumar Sep 2012 B1
8265790 Amiot et al. Sep 2012 B2
8268099 O'Neill et al. Sep 2012 B2
8268100 O'Neill et al. Sep 2012 B2
D669176 Frey Oct 2012 S
8282646 Schoenefeld et al. Oct 2012 B2
8298237 Schoenefeld et al. Oct 2012 B2
8303596 Plaβky et al. Nov 2012 B2
8313491 Green, II et al. Nov 2012 B2
D672038 Frey Dec 2012 S
8333772 Fox et al. Dec 2012 B2
8337426 Nycz Dec 2012 B2
8337501 Fitz et al. Dec 2012 B2
8337503 Lian Dec 2012 B2
8355773 Leitner et al. Jan 2013 B2
8372078 Collazo Feb 2013 B2
8377066 Katrana et al. Feb 2013 B2
8388690 Singhatat et al. Mar 2013 B2
8398646 Metzger et al. Mar 2013 B2
8407067 Uthgenannt et al. Mar 2013 B2
8414594 Berger et al. Apr 2013 B2
8419741 Carignan et al. Apr 2013 B2
8425522 Bonutti Apr 2013 B2
8430882 Lowry et al. Apr 2013 B2
8430931 Acker et al. Apr 2013 B2
8439675 De Moyer May 2013 B2
8439925 Marino et al. May 2013 B2
8444564 Mahfouz et al. May 2013 B2
8444651 Kunz et al. May 2013 B2
8457930 Schroeder Jun 2013 B2
8460302 Park et al. Jun 2013 B2
8469961 Alleyne et al. Jun 2013 B2
8473305 Belcher et al. Jun 2013 B2
8486150 White et al. Jul 2013 B2
8500740 Bojarski et al. Aug 2013 B2
8529578 Daniels et al. Sep 2013 B2
8532361 Pavlovskaia et al. Sep 2013 B2
8532806 Masson Sep 2013 B1
8532807 Metzger Sep 2013 B2
8535387 Meridew et al. Sep 2013 B2
8543234 Gao Sep 2013 B2
8545508 Collazo Oct 2013 B2
8551099 Lang et al. Oct 2013 B2
8568487 Witt et al. Oct 2013 B2
8591516 Metzger et al. Nov 2013 B2
8597365 Meridew Dec 2013 B2
8603180 White et al. Dec 2013 B2
8608748 Metzger et al. Dec 2013 B2
8608749 Meridew et al. Dec 2013 B2
8617170 Ashby et al. Dec 2013 B2
8617174 Axelson, Jr. et al. Dec 2013 B2
8617175 Park et al. Dec 2013 B2
8632547 Maxson et al. Jan 2014 B2
8652142 Geissler Feb 2014 B2
8668700 Catanzarite et al. Mar 2014 B2
8702712 Jordan et al. Apr 2014 B2
8702715 Ammann et al. Apr 2014 B2
8706285 Narainasamy et al. Apr 2014 B2
8715289 Smith May 2014 B2
8728387 Jones et al. May 2014 B2
8735773 Lang May 2014 B2
8764760 Metzger et al. Jul 2014 B2
8775133 Schroeder Jul 2014 B2
8777875 Park Jul 2014 B2
8781557 Dean et al. Jul 2014 B2
8828016 Major et al. Sep 2014 B2
8828087 Stone et al. Sep 2014 B2
8828089 Perez et al. Sep 2014 B1
8834568 Shapiro Sep 2014 B2
8858561 White et al. Oct 2014 B2
8864769 Stone et al. Oct 2014 B2
8900244 Meridew et al. Dec 2014 B2
8903530 Metzger Dec 2014 B2
8956364 Catanzarite et al. Feb 2015 B2
8979936 White et al. Mar 2015 B2
8986309 Murphy Mar 2015 B1
9005297 Katrana et al. Apr 2015 B2
9060788 Bollinger Jun 2015 B2
9066734 Schoenefeld et al. Jun 2015 B2
9107139 Sirotkin et al. Aug 2015 B2
9113971 Metzger et al. Aug 2015 B2
9173661 Metzger et al. Nov 2015 B2
9186254 Fitz et al. Nov 2015 B2
9208558 Dean et al. Dec 2015 B2
9241745 Smith et al. Jan 2016 B2
9275191 Dean et al. Mar 2016 B2
9289253 Vanasse et al. Mar 2016 B2
9292920 Dean et al. Mar 2016 B2
9330206 Dean et al. May 2016 B2
9339278 Meridew et al. May 2016 B2
9345548 Schoenefeld et al. May 2016 B2
9445907 Meridew et al. May 2016 B2
9480490 Metzger et al. Nov 2016 B2
9480580 White et al. Nov 2016 B2
9522010 Metzger et al. Dec 2016 B2
9539013 Katrana et al. Jan 2017 B2
9662127 Meridew et al. May 2017 B2
9662216 Witt et al. May 2017 B2
9700329 Metzger et al. Jul 2017 B2
9730616 Hershberger Aug 2017 B2
9743935 Smith et al. Aug 2017 B2
9795399 Metzger et al. Oct 2017 B2
9861387 Metzger et al. Jan 2018 B2
9907659 Belcher et al. Mar 2018 B2
9913734 White et al. Mar 2018 B2
9918740 Uthgenannt et al. Mar 2018 B2
9968376 Metzger et al. May 2018 B2
9993344 White et al. Jun 2018 B2
20010005797 Barlow et al. Jun 2001 A1
20010011190 Park Aug 2001 A1
20010018589 Muller Aug 2001 A1
20010021876 Terrill-Grisoni et al. Sep 2001 A1
20010034554 Pappas Oct 2001 A1
20010037155 Merchant Nov 2001 A1
20010054478 Watanabe et al. Dec 2001 A1
20020007294 Bradbury et al. Jan 2002 A1
20020029038 Haines Mar 2002 A1
20020029045 Bonutti Mar 2002 A1
20020052606 Bonutti May 2002 A1
20020059049 Bradbury et al. May 2002 A1
20020062127 Schumacher et al. May 2002 A1
20020082741 Mazumder et al. Jun 2002 A1
20020087274 Alexander et al. Jul 2002 A1
20020092532 Yoon Jul 2002 A1
20020107522 Picard et al. Aug 2002 A1
20020116023 Fletcher et al. Aug 2002 A1
20020120342 Gibbs Aug 2002 A1
20020128872 Giammattei Sep 2002 A1
20020147415 Martelli Oct 2002 A1
20020173797 Van Zile et al. Nov 2002 A1
20020186818 Arnaud et al. Dec 2002 A1
20020193797 Johnson et al. Dec 2002 A1
20020198528 Engh et al. Dec 2002 A1
20020198529 Masini Dec 2002 A1
20020198531 Millard et al. Dec 2002 A1
20030009171 Tornier Jan 2003 A1
20030009234 Treacy et al. Jan 2003 A1
20030011624 Ellis Jan 2003 A1
20030018338 Axelson et al. Jan 2003 A1
20030028196 Bonutti Feb 2003 A1
20030039676 Boyce et al. Feb 2003 A1
20030055502 Lang et al. Mar 2003 A1
20030060831 Bonutti Mar 2003 A1
20030069897 Roy et al. Apr 2003 A1
20030074800 Huang Apr 2003 A1
20030100906 Rosa et al. May 2003 A1
20030100907 Rosa et al. May 2003 A1
20030105526 Bryant et al. Jun 2003 A1
20030109784 Loh et al. Jun 2003 A1
20030120276 Tallarida et al. Jun 2003 A1
20030130665 Pinczewski et al. Jul 2003 A1
20030130741 McMinn Jul 2003 A1
20030139817 Tuke et al. Jul 2003 A1
20030158606 Coon et al. Aug 2003 A1
20030171757 Coon et al. Sep 2003 A1
20030212403 Swanson Nov 2003 A1
20030212459 Gibbs Nov 2003 A1
20030216669 Lang et al. Nov 2003 A1
20030216741 Sanford et al. Nov 2003 A1
20030220641 Thelen et al. Nov 2003 A1
20030225413 Sanford et al. Dec 2003 A1
20040018144 Briscoe Jan 2004 A1
20040030245 Noble et al. Feb 2004 A1
20040039395 Coon et al. Feb 2004 A1
20040054372 Corden et al. Mar 2004 A1
20040054416 Wyss Mar 2004 A1
20040068187 Krause et al. Apr 2004 A1
20040092932 Aubin et al. May 2004 A1
20040098133 Carignan et al. May 2004 A1
20040102785 Hodorek et al. May 2004 A1
20040102852 Johnson et al. May 2004 A1
20040102866 Harris et al. May 2004 A1
20040106926 Leitner et al. Jun 2004 A1
20040115586 Andreiko et al. Jun 2004 A1
20040122436 Grimm Jun 2004 A1
20040122439 Dwyer et al. Jun 2004 A1
20040128026 Harris et al. Jul 2004 A1
20040133276 Lang et al. Jul 2004 A1
20040138670 Metzger Jul 2004 A1
20040138754 Lang et al. Jul 2004 A1
20040143336 Burkinshaw Jul 2004 A1
20040147927 Tsougarakis et al. Jul 2004 A1
20040148026 Bonutti Jul 2004 A1
20040153079 Tsougarakis et al. Aug 2004 A1
20040153087 Sanford et al. Aug 2004 A1
20040158254 Eisermann Aug 2004 A1
20040162619 Blaylock et al. Aug 2004 A1
20040167390 Alexander et al. Aug 2004 A1
20040171924 Mire et al. Sep 2004 A1
20040172137 Blaylock et al. Sep 2004 A1
20040181144 Cinquin et al. Sep 2004 A1
20040193169 Schon et al. Sep 2004 A1
20040204644 Tsougarakis et al. Oct 2004 A1
20040204760 Fitz et al. Oct 2004 A1
20040212586 Denny Oct 2004 A1
20040220583 Pieczynski et al. Nov 2004 A1
20040225369 Lakin et al. Nov 2004 A1
20040236341 Petersen Nov 2004 A1
20040236424 Berez et al. Nov 2004 A1
20040243481 Bradbury et al. Dec 2004 A1
20040249386 Faoro Dec 2004 A1
20040254584 Sarin et al. Dec 2004 A1
20040260301 Lionberger et al. Dec 2004 A1
20050008887 Heymann et al. Jan 2005 A1
20050010227 Paul Jan 2005 A1
20050010300 Disilvestro et al. Jan 2005 A1
20050015022 Richard et al. Jan 2005 A1
20050019664 Matsumoto Jan 2005 A1
20050021148 Gibbs Jan 2005 A1
20050027303 Lionberger et al. Feb 2005 A1
20050027361 Reiley Feb 2005 A1
20050043806 Cook et al. Feb 2005 A1
20050043837 Rubbed et al. Feb 2005 A1
20050049524 Lefevre et al. Mar 2005 A1
20050049603 Calton et al. Mar 2005 A1
20050059873 Glozman et al. Mar 2005 A1
20050060040 Auxepaules et al. Mar 2005 A1
20050065628 Roose Mar 2005 A1
20050070897 Petersen Mar 2005 A1
20050071015 Sekel Mar 2005 A1
20050075641 Singhatat et al. Apr 2005 A1
20050096535 de la Barrera May 2005 A1
20050113840 Metzger et al. May 2005 A1
20050113841 Sheldon et al. May 2005 A1
20050113846 Carson May 2005 A1
20050119664 Carignan et al. Jun 2005 A1
20050131662 Ascenzi et al. Jun 2005 A1
20050137708 Clark Jun 2005 A1
20050148843 Roose Jul 2005 A1
20050149042 Metzger Jul 2005 A1
20050171545 Walsh et al. Aug 2005 A1
20050177170 Fisher et al. Aug 2005 A1
20050177245 Leatherbury et al. Aug 2005 A1
20050203536 Laffargue et al. Sep 2005 A1
20050203540 Broyles Sep 2005 A1
20050209597 Long et al. Sep 2005 A1
20050209605 Grimm et al. Sep 2005 A1
20050216305 Funderud Sep 2005 A1
20050222571 Ryan Oct 2005 A1
20050222573 Branch et al. Oct 2005 A1
20050228393 Williams et al. Oct 2005 A1
20050234461 Burdulis et al. Oct 2005 A1
20050234465 McCombs et al. Oct 2005 A1
20050234468 Carson Oct 2005 A1
20050240195 Axelson et al. Oct 2005 A1
20050240267 Randall et al. Oct 2005 A1
20050244239 Shimp Nov 2005 A1
20050245934 Tuke et al. Nov 2005 A1
20050245936 Tuke et al. Nov 2005 A1
20050251147 Novak Nov 2005 A1
20050267353 Marquart et al. Dec 2005 A1
20050267485 Cordes et al. Dec 2005 A1
20050267584 Burdulis et al. Dec 2005 A1
20050273114 Novak Dec 2005 A1
20050283252 Coon et al. Dec 2005 A1
20050283253 Coon et al. Dec 2005 A1
20060004284 Grunschlager et al. Jan 2006 A1
20060015120 Richard et al. Jan 2006 A1
20060025778 Ferree Feb 2006 A1
20060030853 Haines Feb 2006 A1
20060038520 Negoro et al. Feb 2006 A1
20060052725 Santilli Mar 2006 A1
20060058803 Cuckler et al. Mar 2006 A1
20060058809 Zink et al. Mar 2006 A1
20060058884 Aram et al. Mar 2006 A1
20060058886 Wozencroft Mar 2006 A1
20060069444 Deffenbaugh Mar 2006 A1
20060089621 Fard Apr 2006 A1
20060093988 Swaelens et al. May 2006 A1
20060094951 Dean et al. May 2006 A1
20060095044 Grady et al. May 2006 A1
20060095049 Zannis et al. May 2006 A1
20060100832 Bowman May 2006 A1
20060105011 Sun et al. May 2006 A1
20060111722 Bouadi May 2006 A1
20060122491 Murray et al. Jun 2006 A1
20060122616 Bennett et al. Jun 2006 A1
20060122618 Claypool et al. Jun 2006 A1
20060136058 Pietrzak Jun 2006 A1
20060142657 Quaid et al. Jun 2006 A1
20060142774 Metzger Jun 2006 A1
20060142778 Dees Jun 2006 A1
20060147332 Jones et al. Jul 2006 A1
20060149283 May et al. Jul 2006 A1
20060155380 Clemow et al. Jul 2006 A1
20060161165 Swanson Jul 2006 A1
20060161167 Myers et al. Jul 2006 A1
20060172263 Quadling et al. Aug 2006 A1
20060178497 Gevaert et al. Aug 2006 A1
20060184177 Echeverri Aug 2006 A1
20060184250 Bandoh et al. Aug 2006 A1
20060190086 Clemow et al. Aug 2006 A1
20060192319 Solar Aug 2006 A1
20060195111 Couture Aug 2006 A1
20060195194 Gunther Aug 2006 A1
20060195198 James Aug 2006 A1
20060198943 Kumar Sep 2006 A1
20060200158 Farling et al. Sep 2006 A1
20060204932 Haymann et al. Sep 2006 A1
20060210644 Levin Sep 2006 A1
20060217808 Novak et al. Sep 2006 A1
20060235421 Rosa et al. Oct 2006 A1
20060241635 Stumpo et al. Oct 2006 A1
20060241636 Novak et al. Oct 2006 A1
20060241775 Buss Oct 2006 A1
20060241776 Brown et al. Oct 2006 A1
20060241781 Brown et al. Oct 2006 A1
20060271058 Ashton et al. Nov 2006 A1
20060276796 Creger et al. Dec 2006 A1
20060276797 Botimer Dec 2006 A1
20060287733 Bonutti Dec 2006 A1
20060287891 Grasso et al. Dec 2006 A1
20060293681 Claypool et al. Dec 2006 A1
20070015995 Lang et al. Jan 2007 A1
20070016008 Schoenefeld Jan 2007 A1
20070016209 Ammann et al. Jan 2007 A1
20070027680 Ashley et al. Feb 2007 A1
20070039205 Erb et al. Feb 2007 A1
20070043582 Peveto et al. Feb 2007 A1
20070066917 Hodorek et al. Mar 2007 A1
20070073133 Schoenefeld Mar 2007 A1
20070073136 Metzger Mar 2007 A1
20070073137 Schoenefeld Mar 2007 A1
20070083209 Schenberger et al. Apr 2007 A1
20070083214 Duncan et al. Apr 2007 A1
20070083266 Lang Apr 2007 A1
20070100258 Shoham et al. May 2007 A1
20070100450 Hodorek May 2007 A1
20070100462 Lang et al. May 2007 A1
20070106299 Manspeizer May 2007 A1
20070106391 Ronk May 2007 A1
20070118055 McCombs May 2007 A1
20070118138 Seo et al. May 2007 A1
20070118243 Schroeder et al. May 2007 A1
20070129809 Meridew et al. Jun 2007 A1
20070142914 Jones et al. Jun 2007 A1
20070150068 Dong et al. Jun 2007 A1
20070156066 McGinley et al. Jul 2007 A1
20070156171 Lang et al. Jul 2007 A1
20070162038 Tuke Jul 2007 A1
20070162039 Wozencroft Jul 2007 A1
20070173946 Bonutti Jul 2007 A1
20070173948 Meridew et al. Jul 2007 A1
20070185498 Lavallee Aug 2007 A2
20070191962 Jones et al. Aug 2007 A1
20070198022 Lang et al. Aug 2007 A1
20070203430 Lang et al. Aug 2007 A1
20070203583 Slone Aug 2007 A1
20070203605 Melton et al. Aug 2007 A1
20070219562 Slone et al. Sep 2007 A1
20070219639 Otto et al. Sep 2007 A1
20070219640 Steinberg Sep 2007 A1
20070224238 Mansmann et al. Sep 2007 A1
20070225719 Stone et al. Sep 2007 A1
20070226986 Park et al. Oct 2007 A1
20070233121 Carson et al. Oct 2007 A1
20070233136 Wozencroft Oct 2007 A1
20070233140 Metzger et al. Oct 2007 A1
20070233141 Park et al. Oct 2007 A1
20070233269 Staines et al. Oct 2007 A1
20070233272 Boyce et al. Oct 2007 A1
20070238069 Lovald et al. Oct 2007 A1
20070239282 Caylor et al. Oct 2007 A1
20070239481 DiSilvestro et al. Oct 2007 A1
20070244487 Ammann et al. Oct 2007 A1
20070250169 Lang Oct 2007 A1
20070250175 Meridew et al. Oct 2007 A1
20070253617 Arata et al. Nov 2007 A1
20070255288 Mahfouz et al. Nov 2007 A1
20070255412 Hajaj et al. Nov 2007 A1
20070262867 Westrick et al. Nov 2007 A1
20070270680 Sheffer et al. Nov 2007 A1
20070272747 Woods et al. Nov 2007 A1
20070276224 Lang et al. Nov 2007 A1
20070276400 Moore et al. Nov 2007 A1
20070276501 Betz et al. Nov 2007 A1
20070282451 Metzger et al. Dec 2007 A1
20070288029 Justin et al. Dec 2007 A1
20070288030 Metzger et al. Dec 2007 A1
20080009874 Meridew et al. Jan 2008 A1
20080009952 Hodge Jan 2008 A1
20080014618 Bathe et al. Jan 2008 A1
20080015599 D'Alessio et al. Jan 2008 A1
20080015603 Collazo Jan 2008 A1
20080015604 Collazo Jan 2008 A1
20080015605 Collazo Jan 2008 A1
20080015607 D'Alessio et al. Jan 2008 A1
20080021299 Meulink Jan 2008 A1
20080021494 Schmelzeisen-Redeker et al. Jan 2008 A1
20080021567 Meulink et al. Jan 2008 A1
20080027563 Johnson et al. Jan 2008 A1
20080033442 Amiot et al. Feb 2008 A1
20080039850 Rowley et al. Feb 2008 A1
20080051799 Bonutti Feb 2008 A1
20080051910 Kammerzell et al. Feb 2008 A1
20080058945 Hajaj et al. Mar 2008 A1
20080058947 Earl et al. Mar 2008 A1
20080062183 Swaelens Mar 2008 A1
20080065225 Wasielewski et al. Mar 2008 A1
20080094396 Sabczynsdi et al. Apr 2008 A1
20080097451 Chen et al. Apr 2008 A1
20080112996 Harlow et al. May 2008 A1
20080114370 Schoenefeld May 2008 A1
20080133022 Caylor Jun 2008 A1
20080140081 Heavener et al. Jun 2008 A1
20080140209 Iannotti et al. Jun 2008 A1
20080140213 Ammann et al. Jun 2008 A1
20080146969 Kurtz Jun 2008 A1
20080147072 Park et al. Jun 2008 A1
20080147073 Ammann et al. Jun 2008 A1
20080147074 Ammann et al. Jun 2008 A1
20080161815 Schoenefeld et al. Jul 2008 A1
20080161816 Stevens et al. Jul 2008 A1
20080172125 Ek Jul 2008 A1
20080195099 Minas Aug 2008 A1
20080195107 Cuckler et al. Aug 2008 A1
20080195108 Bhatnagar et al. Aug 2008 A1
20080195109 Hunter et al. Aug 2008 A1
20080195216 Philipp Aug 2008 A1
20080200926 Verard et al. Aug 2008 A1
20080208200 Crofford Aug 2008 A1
20080208353 Kumar et al. Aug 2008 A1
20080215059 Carignan et al. Sep 2008 A1
20080221699 Meridew et al. Sep 2008 A1
20080230422 Pleil et al. Sep 2008 A1
20080234664 May et al. Sep 2008 A1
20080234683 May Sep 2008 A1
20080234685 Gjerde Sep 2008 A1
20080234833 Bandoh et al. Sep 2008 A1
20080243127 Lang et al. Oct 2008 A1
20080255674 Rahaman et al. Oct 2008 A1
20080257363 Schoenefeld et al. Oct 2008 A1
20080262499 Giori et al. Oct 2008 A1
20080262500 Collazo Oct 2008 A1
20080262624 White et al. Oct 2008 A1
20080269596 Revie et al. Oct 2008 A1
20080269906 Iannotti et al. Oct 2008 A1
20080275452 Lang et al. Nov 2008 A1
20080281328 Lang et al. Nov 2008 A1
20080281329 Fitz et al. Nov 2008 A1
20080281426 Fitz et al. Nov 2008 A1
20080287926 Abou El Kheir Nov 2008 A1
20080287954 Kunz et al. Nov 2008 A1
20080287959 Quest et al. Nov 2008 A1
20080294170 O'Brien Nov 2008 A1
20080294266 Steinberg Nov 2008 A1
20080300600 Guelat et al. Dec 2008 A1
20080306485 Coon et al. Dec 2008 A1
20080306558 Hakki Dec 2008 A1
20080312659 Metzger et al. Dec 2008 A1
20080312746 Unger Dec 2008 A1
20080319448 Lavallee et al. Dec 2008 A1
20090012526 Fletcher Jan 2009 A1
20090018546 Daley Jan 2009 A1
20090018666 Grundei et al. Jan 2009 A1
20090022015 Harrison Jan 2009 A1
20090024131 Metzger et al. Jan 2009 A1
20090024169 Triplett et al. Jan 2009 A1
20090043556 Axelson et al. Feb 2009 A1
20090048618 Harrison et al. Feb 2009 A1
20090066936 Huang et al. Mar 2009 A1
20090076371 Lang et al. Mar 2009 A1
20090076512 Ammann et al. Mar 2009 A1
20090076520 Choi Mar 2009 A1
20090076555 Lowry et al. Mar 2009 A1
20090082770 Worner et al. Mar 2009 A1
20090082774 Oti et al. Mar 2009 A1
20090087276 Rose Apr 2009 A1
20090088674 Caillouette et al. Apr 2009 A1
20090088753 Aram et al. Apr 2009 A1
20090088754 Aker et al. Apr 2009 A1
20090088755 Aker et al. Apr 2009 A1
20090088758 Bennett Apr 2009 A1
20090088759 Aram et al. Apr 2009 A1
20090088760 Aram et al. Apr 2009 A1
20090088761 Roose et al. Apr 2009 A1
20090088763 Aram et al. Apr 2009 A1
20090088865 Brehm Apr 2009 A1
20090088866 Case Apr 2009 A1
20090089034 Penney et al. Apr 2009 A1
20090089081 Haddad Apr 2009 A1
20090093815 Fletcher et al. Apr 2009 A1
20090093816 Roose et al. Apr 2009 A1
20090096613 Westrick Apr 2009 A1
20090099567 Zajac Apr 2009 A1
20090105837 Lafosse et al. Apr 2009 A1
20090116621 Yuan et al. May 2009 A1
20090118736 Kreuzer May 2009 A1
20090118769 Sixto, Jr. et al. May 2009 A1
20090129067 Fan May 2009 A1
20090131941 Park et al. May 2009 A1
20090131942 Aker et al. May 2009 A1
20090138020 Park et al. May 2009 A1
20090149964 May et al. Jun 2009 A1
20090149965 Quaid Jun 2009 A1
20090149977 Schendel Jun 2009 A1
20090151736 Belcher et al. Jun 2009 A1
20090157083 Park et al. Jun 2009 A1
20090163922 Meridew et al. Jun 2009 A1
20090163923 Flett et al. Jun 2009 A1
20090164024 Rudan et al. Jun 2009 A1
20090177282 Bureau et al. Jul 2009 A1
20090187193 Maroney et al. Jul 2009 A1
20090204225 Meridew et al. Aug 2009 A1
20090209884 Van Vorhis et al. Aug 2009 A1
20090209961 Ferrante et al. Aug 2009 A1
20090210067 Meridew Aug 2009 A1
20090222014 Bojarski et al. Sep 2009 A1
20090222015 Park et al. Sep 2009 A1
20090222016 Park et al. Sep 2009 A1
20090222103 Fitz et al. Sep 2009 A1
20090226068 Fitz et al. Sep 2009 A1
20090228016 Alvarez et al. Sep 2009 A1
20090234360 Alexander Sep 2009 A1
20090248044 Amiot et al. Oct 2009 A1
20090250413 Hoeppner Oct 2009 A1
20090254093 White et al. Oct 2009 A1
20090254367 Belcher et al. Oct 2009 A1
20090259312 Shterling et al. Oct 2009 A1
20090270868 Park et al. Oct 2009 A1
20090274350 Pavlovskaia et al. Nov 2009 A1
20090287217 Ammann et al. Nov 2009 A1
20090287309 Walch et al. Nov 2009 A1
20090306676 Lang et al. Dec 2009 A1
20090307893 Burdulis, Jr. et al. Dec 2009 A1
20090318836 Stone et al. Dec 2009 A1
20090318921 White et al. Dec 2009 A1
20100010493 Dower Jan 2010 A1
20100015082 Ting-jenulis et al. Jan 2010 A1
20100016984 Trabish Jan 2010 A1
20100016986 Trabish Jan 2010 A1
20100023015 Park Jan 2010 A1
20100030231 Revie et al. Feb 2010 A1
20100036404 Yi et al. Feb 2010 A1
20100042105 Park et al. Feb 2010 A1
20100049195 Park et al. Feb 2010 A1
20100049327 Isch et al. Feb 2010 A1
20100057088 Shah Mar 2010 A1
20100076439 Hatch Mar 2010 A1
20100076505 Borja Mar 2010 A1
20100076563 Otto et al. Mar 2010 A1
20100076571 Hatch Mar 2010 A1
20100082034 Remia Apr 2010 A1
20100082035 Keefer Apr 2010 A1
20100082067 Kondrashov Apr 2010 A1
20100087829 Metzger et al. Apr 2010 A1
20100094295 Schnieders et al. Apr 2010 A1
20100099977 Hershberger Apr 2010 A1
20100105011 Karkar et al. Apr 2010 A1
20100121334 Couture et al. May 2010 A1
20100121335 Penenberg et al. May 2010 A1
20100131073 Meridew et al. May 2010 A1
20100136214 Kumar Jun 2010 A1
20100137869 Borja et al. Jun 2010 A1
20100137924 Tuke et al. Jun 2010 A1
20100139377 Huang et al. Jun 2010 A1
20100145343 Johnson et al. Jun 2010 A1
20100145344 Jordan et al. Jun 2010 A1
20100145466 Slone Jun 2010 A1
20100152782 Stone et al. Jun 2010 A1
20100160917 Fitz et al. Jun 2010 A1
20100160919 Axelson, Jr. et al. Jun 2010 A1
20100168752 Edwards Jul 2010 A1
20100168754 Fitz et al. Jul 2010 A1
20100168857 Hatch Jul 2010 A1
20100168866 Shih Jul 2010 A1
20100179663 Steinberg Jul 2010 A1
20100185202 Lester et al. Jul 2010 A1
20100191244 White et al. Jul 2010 A1
20100198067 Mahfouz et al. Aug 2010 A1
20100198224 Metzger et al. Aug 2010 A1
20100212138 Carroll et al. Aug 2010 A1
20100217109 Belcher Aug 2010 A1
20100217270 Polinski et al. Aug 2010 A1
20100217336 Crawford et al. Aug 2010 A1
20100217338 Carroll et al. Aug 2010 A1
20100217399 Groh Aug 2010 A1
20100228257 Bonutti Sep 2010 A1
20100249657 Nycz et al. Sep 2010 A1
20100249796 Nycz Sep 2010 A1
20100256649 Capsal et al. Oct 2010 A1
20100262150 Lian Oct 2010 A1
20100274253 Ure Oct 2010 A1
20100281678 Burdulis, Jr. et al. Nov 2010 A1
20100286700 Snider et al. Nov 2010 A1
20100286789 Meridew Nov 2010 A1
20100291401 Medina et al. Nov 2010 A1
20100292743 Singhal et al. Nov 2010 A1
20100298894 Bojarski et al. Nov 2010 A1
20100305574 Fitz et al. Dec 2010 A1
20100318088 Warne et al. Dec 2010 A1
20100324692 Uthgenannt et al. Dec 2010 A1
20110004317 Hacking et al. Jan 2011 A1
20110008754 Bassett et al. Jan 2011 A1
20110009869 Marino et al. Jan 2011 A1
20110014081 Jones et al. Jan 2011 A1
20110015636 Katrana et al. Jan 2011 A1
20110015637 De Smedt et al. Jan 2011 A1
20110015639 Metzger et al. Jan 2011 A1
20110015752 Meridew Jan 2011 A1
20110015753 Meridew Jan 2011 A1
20110016690 Narainasamy et al. Jan 2011 A1
20110022049 Huebner et al. Jan 2011 A1
20110022174 Holdstein et al. Jan 2011 A1
20110029088 Rauscher et al. Feb 2011 A1
20110029091 Bojarski et al. Feb 2011 A1
20110029093 Bojarski et al. Feb 2011 A1
20110029116 Jordan et al. Feb 2011 A1
20110035012 Linares Feb 2011 A1
20110040303 Iannotti Feb 2011 A1
20110040334 Kaes et al. Feb 2011 A1
20110046735 Metzger et al. Feb 2011 A1
20110054478 Vanasse et al. Mar 2011 A1
20110066193 Lang et al. Mar 2011 A1
20110066245 Lang et al. Mar 2011 A1
20110071528 Carson Mar 2011 A1
20110071529 Carson Mar 2011 A1
20110071530 Carson Mar 2011 A1
20110071532 Carson Mar 2011 A1
20110071533 Metzger et al. Mar 2011 A1
20110071581 Lang et al. Mar 2011 A1
20110071802 Bojarski et al. Mar 2011 A1
20110087332 Bojarski et al. Apr 2011 A1
20110092804 Schoenefeld et al. Apr 2011 A1
20110093086 Witt et al. Apr 2011 A1
20110106093 Romano et al. May 2011 A1
20110106254 Abel et al. May 2011 A1
20110125264 Bagga et al. May 2011 A1
20110125284 Gabbrielli et al. May 2011 A1
20110130795 Ball Jun 2011 A1
20110151027 Clineff et al. Jun 2011 A1
20110151259 Jarman-Smith et al. Jun 2011 A1
20110153025 McMinn Jun 2011 A1
20110160736 Meridew et al. Jun 2011 A1
20110160867 Meridew et al. Jun 2011 A1
20110166578 Stone et al. Jul 2011 A1
20110172672 Dubeau et al. Jul 2011 A1
20110177590 Clyne et al. Jul 2011 A1
20110184419 Meridew et al. Jul 2011 A1
20110184424 Isch et al. Jul 2011 A1
20110184526 White et al. Jul 2011 A1
20110190899 Pierce et al. Aug 2011 A1
20110190901 Weissberg et al. Aug 2011 A1
20110213376 Maxson et al. Sep 2011 A1
20110214279 Park et al. Sep 2011 A1
20110218545 Catanzarite et al. Sep 2011 A1
20110224674 White et al. Sep 2011 A1
20110238071 Fernandez-Scoma Sep 2011 A1
20110245835 Dodds et al. Oct 2011 A1
20110251617 Ammann et al. Oct 2011 A1
20110257657 Turner et al. Oct 2011 A1
20110269100 Furrer et al. Nov 2011 A1
20110275032 Tardieu et al. Nov 2011 A1
20110276053 Birkbeck et al. Nov 2011 A1
20110276145 Carignan et al. Nov 2011 A1
20110282473 Pavlovskaia et al. Nov 2011 A1
20110295887 Palmese et al. Dec 2011 A1
20110313424 Bono et al. Dec 2011 A1
20110319745 Frey Dec 2011 A1
20120010619 Barsoum Jan 2012 A1
20120010710 Frigg Jan 2012 A1
20120010711 Antonyshyn et al. Jan 2012 A1
20120029345 Mahfouz et al. Feb 2012 A1
20120029520 Lang et al. Feb 2012 A1
20120041445 Roose et al. Feb 2012 A1
20120041446 Wong et al. Feb 2012 A1
20120041564 Landon Feb 2012 A1
20120053590 Allen et al. Mar 2012 A1
20120063655 Dean et al. Mar 2012 A1
20120065640 Metzger et al. Mar 2012 A1
20120078254 Ashby et al. Mar 2012 A1
20120078258 Lo et al. Mar 2012 A1
20120078259 Meridew Mar 2012 A1
20120089595 Jaecksch Apr 2012 A1
20120101586 Carson Apr 2012 A1
20120109137 Iannotti et al. May 2012 A1
20120109138 Meridew et al. May 2012 A1
20120109226 Iannotti et al. May 2012 A1
20120116203 Vancraen et al. May 2012 A1
20120123422 Agnihotri et al. May 2012 A1
20120123423 Fryman May 2012 A1
20120130382 Iannotti et al. May 2012 A1
20120136365 Iannotti et al. May 2012 A1
20120141034 Iannotti et al. Jun 2012 A1
20120143197 Lang et al. Jun 2012 A1
20120143267 Iannotti et al. Jun 2012 A1
20120150242 Mannion Jun 2012 A1
20120158002 Carignan et al. Jun 2012 A1
20120165954 Nimal Jun 2012 A1
20120190971 De Jul 2012 A1
20120192401 Pavlovskaia et al. Aug 2012 A1
20120196314 Nawaz et al. Aug 2012 A1
20120209276 Schuster Aug 2012 A1
20120215225 Philippon et al. Aug 2012 A1
20120215310 Sharp et al. Aug 2012 A1
20120221017 Bonutti Aug 2012 A1
20120226283 Meridew et al. Sep 2012 A1
20120232596 Ribeiro Sep 2012 A1
20120245587 Fang et al. Sep 2012 A1
20120245647 Kunz et al. Sep 2012 A1
20120259335 Scifert et al. Oct 2012 A1
20120265208 Smith Oct 2012 A1
20120271131 Kling et al. Oct 2012 A1
20120271314 Stemniski et al. Oct 2012 A1
20120271366 Katrana et al. Oct 2012 A1
20120276509 Iannotti et al. Nov 2012 A1
20120277751 Catanzarite et al. Nov 2012 A1
20120289955 Gelaude et al. Nov 2012 A1
20120296339 Iannotti et al. Nov 2012 A1
20120303004 Uthgenannt et al. Nov 2012 A1
20120303033 Weiner et al. Nov 2012 A1
20120310364 Li et al. Dec 2012 A1
20120310399 Metzger Dec 2012 A1
20120316564 Serbousek et al. Dec 2012 A1
20120323246 Catanzarite et al. Dec 2012 A1
20120323282 Brianza et al. Dec 2012 A1
20120323323 Vargas et al. Dec 2012 A1
20120330319 Birkbeck et al. Dec 2012 A1
20130001121 Metzger Jan 2013 A1
20130006250 Metzger et al. Jan 2013 A1
20130018483 Li et al. Jan 2013 A1
20130035766 Meridew Feb 2013 A1
20130046310 Ranawat et al. Feb 2013 A1
20130053854 Schoenefeld et al. Feb 2013 A1
20130056912 O'Neill et al. Mar 2013 A1
20130060253 Couture et al. Mar 2013 A1
20130066323 Nycz et al. Mar 2013 A1
20130072940 Dawood et al. Mar 2013 A1
20130085500 Meridew et al. Apr 2013 A1
20130085590 Bryan et al. Apr 2013 A1
20130110116 Kehres et al. May 2013 A1
20130110470 Vanasse et al. May 2013 A1
20130116699 Smith et al. May 2013 A1
20130119579 Iannotti et al. May 2013 A1
20130123850 Schoenefeld et al. May 2013 A1
20130131681 Katrana et al. May 2013 A1
20130144392 Hughes Jun 2013 A1
20130158671 Uthgenannt et al. Jun 2013 A1
20130197528 Zakaria et al. Aug 2013 A1
20130197529 Metzger et al. Aug 2013 A1
20130197687 Pavlovskaia et al. Aug 2013 A1
20130218163 Frey Aug 2013 A1
20130245631 Bettenga Sep 2013 A1
20130245801 Schroeder Sep 2013 A1
20130261503 Sherman et al. Oct 2013 A1
20130264749 Jones et al. Oct 2013 A1
20130268085 Dong et al. Oct 2013 A1
20130289730 Gabriel et al. Oct 2013 A1
20130292870 Roger Nov 2013 A1
20130317511 Bojarski et al. Nov 2013 A1
20130317621 Metzger et al. Nov 2013 A1
20130326878 Boehm et al. Dec 2013 A1
20130338673 Keppler Dec 2013 A1
20140001226 Scabin et al. Jan 2014 A1
20140005672 Edwards et al. Jan 2014 A1
20140012266 Bonin, Jr. et al. Jan 2014 A1
20140018934 Meridew et al. Jan 2014 A1
20140052270 Witt et al. Feb 2014 A1
20140066937 Wiebe, III et al. Mar 2014 A1
20140081275 Metzger et al. Mar 2014 A1
20140081659 Nawana et al. Mar 2014 A1
20140088724 Meridew Mar 2014 A1
20140094816 White et al. Apr 2014 A1
20140100578 Metzger et al. Apr 2014 A1
20140107651 Meridew et al. Apr 2014 A1
20140107654 Kehres et al. Apr 2014 A1
20140107715 Heilman et al. Apr 2014 A1
20140127211 Geles et al. May 2014 A1
20140135775 Maxson et al. May 2014 A1
20140163564 Bollinger Jun 2014 A1
20140163565 Bollinger Jun 2014 A1
20140172116 Maxson et al. Jun 2014 A1
20140188119 Catanzarite et al. Jul 2014 A1
20140222157 Al Hares et al. Aug 2014 A1
20140243833 Smith Aug 2014 A1
20140257304 Eash Sep 2014 A1
20140257508 Bojarski et al. Sep 2014 A1
20140276854 Schoenefeld et al. Sep 2014 A1
20140276856 Schoenefeld Sep 2014 A1
20140276870 Eash Sep 2014 A1
20140276873 Meridew et al. Sep 2014 A1
20140303938 Schoenefeld et al. Oct 2014 A1
20140303990 Schoenefeld et al. Oct 2014 A1
20140309644 Metzger et al. Oct 2014 A1
20140324058 Metzger et al. Oct 2014 A1
20140378979 Stone et al. Dec 2014 A1
20150088293 Metzger Mar 2015 A1
20150112348 Schoenefeld et al. Apr 2015 A1
20150112349 Schoenefeld Apr 2015 A1
20150150688 Vanasse et al. Jun 2015 A1
20150157341 Catanzarite et al. Jun 2015 A1
20150320429 Katrana et al. Nov 2015 A1
20150320508 White et al. Nov 2015 A1
20150335438 Pierce et al. Nov 2015 A1
20160008013 Metzger et al. Jan 2016 A1
20160038160 Metzger Feb 2016 A1
20160100845 Smith et al. Apr 2016 A1
20160135824 Vanasse et al. May 2016 A1
20160196651 Dean et al. Jul 2016 A1
20160203241 Dean et al. Jul 2016 A1
20160213491 Schoenefeld et al. Jul 2016 A1
20160228133 Meridew et al. Aug 2016 A1
20160338838 Meridew et al. Nov 2016 A1
20170000626 White et al. Jan 2017 A1
20170056030 Metzger et al. Mar 2017 A1
20170224496 Witt et al. Aug 2017 A1
20170273718 Metzger et al. Sep 2017 A1
20170311846 Hershberger Nov 2017 A1
20170333194 Pierce et al. Nov 2017 A1
20180008292 Metzger et al. Jan 2018 A1
20180140426 Belcher et al. May 2018 A1
20180153565 Stone et al. Jun 2018 A1
20180168690 Uthgenannt et al. Jun 2018 A1
20180168822 White et al. Jun 2018 A1
20180206888 Metzger et al. Jul 2018 A1
Foreign Referenced Citations (199)
Number Date Country
2447694 Dec 2002 CA
2501041 Apr 2004 CA
2505371 May 2004 CA
2505419 Jun 2004 CA
2506849 Jun 2004 CA
2546958 Jun 2005 CA
2546965 Jun 2005 CA
2588907 Jun 2006 CA
2590534 Jun 2006 CA
117960 May 1927 CH
1630495 Jun 2005 CN
1728976 Feb 2006 CN
1729483 Feb 2006 CN
1729484 Feb 2006 CN
1913844 Feb 2007 CN
101111197 Jan 2008 CN
102038553 May 2011 CN
102335742 Feb 2012 CN
337437 May 1921 DE
3447365 Jul 1986 DE
04219939 Dec 1993 DE
4421153 Dec 1995 DE
10341187 Mar 2005 DE
102009028503 Feb 2011 DE
102011082902 Mar 2012 DE
102012205820 Oct 2012 DE
112010003901 Nov 2012 DE
0114505 Aug 1984 EP
0255797 Feb 1988 EP
0326768 Aug 1989 EP
0579868 Jan 1994 EP
0591985 Apr 1994 EP
0645984 Apr 1995 EP
0650706 May 1995 EP
0916324 May 1999 EP
1321107 Jun 2003 EP
1327424 Jul 2003 EP
1437102 Jul 2004 EP
01486900 Dec 2004 EP
1588669 Oct 2005 EP
1634551 Mar 2006 EP
1832239 Sep 2007 EP
1852072 Nov 2007 EP
1852072 Nov 2007 EP
2029061 Mar 2009 EP
2168507 Mar 2010 EP
2303146 Apr 2011 EP
2303192 Apr 2011 EP
2352445 Aug 2011 EP
2396741 Dec 2011 EP
2398381 Dec 2011 EP
2403437 Jan 2012 EP
2491873 Aug 2012 EP
2502582 Sep 2012 EP
2709568 Mar 2014 EP
2816962 Dec 2014 EP
2029061 Feb 2017 EP
1111677 Mar 1956 FR
2429582 Jan 1980 FR
2659226 Sep 1991 FR
2721195 Dec 1995 FR
2768916 Apr 1999 FR
2979817 Mar 2013 FR
2094590 Sep 1982 GB
2197790 Jun 1988 GB
2423021 Aug 2006 GB
2442441 Apr 2008 GB
2447702 Sep 2008 GB
2483980 Mar 2012 GB
2486390 Jun 2012 GB
2490220 Oct 2012 GB
2491526 Dec 2012 GB
2486390 Nov 2015 GB
2527690 Jun 2016 GB
2483980 Dec 2016 GB
2491526 Jan 2017 GB
59157715 Sep 1984 JP
60231208 Nov 1985 JP
6-233790 Aug 1994 JP
2000245758 Sep 2000 JP
2004008797 Jan 2004 JP
2005-218861 Aug 2005 JP
2009514612 Apr 2009 JP
2009515610 Apr 2009 JP
2011505080 Feb 2011 JP
2011517996 Jun 2011 JP
2011527885 Nov 2011 JP
5710014 Apr 2015 JP
20050072500 Jul 2005 KR
20050084024 Aug 2005 KR
2083179 Jul 1997 RU
2113182 Jun 1998 RU
2125835 Feb 1999 RU
2138223 Sep 1999 RU
2175534 Nov 2001 RU
2187975 Aug 2002 RU
2218242 Dec 2003 RU
231755 May 2005 TW
201114409 May 2011 TW
WO-8807840 Oct 1988 WO
WO-8909028 Oct 1989 WO
WO-9014806 Dec 1990 WO
WO-9107139 May 1991 WO
WO-9325157 Dec 1993 WO
WO-9413218 Jun 1994 WO
WO-9528688 Oct 1995 WO
WO-9607361 Mar 1996 WO
WO-9729703 Aug 1997 WO
WO-9901073 Jan 1999 WO
WO-9952473 Oct 1999 WO
WO-9959106 Nov 1999 WO
WO-0110339 Feb 2001 WO
WO-0133511 May 2001 WO
WO-0170142 Sep 2001 WO
WO-0184479 Nov 2001 WO
WO-0217821 Mar 2002 WO
WO-2002026145 Apr 2002 WO
WO-0236024 May 2002 WO
WO-02096268 Dec 2002 WO
WO-03051210 Jun 2003 WO
WO-03051211 Jun 2003 WO
WO-2004032806 Apr 2004 WO
WO-2004049981 Jun 2004 WO
WO-2004051301 Jun 2004 WO
WO-2004078069 Sep 2004 WO
WO-2005051209 Jun 2005 WO
WO-2005051233 Jun 2005 WO
WO-2005051239 Jun 2005 WO
WO-2005051240 Jun 2005 WO
WO-2005077039 Aug 2005 WO
WO-2005099636 Oct 2005 WO
WO-06058057 Jun 2006 WO
WO-06060795 Jun 2006 WO
WO-2006058057 Jun 2006 WO
WO-2006092600 Sep 2006 WO
WO-2006127486 Nov 2006 WO
WO-2006134345 Dec 2006 WO
WO-2006136955 Dec 2006 WO
WO-07041375 Apr 2007 WO
WO-2007053572 May 2007 WO
WO-2007062079 May 2007 WO
WO-2007092841 Aug 2007 WO
WO-2007137327 Dec 2007 WO
WO-2007145937 Dec 2007 WO
WO-2007145937 Dec 2007 WO
WO-2008014618 Feb 2008 WO
WO-2008021494 Feb 2008 WO
WO-2008040961 Apr 2008 WO
WO-2008044055 Apr 2008 WO
WO-2008091358 Jul 2008 WO
WO-2008101090 Aug 2008 WO
WO-2008109751 Sep 2008 WO
WO-2008112996 Sep 2008 WO
WO-2008140748 Nov 2008 WO
WO-2009001083 Dec 2008 WO
WO-2009001109 Dec 2008 WO
WO-2009025783 Feb 2009 WO
WO-2009073781 Jun 2009 WO
WO-2009129063 Oct 2009 WO
WO-2009129067 Oct 2009 WO
WO-2010033431 Mar 2010 WO
WO-2010045537 Apr 2010 WO
WO-2010048257 Apr 2010 WO
WO-2010088696 Aug 2010 WO
WO-2010093902 Aug 2010 WO
WO-2010096553 Aug 2010 WO
WO-2010096557 Aug 2010 WO
WO-2010124164 Oct 2010 WO
WO-2010129870 Nov 2010 WO
WO-2010144705 Dec 2010 WO
WO-2010148103 Dec 2010 WO
WO-2010150223 Dec 2010 WO
WO-2011018458 Feb 2011 WO
WO-2011041398 Apr 2011 WO
WO-2011060536 May 2011 WO
WO-2011063231 May 2011 WO
WO-2011019797 Jul 2011 WO
WO-2011080260 Jul 2011 WO
WO-2011106711 Sep 2011 WO
WO-2011109260 Sep 2011 WO
WO-2011110374 Sep 2011 WO
WO-2011117644 Sep 2011 WO
WO-2012006444 Jan 2012 WO
WO-2012033821 Mar 2012 WO
WO-2012058344 May 2012 WO
WO-2012061042 May 2012 WO
WO-2012058353 Jun 2012 WO
WO-2012058355 Jul 2012 WO
WO-2012058349 Aug 2012 WO
WO-2012116206 Aug 2012 WO
WO-2012141790 Oct 2012 WO
WO-2012158917 Nov 2012 WO
WO-2012173929 Dec 2012 WO
WO-2012174008 Dec 2012 WO
WO-2013126416 Aug 2013 WO
WO-2013170872 Nov 2013 WO
WO-2014019712 Feb 2014 WO
WO-2015084831 Jun 2015 WO
WO-2016007631 Jan 2016 WO
Non-Patent Literature Citations (904)
Entry
“U.S. Appl. No. 12/255,945, Appeal Decision mailed Feb. 27, 2017”, 12 pgs.
“U.S. Appl. No. 12/255,945, Notice of Allowance dated May 5, 2017”, 7 pgs.
“U.S. Appl. No. 13/041,883, Examiner's Answer dated Mar. 8, 2017”, 8 pgs.
“U.S. Appl. No. 13/041,883, Reply Brief Filed May 2, 2017 to Examiner's Answer dated Mar. 8, 2017”, 8 pgs.
“U.S. Appl. No. 13/527,981, Examiner Interview Summary dated Apr. 24, 2017”, 5 pgs.
“U.S. Appl. No. 13/527,981, Final Office Action dated Feb. 8, 2017”, 17 pgs.
“U.S. Appl. No. 13/527,981, Non Final Office Action dated Jun. 22, 2017”, 6 pgs.
“U.S. Appl. No. 13/527,981, Response filed May 8, 2017 to Final Office Action dated Feb. 8, 2017”, 18 pgs.
“U.S. Appl. No. 13/800,334, Final Office Action dated Jun. 15, 2017”, 22 pgs.
“U.S. Appl. No. 13/800,334, Response filed Mar. 15, 2017 to Non Final Office Action dated Dec. 15, 2016”, 16 pgs.
“U.S. Appl. No. 14/064,970, Notice of Allowability dated Feb. 10, 2017”, 2 pgs.
“U.S. Appl. No. 14/064,970, Notice of Allowability dated Feb. 17, 2017”, 2 pgs.
“U.S. Appl. No. 14/064,970, Notice of Allowance dated Jan. 27, 2017”, 10 pgs.
“U.S. Appl. No. 14/105,669, Notice of Allowance dated Jan. 26, 2017”, 7 pgs.
“U.S. Appl. No. 14/327,234, Response filed May 17, 2017 to Restriction Requriement dated Apr. 6, 2017”, 8 pgs.
“U.S. Appl. No. 14/327,234, Restriction Requirement dated Apr. 6, 2017”, 7 pgs.
“U.S. Appl. No. 14/483,214, Examiner Interview Summary dated Apr. 12, 2017”, 3 pgs.
“U.S. Appl. No. 14/483,214, Non Final Office Action dated May 2, 2017”, 10 pgs.
“U.S. Appl. No. 14/658,429, Final Office Action dated Jun. 15, 2017”, 7 pgs.
“U.S. Appl. No. 14/658,429, Non Final Office Action dated Feb. 23, 2017”, 6 pgs.
“U.S. Appl. No. 14/658,429, Response Filed May 19, 2017 to Non-Final Office Action dated Feb. 23, 2017”, 15 pgs.
“U.S. Appl. No. 14/798,809, Response filed Apr. 3, 2017 to Restriction Requirement dated Jan. 4, 2017”, 8 pgs.
“U.S. Appl. No. 14/812,583, Non Final Office Action dated May 9, 2017”, 14 pgs.
“U.S. Appl. No. 14/812,583, Response filed Mar. 16. 2017 to Restriction Requirement dated Jan. 23, 2017”, 6 pgs.
“U.S. Appl. No. 14/812,583, Restriction Requirement dated Jan. 23, 2017”, 8 pgs.
“U.S. Appl. No. 14/865,762, Non Final Office Action dated Jun. 13, 2017”, 13 pgs.
“U.S. Appl. No. 14/865,762, Response filed May 17, 2017 to Restrictiion Requirement dated Apr. 13, 2017”, 8 pgs.
“U.S. Appl. No. 14/865,762, Restriction Requirement dated Apr. 13, 2017”, 6 pgs.
“U.S. Appl. No. 14/973,057, Corrected Notice of Allowance dated May 30, 2017”, 2 pgs.
“U.S. Appl. No. 14/973,057, Final Office Action dated Feb. 13, 2017”, 7 pgs.
“U.S. Appl. No. 14/973,057, Notice of Allowance dated Apr. 27, 2017”, 7 pgs.
“U.S. Appl. No. 14/973,057, Response filed Jan. 18, 2017 to Non Final Office Action dated Oct. 18, 2016”, 8 pgs.
“U.S. Appl. No. 14/973,057, Response filed Apr. 5, 2017 to Final Office Action dated Feb. 13, 2017”, 9 pgs.
“U.S. Appl. No. 15/130,414, Preliminary Amendment filed Mar. 9, 2017”, 6 pgs.
“U.S. Appl. No. 15/267,714, Non Final Office Action dated May 10, 2017”, 23 pgs.
“U.S. Appl. No. 15/267,714, Response filed Feb. 28, 2017 to Restriction Requirement dated Jan. 5, 2017”, 8 pgs.
“U.S. Appl. No. 15/352,721, Corrected Notice of Allowance dated Apr. 27, 2017”, 2 pgs.
“U.S. Appl. No. 15/352,721, Notice of Allowance dated Mar. 10, 2017”, 11 pgs.
“U.S. Appl. No. 15/352,721, Preliminary Amendment filed Feb. 3, 2017”, 6 pgs.
“U.S. Appl. No. 15/495,432, Preliminary Amendment filed May 17, 2017”, 8 pgs.
“European Application Serial No. 09731923.0, Response filed Apr. 10, 2017 to Communication Pursuant to Article 94(3) EPC dated Nov. 29, 2016”, 18 pgs.
“European Application Serial No. 09732174.9, Response filed Feb. 22, 2017 to Communication Pursuant to Article 94(3) EPC dated Oct. 17, 2016”, 6 pgs.
“European Application Serial No. 12724475.4, Response filed Jan. 10, 2017 to Communication Pursuant to Article 94(3) EPC dated Aug. 31, 2016”, 17 pgs.
“European Application Serial No. 16179349.2, Extended European Search Report dated Mar. 22, 2017”, 9 pgs.
“International Application Serial No. PCT/US2015/039561, International Preliminary Report on Patentability dated Jan. 19, 2017”, 8 pgs.
U.S. Appl. No. 15/672,724, filed Aug. 9, 2017, Patient-Specific Augments.
U.S. Appl. No. 15/650,035, filed Jul. 14, 2017, Mechanical Axis Alignment Using MRI Imaging.
U.S. Appl. No. 15/712,679, filed Sep. 22, 2017, Patient-Specific Knee Alignment Guide and Associated Method.
U.S. Appl. No. 11/363,548 U.S. Pat. No. 7,780,672, filed Feb. 27, 2006, Femoral Adjustment Device and Associated Method.
U.S. Appl. No. 11/756,057 U.S. Pat. No. 8,092,465, filed May 31, 2007, Patient Specific Knee Alignment Guide and Associated Method.
U.S. Appl. No. 13/303,546 U.S. Pat. No. 8,398,646, filed Nov. 23, 2011, Patient-Specific Knee Alignment Guide and Associated Method.
U.S. Appl. No. 13/800,334, filed Mar. 13, 2013, Patient-Specific Knee Alignment Guide and Associated Method.
U.S. Appl. No. 12/103,834 U.S. Pat. No. 7,967,868, filed Apr. 16, 2008, Patient-Modified Implant and Associated Method.
U.S. Appl. No. 12/103,824, filed Apr. 16, 2008, Method and Apparatus for Manufacturing an Implant.
U.S. Appl. No. 13/081,618 U.S. Pat. No. 8,486,150, filed Apr. 7, 2011, Patient-Modified Implant.
U.S. Appl. No. 13/923,827 U.S. Pat. No. 8,979,936, filed Jun. 21, 2013, Patient-Modified Implant
U.S. Appl. No. 14/658,429, filed Mar. 16, 2015, Patient-Modified Implant.
U.S. Appl. No. 13/041,883, filed Mar. 7, 2011, Patient-Specific Femoral Guide.
U.S. Appl. No. 15/130,414, filed Apr. 15, 2016, Patient-Specific Acetabular Guides and Associated Instruments.
U.S. Appl. No. 13/041,495 U.S. Pat. No. 8,864,769, filed Mar. 7, 2011, Alignment Guides With Patient-Specific Anchoring Elements.
U.S. Appl. No. 13/041,469 U.S. Pat. No. 8,608,749, filed Mar. 7, 2011, Patient-Specific Acetabular Guides and Associated Instruments.
U.S. Appl. No. 13/047,924, filed Mar. 15, 2011, Patient-Specific Augments.
U.S. Appl. No. 13/045,169, filed Mar. 10, 2011, Instrument With Transparent Portion for Use With Patient-Specific Alignment Guide.
U.S. Appl. No. 13/400,652 U.S. Pat. No. 9,339,278, filed Feb. 21, 2012, Patient-Specific Acetabular Guides and Associated Instruments.
U.S. Appl. No. 14/483,214, filed Sep. 11, 2014, Alignment Guides With Patient-Specific Anchoring Elements.
U.S. Appl. No. 14/105,669, filed Dec. 13, 2013, Patient-Specific Acetabular Guides and Associated Instruments.
U.S. Appl. No. 14/812,583, filed Jul. 29, 2015, Patient-Specific Augments.
U.S. Appl. No. 12/872,663 U.S. Pat. No. 8,407,067, filed Aug. 31, 2010, Method and Apparatus for Manufacturing an Implant.
U.S. Appl. No. 13/766,419, filed Feb. 13, 2013, Method and Apparatus for Manufacturing an Implant.
U.S. Appl. No. 11/971,390 U.S. Pat. No. 8,070,752, filed Jan. 9, 2008, Patient Specific Alignment Guide and Inter-Operative Adjustment.
U.S. Appl. No. 12/025,414 U.S. Pat. No. 8,298,237, filed Feb. 4, 2008, Patient-Specific Alignment Guide for Multiple Incisions.
U.S. Appl. No. 12/371,096, filed Feb. 13, 2009, Method and Apparatus for Manufacturing an Implant.
U.S. Appl. No. 12/483,807 U.S. Pat. No. 8,473,305, filed Jun. 12, 2009, Method and Apparatus for Manufacturing an Implant.
U.S. Appl. No. 12/039,849 U.S. Pat. No. 8,282,646, filed Feb. 29, 2008, Patient Specific Knee Alignment Guide and Associated Method.
U.S. Appl. No. 12/211,407 U.S. Pat. No. 8,608,748, filed Sep. 16, 2008, Patient Specific Guides.
U.S. Appl. No. 14/107,316 U.S. Pat. No. 9,480,490, filed Dec. 16, 2013, Patient-Specific Guides.
U.S. Appl. No. 12/389,901 U.S. Pat. No. 8,133,234, filed Feb. 20, 2009, Patient Specific Acetabular Guide and Method.
U.S. Appl. No. 13/343,957 U.S. Pat. No. 8,900,244, filed Jan. 5, 2012, Patient Specific Acetabular Guide and Method.
U.S. Appl. No. 12/486,992 U.S. Pat. No. 8,858,561, filed Jun. 18, 2009, Patient-Specific Alignment Guide.
U.S. Appl. No. 12/571,969 U.S. Pat. No. 9,173,661, filed Oct. 1, 2009, Patient Specific Alignment Guide With Cutting Surface and Laser Indicator.
U.S. Appl. No. 14/865,762, filed Sep. 25, 2015, Patient Specific Alignment Guide With Cutting Surface And Laser Indicator.
U.S. Appl. No. 12/714,023 U.S. Pat. No. 8,241,293, filed Feb. 26, 2010, Patient Specific High Tibia Osteotomy.
U.S. Appl. No. 13/572,895 U.S. Pat. No. 8,828,087, filed Aug. 13, 2012, Patient-Specific High Tibia Osteotomy.
U.S. Appl. No. 12/888,005 U.S. Pat. No. 8,377,066, filed Sep. 22, 2010, Patient-Specific Elbow Guides and Associated Methods.
U.S. Appl. No. 13/744,022 U.S. Pat. No. 9,005,297, filed Jan. 17, 2013, Patient-Specific Elbow Guides and Associated Methods.
U.S. Appl. No. 14/684,936 U.S. Pat. No. 9,539,013, filed Apr. 13, 2015, Patient-Specific Elbow Guides and Associated Methods.
U.S. Appl. No. 12/893,306 U.S. Pat. No. 9,113,971, filed Sep. 29, 2010, Femoral Acetabular Impingement Guide.
U.S. Appl. No. 14/798,809, filed Jul. 14, 2015, Femoral Acetabular Impingement Guide.
U.S. Appl. No. 12/938,913 U.S. Pat. No. 9,289,253, filed Nov. 3, 2010, Patient-Specific Shoulder Guide.
U.S. Appl. No. 15/008,528, filed Jan. 28, 2016, Patient-Specific Shoulder Guide.
U.S. Appl. No. 12/938,905, filed Nov. 3, 2010, Patient-Specific Implants.
U.S. Appl. No. 12/955,361 U.S. Pat. No. 8,591,516, filed Nov. 29, 2010, Patient-Specific Orthopedic Instruments.
U.S. Appl. No. 12/973,214 U.S. Pat. No. 9,345,548, filed Dec. 20, 2010, Patient-Specific Pre-Operative Planning.
U.S. Appl. No. 15/093,384, filed Apr. 7, 2016, Patient-Specific Pre-Operative Planning.
U.S. Appl. No. 12/255,945, filed Oct. 22, 2008, Mechanical Axis Alignment Using MRI Imaging.
U.S. Appl. No. 12/978,069 U.S. Pat. No. 8,568,487, filed Dec. 23, 2010, Patient-Specific Hip Joint Devices.
U.S. Appl. No. 14/064,970, filed Oct. 28, 2013, Patient-Specific Hip Joint Devices.
U.S. Appl. No. 13/041,665 U.S. Pat. No. 8,535,387, filed Mar. 7, 2011, Patient-Specific Tools and Implants.
U.S. Appl. No. 14/027,340 U.S. Pat. No. 9,445,907, filed Sep. 16, 2013, Patient-Specific Tools and Implants.
U.S. Appl. No. 15/224,741, filed Aug. 1, 2016, Patient-Specific Tools and Implants.
U.S. Appl. No. 13/111,007 U.S. Pat. No. 8,603,180, filed May 19, 2011, Patient-Specific Acetabular Guides and Associated Instruments.
U.S. Appl. No. 14/100,134 U.S. Pat. No. 9,480,580, filed Dec. 9, 2013, Patient-Specific Acetabular Alignment Guides.
U.S. Appl. No. 15/267,714, filed Sep. 16, 2016, Patient-Specific Acetabular Alignment Guides.
U.S. Appl. No. 13/527,981, filed Jun. 20, 2012, Backup Surgical Instrument System and Method.
U.S. Appl. No. 14/327,234, filed Jul. 9, 2014, Patient-Specific Knee Alignment Guide and Associated Method.
U.S. Appl. No. 13/713,710 U.S. Pat. No. 9,241,745, filed Dec. 13, 2012, Patient-Specific Femoral Version Guide
U.S. Appl. No. 14/973,057, filed Dec. 17, 2015, Patient-Specific Femoral Version Guide.
U.S. Appl. No. 13/106,295 U.S. Pat. No. 8,632,547, filed May 12, 2011, Patient-Specific Osteotomy Devices and Methods.
U.S. Appl. No. 14/086,447 U.S. Pat. No. 9,522,010, filed Nov. 21, 2013, Patient-Specific Orthopedic Instruments.
U.S. Appl. No. 15/352,721, filed Nov. 16, 2016, Patient-Specific Orthopedic Instruments.
“Amazing Precision. Beautiful Results. The next evolution of MAKOplasty® is here,” brochure. (Feb. 2009) MAKO Surgical Corp. 6 pages.
“Ascent Total Knee System,” brochure. Biomet, Inc. (Oct. 31, 1999) 16 sheets.
“Comprehensive® Reverse Shoulder System Surgical Technique,” Biomet Orthopedics brochure (2009-2012), 48 pages.
“Comprehensive® Reverse Shoulder System Technical Design Features,” Biomet Orthopedics brochure (2009), 3 pages.
“Comprehensive® Reverse Shoulder System,” Biomet Orthopedics brochure (2009), 8 pages.
“Comprehensive® Shoulder System Surgical Technique,” Biomet Orthopedics brochure (2007), pp. 1-53.
“Comprehensive® Total Shoulder System,” Biomet Orthopedics brochure (2011), 4 pages.
“Customized Patient Instruments, Patient specific instruments for patient specific needs,” brochure. (2008) DePuy Orthopaedics, Inc. 14 sheets.
“Customized Patient Instruments, Primary Cruciate Retaining Surgical Technique for use with the Sigma® Knee System Utilizing Specialist® 2 Instrumentation,” brochure. (2008) DePuy Orthopaedics, Inc. pp. 1-23.
“Discovery® Elbow System Surgical Technique,” brochure. Biomet Orthopedics, Inc. (Dec. 31, 2008) pp. 1-25.
“Discovery® Elbow System,” brochure. Biomet Orthopedics, Inc. (Nov. 30, 2007) 3 sheets.
“Hipsextant Instructions of Use.” (2011) Surgical Planning Associates, Inc. 19 pages.
“Is Subchondroplasty® Right for Me?” Retrieved from <http://www.subchondroplasty.com/about_subchondroplasty/is_subchondroplasty_right_for_> . . . Jul. 1, 2013. 1 sheet.
“Knee tensor combined with laser femoral head locator,” Research Disclosure. Jul. 2006. No. 507; p. 903.
“Method for constructing an allograft sleeve.” Research Disclosure (Dec. 2003) No. 476, p. 1294.
“OSS™ Orthopaedic Salvage System, Femoral/Tibial Augmentation,” brochure. Biomet Orthopedics, Inc., (Mar. 31, 2004) pp. 1-8 (12 sheets).
“Patient Matched PMI Implants, C.A.M.R.A. 3-D Imaging,” brochure, Biomet, Inc. (Jan. 31, 1991) 6 pages.
“Regenerex® Tibial Cone Augment, Surgical Technique Addendum to the Vanguard® SSK Revision System,” brochure. Biomet® Orthopedics. (Mar. 31, 2010) pp. 1-8 (12 sheets).
“Signature™ Personalized Patient Care, Surgical Technique Addendum to the Vanguard Knee System” brochure. Biomet® Orthopedics, Inc. (May 15, 2009) pp. 1-8.
“Subchondroplasty,” Retrieved from <http://www.subchondroplasty.com/>. Jul. 1, 2013. 1 sheet.
“TruMatch™ Personalized knee replacement solutions,” tri-fold brochure. (2009) SIGMA® DePuy Orthopaedics, Inc. 2 pages.
“Vanguard® PFR Partial Knee Patellofemoral Replacement System,” Surgical Technique brochure. Biomet Orthopaedics, (Aug. 31, 2010) pp. 1-25.
“Zimmer® UniSpacer® Knee System,” brochure. (2005) Zimmer, Inc. 4 sheets.
Biomet “Oxford® Partial Knee” brochure, 8 pages (Feb. 2011).
Biomet “The Oxford® Partial Knee Surgical Technique,” brochure, pp. 1-38, (Feb. 2010).
Biomet, “Oxford® Partial Knee Microplasty® Instrumentation Surgical Technique”, brochure, pp. 1-54 (May 2011).
Birnbaum, Klaus, M.D., “Computer-Assisted Orthopedic Surgery With Individual Templates and Comparison to Conventional Method,” SPINE vol. 26, No. 4, pp. 365-370 (2001) Lippincott Williams & Wilkins, Inc.
Botha, Charl P., Technical Report: DeVIDE—The Delft Visualisation and Image processing Development Environment, pp. 1-49 (May 31, 2006).
Cohen, Zohara A., et al. “Knee cartilage topography, thickness, and contact areas from MRI: in-vitro calibration and in-vivo measurements.” Journal of the OsteoArthritis Research Society International. Osteoarthritis and Cartilage, (1999) vol. 7; No. 1 pp. 95-109.
Deakon, Timothy, MD, Posterior Cruciate Ligament Reconstruction Technique Using the Modular ACL/PCL Guide Rationale and Surgical Technique, Arthrotek®, a Biomet Company. (2003). (6 pages).
Eckhoff, Donald G., et al., “Three-Dimensional Mechanics, Kinematics, and Morphology of the Knee Viewed in Virtual Reality,” The Journal of Bone & Joint Surgery, vol. 81 (Dec. 4, 2005) pp. 71-80.
European Communication Pursuant to Article 94(3) EPC dated Jan. 22, 2015 for PCT/US2007/013223 filed Jun. 5, 2007, which claims benefit of U.S. Appl. No. 60/812,694, filed Jun. 9, 2006 and U.S. Appl. No. 11/756,057, filed May 31, 2007.
European Communication Pursuant to Article 94(3) EPC dated Feb. 4, 2015 for PCT/US2010/024584 filed Feb. 18, 2010, which claims benefit of U.S. Appl. No. 12/389,901, filed Feb. 20, 2009.
European Communication Pursuant to Article 94(3) EPC dated Feb. 10, 2015 for PCT/US2009/039507 filed Apr. 3, 2009, which claims benefit of U.S. Appl. No. 12/103,824, filed Apr. 16, 2008.
European Communication Pursuant to Article 94(3) EPC dated Nov. 24, 2014 for PCT/US2012/038351 which claims benefit of U.S. Appl. No. 13/111,007, filed May 19, 2011.
Farr, J., Cole, B. , Kercher, J., Batty, L. and Bajaj, S., Anteromedial Tibial Tubercle Osteotomy (Fulkerson Osteotomy). Re-print from V. Sanchis-Alfonso (ed), Anterior Knee Pain and patellar Instability, DOI: 10.1007/978-0-85729-507-1_40, © Springer-Verlag London Limited 2011.(9 pages).
Farr, J., Fulkerson, J. Surgical Technique for Anteromedialization of the Tibial Tubercle with the Tracker™ AMZ Guide System. Sports Medicine and Arthroscopy Review, vol. 2, No. 3, 1994. (12 pages).
Fortin, Thomas, D.D.S., Ph.D., et al., “Precise Dental Implant Placement in Bone Using Surgical Guides in Conjunction with Medical Imaging Techniques,” Journal of Oral Implantology, Clinical, vol. 26, No. 4 (2000) pp. 300-303.
Friedman, R.J. et al., “The Use of Computerized Tomography in the Measurement of Glenoid Version”, Journal of Bone & Joint Surgery Am. (JBJS) 1992;74:1032-1037 (Aug. 1992).
Genant, H.K. et al., Advanced CT bone imaging in osteoporosis, Rheumatology, 47:iv9-iv16 (2008).
Great Britain Search Report dated Dec. 21, 2011 for GB1116054.6, claiming benefit of U.S. Appl. No. 12/888,005, filed Sep. 22, 2010.
Guldberg et al., 3D Imaging of Tissue Integration with Porous Biomaterials, Biomaterials, 29(28): 3757-3761 (Oct. 2008).
Haaker, R.G., et al., “Minimal-invasive navigiert implantierte unikondylare Knieendoprothese,” Orthopade 2006 35:1073-1079 (Sep. 13, 2006) Spinger Medizin Verlag.
Hafez, M.A., et al., “Computer-assisted Total Knee Arthroplasty Using Patient-specific Templating,” Clinical Orthopaedics and Related Research, No. 444 (pp. 184-192) 2006 Lippincott Williams & Wilkins.
Hazen, Eric J., M.D., “Computer-Assisted Orthopaedic Sugery, A New Paradigm,” Techniques in Orthopaedics® vol. 18, No. 2, (2003) pp. 221-229.
Hutmacher, Dietmar, W., “Scaffolds in tissue engineering bone and cartilage,” Biomaterials, 2000 Elsevier Science Ltd. (pp. 2529-2543).
International Preliminary Report and Written Opinion dated Jan. 5, 2012 for PCT/US2010/038845 claiming benefit of U.S. Appl. No. 12/486,992, filed Jun. 18, 2009.
International Preliminary Report on Patentability and Written Opinion for PCT/US2009/039578 dated Oct. 28, 2010 claiming benefit of U.S. Appl. No. 12/103,834, filed Apr. 16, 2008.
International Preliminary Report on Patentability and Written Opinion dated Apr. 24, 2014 for PCT/US2012/059189 claiming benefit of U.S. Appl. No. 13/597,478, filed Aug. 29, 2012.
International Preliminary Report on Patentability and Written Opinion dated Dec. 22, 2011 for PCT/US2010/038177 claiming benefit of U.S. Appl. No. 12/483,807, filed Jun. 12, 2009.
International Preliminary Report on Patentability and Written Opinion dated Jan. 3, 2014 for PCT/US2012/042081 claiming benefit of U.S. Appl. No. 13/493,509, filed Jun. 11, 2012.
International Preliminary Report on Patentability and Written Opinion dated Mar. 13, 2014 for PCT/US2012/052853 claiming benefit of U.S. Appl. No. 13/221,968, filed Aug. 31, 2011.
International Preliminary Report on Patentability and Written Opinion dated May 8, 2014 for PCT/US2012/060842 claiming benefit of U.S. Appl. No. 13/653,868, filed Oct. 17, 2012.
International Preliminary Report on Patentability and Written Opinion dated May 8, 2014 for PCT/US2012/060848 claiming benefit of U.S. Appl. No. 13/653,878, filed Oct. 17, 2012.
International Preliminary Report on Patentability and Written Opinion dated May 8, 2014 for PCT/US2012/060853 claiming benefit of U.S. Appl. No. 13/653,886, filed Oct. 17, 2012.
International Preliminary Report on Patentability and Written Opinion dated May 8, 2014 for PCT/US2012/060854 claiming benefit of U.S. Appl. No. 13/653,893, filed Oct. 17, 2012.
International Preliminary Report on Patentability and Written Opinion dated Nov. 28, 2013 for PCT/US2012/038351 claiming benefit of U.S. Appl. No. 13/111,007, filed May 19, 2011.
International Preliminary Report on Patentability and Written Opinion dated Oct. 28, 2010 for PCT/US2009/039507 claiming benefit of U.S. Appl. No. 12/103,824, filed Apr. 16, 2008.
International Preliminary Report on Patentability and Written Opinion dated Mar. 12, 2015 for PCT/US2013/057097 claiming benefit of U.S. Appl. No. 13/597,478, filed Aug. 29, 2012.
International Preliminary Report on Patentability and Written Opinion dated May 14, 2015 for PCT/US2013/067505 claiming benefit of U.S. Appl. No. 13/718,129, filed Dec. 18, 2012.
International Preliminary Report on Patentability and Written Opinion dated Sep. 7, 2012 for PCT/US2011/026333 claiming benefit of U.S. Appl. No. 12/714,023, filed Feb. 26, 2010.
International Preliminary Report on Patentability for PCT/US2007/013223 dated Dec. 24, 2008 claiming benefit of U.S. Appl. No. 11/756,057, filed May 31, 2007.
International Preliminary Report on Patentability for PCT/US2010/050701 dated Apr. 12, 2012 claiming benefit of U.S. Appl. No. 12/571,969, filed Oct. 1, 2009.
International Preliminary Report on Patentability dated Aug. 25, 2011 for PCT/US2010/024073 filed Feb. 12, 2010, claiming benefit of U.S. Appl. No. 12/371,096, filed Feb. 13, 2009.
International Preliminary Report on Patentability dated Mar. 31, 2011 for PCT/US2009/056670 claiming benefit of U.S. Appl. No. 12/211,407, filed Sep. 16, 2008.
International Preliminary Report on Patentability dated Sep. 1, 2011 for PCT/US2010/024579 claiming benefit of U.S. Appl. No. 12/389,930, filed Feb. 20, 2009.
International Preliminary Report on Patentability dated Sep. 1, 2011 for PCT/US2010/024584 claiming benefit of U.S. Appl. No. 12/389,901, filed Feb. 20, 2009.
International Preliminary Report on Patentability dated Sep. 6, 2013 for PCT/US2012/026356 claiming benefit of U.S. Appl. No. 13/041,883, filed Mar. 7, 2011.
International Preliminary Report on Patentability Report and Written Opinion dated Sep. 4, 2014 for PCT/US2013/026875 claiming benefit of U.S. Appl. No. 13/400,652, filed Feb. 21, 2012.
International Search Report and Written Opinion for PCT/US2007/013223 dated Nov. 26, 2007, claiming benefit of U.S. Appl. No. 11/756,057, filed May 31, 2007.
International Search Report and Written Opinion for PCT/US2009/039507 dated Jul. 14, 2009, claiming benefit of U.S. Appl. No. 12/103,824, filed Apr. 16, 2008.
International Search Report and Written Opinion for PCT/US2009/056670 dated Mar. 2, 2010 claiming benefit of U.S. Appl. No. 12/211,407, filed Sep. 16, 2008.
International Search Report and Written Opinion for PCT/US2013/026875 dated Jun. 7, 2013, claiming benefit of U.S. Appl. No. 13/400,652, filed Feb. 21, 2012.
International Search Report and Written Opinion dated Apr. 14, 2014 for PCT/US2013/067505 claiming benefit of U.S. Appl. No. 13/718,129, filed Dec. 18, 2012.
International Search Report and Written Opinion dated Apr. 22, 2010 for PCT/US2010/024579 claiming benefit of U.S. Appl. No. 12/389,930, filed Feb. 20, 2009.
International Search Report and Written Opinion dated Aug. 19, 2010 for PCT/US2010/024584 claiming benefit of U.S. Appl. No. 12/389,901, filed Feb. 20, 2009.
International Search Report and Written Opinion dated Aug. 24, 2010 for PCT/US2010/038177 claiming benefit of U.S. Appl. No. 12/483,807, filed Jun. 12, 2009.
International Search Report and Written Opinion dated Aug. 9, 2011 for PCT/US2011/026333 claiming benefit of U.S. Appl. No. 12/714,023, filed Feb. 26, 2010.
International Search Report and Written Opinion dated Dec. 18, 2012 for PCT/US2012/059189, which claims benefit of U.S. Appl. No. 13/597,478, filed Aug. 29, 2011.
International Search Report and Written Opinion dated Dec. 7, 2010 for PCT/US2010/050701 claiming benefit of U.S. Appl. No. 12/571,969, filed Oct. 1, 2009.
International Search Report and Written Opinion dated Feb. 6, 2013 for PCT/US2012/060842, which claims benefit of U.S. Appl. No. 13/653,868, filed Oct. 17, 2012.
International Search Report and Written Opinion dated Feb. 6, 2013 for PCT/US2012/060854, which claims benefit of U.S. Appl. No. 13/653,893, filed Oct. 17, 2012.
International Search Report and Written Opinion dated Jul. 10, 2014 for PCT/US2014/023655 claiming benefit of U.S. Appl. No. 13/800,369, filed Mar. 13, 2013.
International Search Report and Written Opinion dated Jul. 31, 2009 for PCT/US2009/039578 claiming benefit of U.S. Appl. No. 12/103,834, filed Apr. 16, 2008.
International Search Report and Written Opinion dated Jun. 24, 2014 for PCT/US2014/022000 claiming benefit of U.S. Appl. No. 13/889,869, filed May 8, 2013.
International Search Report and Written Opinion dated Jun. 4, 2010 for PCT/US2010/024073 filed Feb. 12, 2010 claiming benefit of U.S. Appl. No. 12/371,096, filed Feb. 13, 2009.
International Search Report and Written Opinion dated Mar. 5, 2012 for PCT/US2011/057300 claiming benefit of U.S. Appl. No. 12/938,905, filed Nov. 3, 2010.
International Search Report and Written Opinion dated May 23, 2014 for PCT/US2013/074288 claiming benefit of U.S. Appl. No. 13/790,770, filed Mar. 8, 2013, which priority is also claimed of U.S. Appl. No. 13/711,306, filed Dec. 11, 2012.
International Search Report and Written Opinion dated May 8, 2012 for PCT/US2012/026356 claiming benefit of U.S. Appl. No. 13/041,883, filed Mar. 7, 2011.
International Search Report and Written Opinion dated May 9, 2011 for PCT/US2011/026412 claiming benefit of U.S. Appl. No. 12/872,663, filed Aug. 31, 2010.
International Search Report and Written Opinion dated Nov. 15, 2012, for PCT/US2012/052853, which claims benefit of U.S. Appl. No. 13/221,968, filed Aug. 31, 2011.
International Search Report and Written Opinion dated Oct. 14, 2013 for PCT/US2013/057097 claiming benefit of U.S. Appl. No. 13/597,478, filed Aug. 29, 2012.
International Search Report and Written Opinion dated Oct. 5, 2010 for PCT/US2010/038845 claiming benefit of U.S. Appl. No. 12/486,992, filed Jun. 18, 2009.
International Search Report dated Nov. 30, 2010 for PCT/EP2010/061630 filed Aug. 10, 2010 claiming benefit of DE102009028503.2 filed Aug. 13, 2009.
International Search Report dated Oct. 23, 2012, for PCT/US2012/041893, which claims benefit of U.S. Appl. No. 61/496,177, filed Jun. 13, 2011.
Invitation to Pay Additional Fees dated Feb. 6, 2013 for PCT/US2012/060848, which claims benefit of U.S. Appl. No. 13/653,878, filed Oct. 17, 2012.
Invitation to Pay Additional Fees dated Feb. 6, 2014 for PCT/US2013/067505, which claims benefit of U.S. Appl. No. 13/718,129, filed Dec. 18, 2012.
Invitation to Pay Additional Fees dated Feb. 7, 2013 for PCT/US2012/060853, which claims benefit of U.S. Appl. No. 13/653,893, filed Oct. 17, 2012.
Invitation to Pay Additional Fees dated May 3, 2011 for PCT/US2011/026333 claiming benefit of U.S. Appl. No. 12/714,023, filed Feb. 26, 2010.
Invitation to Pay Additional Fees with Partial International Search dated Nov. 26, 2009 for PCT/US2009/056670.
Japanese Office Action dated Apr. 7, 2015 for PCT/US2012/038351 filed May 17, 2012 claiming benefit of U.S. Appl. No. 13/111,007, filed May 19, 2011.
K. Subburaj et al., “Automated 3D Geometric Reasoning in Computer Assisted Joint Reconstructive Surgery”, IEEE International Conference on Automation Science and Engineering, Publication Year: 2009, pp. 367-372.
Kaus, Michael R., Ph.D., “Automated Segmentation of MR Images of Brain Tumors,” Radiology, vol. 218, No. 2, (2001) pp. 586-591.
Kelly, Todd C., M.D., “Role of Navigation in Total Hip Arthroplasty.” The Journal of Bone & Joint Surgery(2009) pp. 153-8. vol. 91-A, Supplement 1.
Klein, M., “Robot assisted insertion of craniofacial implants—clinical experience,” Cars 2001, pp. 133-138 (2001) Elsevier Science B.V.
Lombardi, Adolph, et al., “Patient-Specific Approach in Total Knee Arthroplasty,” Knee Orthopedics, ORTHOSuperSite (Sep. 1, 2008), 5 pages, http://www.orthosupersite.com/view.aspx?rid=31419, printed May 20, 2010.
Lynch, John A., et al., “Cartilage segmentation of 3D MRI scans of the osteoarthritic knee combining user knowledge and active contours,” Medical Imaging 2000: Image Processing SPIE vol. 3979 (2000) pp. 925-935.
Murphy, S.B., et al. “The Hip Sextant: Navigation of Acetabular Component Orientation Using a Mechanical Instrument,” brochure. (2009) 1 page.
Nicholls, Paul, M.D., “Trauma Grand Rounds PMI (Patient-Matched Implants)” brochure, Biomet Orthopedics, Inc., (Feb. 29, 2000) 1 page.
Overhoff, H.M., et al., “Total Knee Arthroplasty: Coordinate System Definition and Planning based on 3-D Ultrasound Image Volumes,” CARS 2001, pp. 283-288, (2001) Elsevier Science B.V.
Patent Examiniation Report No. 1 dated Feb. 16, 2015 for PCT/US2013/026875 filed Feb. 20, 2013, which claims benefit of U.S. Appl. No. 13/400,652, filed Feb. 21, 2012.
Patsch, J.M. et al., Noninvasive imaging of bone microarchitecture, Annals ofthe NY Academy of Sciences, 1240:77-87 (2011)—Abstract only.
Portheine, F., “CT-basierte Planung und DISOS-Schablonennavigation in der Kniegelenkendoprothetik,” in Navigation und Robotic in der Gelenk—und Wirbelsaulenchirugie, Kapitel 32, Springer Verlag (2003) pp. 262-269.
Portheine, F., et al., Entwicklung eines klinischen Demonstrators für die computerunterstützte Orthopädische Chirurgie mit CT-Bildbasierten Individualschablonen, Bildverarbeitung fur die Medizin (1998) 5 pages.
Portheine, K., “Development of a clinical demonstrator for computer assisted orthopedic surgery with CT-image based individual templates,” Computer Assisted Radiology arid Surgery, pp. 944-949, (1997) Elsevier Science B.V.
Radermacher, “Computer Assisted Orthopaedic Surgery with Image Based Individual Templates,” Clinical Orthopaedics and Related Research No. 354, pp. 28-38 (Sep. 1998) Lipincott Williams & Wilkins.
Radermacher, K., et al., “Computer Integrated Orthopaedic Surgery: Connection of Planning and Execution in Surgical Intervention,” Computer-integrated surgery: technology and clinical applications, (1996) pp. 451-463.
Radermacher, K., et al., “CT Image-Based Planning and Execution of Interventions in Orthopedic Surgery Using Individual Templates, Experimental Results and Aspects of Clinical Applications,” Computer Assisted Orthopedic Surgery (CAOS), pp. 42-52, (1995) Hogrefe & Huber Publishers.
Radermacher, K., et al., “Image Guided Orthopedic Surgery Using Individual Templates,” Springer Berlin/Heidelberg, CVRMed-MRCAS'97, vol. 1205/1997 pp. 606-615).
Radermacher, K., et al., “Technique for Better Execution of CT Scan Planned Orthopedic Surgery on Bone Structures,” Supplied by the British Library—“The world's knowledge” 2nd Congress of ISCAS Conference in Berlin Germany (Jun. 1995) pp. 933-938.
Radermacher, Klaus, et al. “Computer Assisted Orthopaedic Individual Templates.” Clinical Orthopaedics and Related Research. (Sep. 1998) No. 354; pp. 28-38.
Regenerex® Porous Titanium Construct, Biomet Orthopedics, 12 pages (2011).
Schuller-Götzburg, P., et al., 3D-Implantatplanung und Stereolithographie-Implantatbohrschablonen, Stomatologie 101.3, pp. 55-59 (May 2004).
Sharp, S. Michael, Ph.D., Patient-Specific, Resurfacing Bi-Compartmental Arthuroplasty, Futuretech, Orthopaedic Product News (Mar./Apr. 2008) pp. 12-15.
Signature™ Hip Technology Personalized Patient Care brochure, Biomet® Orthopedics. (2013) (8 pages).
Signature™ Personalized Patient Care, Surgical Technique Addendum Vanguard® Complete Knee System, Biomet® Orthopedics Brochure, (2011), pp. 1-32.
Signature™ Personalized Patient Care. Surgical Technique Acetabular Guide System brochure. Biomet® Orthopedics. (2013) pp. 1-13.
Sisto, Domenick, J., et al., “Custom Patellofemoral Arthroplasty of the Knee Surgical Technique,” Journal of Bone and Joint Surgery, vol. 89-A, pp. 214-225 (Jul. 2006).
Slammin, John et al, “Do You Have This Implant in My Size?”, MDT Medical Design Technology, 3 pages, http://www.mdtmag.com/scripts/ShowPR.asp?PUBCODE.046&ACCT=0007796&ISSUE . . . accessed Jul. 31, 2008.
Steinwachs, Matthias Reinhard, “Cartilage Repair—Autologous Chondrocyte Transplantation and Autologous Matrix-induced Chondrogenesis,” European Musculoskeletal Review (2006) pp. 65-68.
Supplementary European Search Report dated Nov. 15, 2011 for EP07809326, which claims benefit of PCT/US2007/013223, filed Jun. 5, 2007; which claims benefit of U.S. Appl. No. 11/756,057, filed May 31, 2007.
Thomas, W., et al., “Endoprothetischen Versorgung des Kniegelenks auf der Basis eines 3D-computertomographischen Subtraktionversfahrens,” Zuma Thema: Computergestutzte orthopadische Chirugie, Der Orthopade 29:641-644 Springer-Verlag (Jul. 2000) Translation provided: Thomas, W., “Endoprosthetic care of the knee joint based on a 3D computer chromatography subtraction process,” Topic: Computer-aided orthopedic surgery. Orthopedist 2000 29:641-644 Springer Verlag (Jul. 2000).
Tripp et al., A Nondestructive Prescreening Method for Bone Collagen Content Using Micro-Computed Tomography, Radiocarbon, vol. 52, Nr2-3, pp. 612-619 (2010).
Vanguard, System Summary, Vanguard Complete Knee System, Biomet Othopedics, 8 pages (2011).
What is Subchondroplasty, Retrieved from <http://www.subchondroplasty.com/about_subchondroplasty/what_is_subchondroplasty. >, Jul. 1, 2013. 2 sheets.
U.S. Appl. No. 15/911,701, filed Mar. 5, 2018, Virtual Surgery Planning System and Method.
U.S. Appl. No. 15/878,984, filed Jan. 24, 2018, Alignment Guides With Patient-Specific Anchoring Elements.
U.S. Appl. No. 15/875,204, filed Jan. 19, 2018, Method and Apparatus for Manufacturing an Implant.
U.S. Appl. No. 15/863,421, filed Jan. 5, 2018, Patient-Specific Acetabular Alignment Guides.
U.S. Appl. No. 15/887,740, filed Feb. 2, 2018, Backup Surgical Instrument System and Method.
U.S. Appl. No. 15/933,576, filed Mar. 23, 2018, Patient-Specific Orthopedic Instruments.
“U.S. Appl. No. 14/798,809, Corrected Notice of Allowability dated Jun. 27, 2018”, 4 pgs.
“U.S. Appl. No. 14/798,809, Notice of Allowance dated May 3, 2018”, 7 pgs.
“U.S. Appl. No. 14/865,762, Response filed Jun. 8, 2018 to Non Final Office Action dated Mar. 8, 2018”, 17 pgs.
“U.S. Appl. No. 15/008,528, Non Final Office Action dated Jun. 11, 2018”, 13 pgs.
“U.S. Appl. No. 15/224,741, Non Final Office Action dated Jun. 11, 2018”, 10 pgs.
“U.S. Appl. No. 15/224,741, Response filed May 14, 2018 to Restriction Requirement dated Mar. 15, 2018”, 8 pgs.
“U.S. Appl. No. 15/495,432, Non Final Office Action dated May 9, 2018”, 9 pgs.
“U.S. Appl. No. 15/887,740, Preliminary Amendment Filed Apr. 27, 2018”, 8 pgs.
“U.S. Appl. No. 15/933,576, Preliminary Amendment Filed Apr. 17, 2018”, 6 pgs.
“U.S. Appl. No. 15/972,591, Preliminary Amendment Filed May 21, 2018”, 6 pgs.
“European Application Serial No. 10705951.1, Communication Pursuant to Article 94(3) EPC dated May 23, 2018”, 7 pgs.
“U.S. Appl. No. 12/371,096, Corrected Notice of Allowance dated Nov. 13, 2017”, 2 pgs.
“U.S. Appl. No. 12/371,096, Notice of Allowance dated Oct. 20, 2017”, 5 pgs.
“U.S. Appl. No. 13/527,981, Corrected Notice of Allowance dated Nov. 27, 2017”, 2 pgs.
“U.S. Appl. No. 13/527,981, Notice of Allowance dated Nov. 3, 2017”, 5 pgs.
“U.S. Appl. No. 14/483,214, Final Office Action dated Oct. 25, 2017”, 11 pgs.
“U.S. Appl. No. 14/658,429, Examiner Interview Summary dated Dec. 26, 2017”, 2 pgs.
“U.S. Appl. No. 14/658,429, Final Office Action dated Oct. 20, 2017”, 11 pgs.
“U.S. Appl. No. 14/658,429, Notice of Allowance dated Feb. 9, 2018”, 8 pgs.
“U.S. Appl. No. 14/658,429, Response filed Jan. 4, 2018 to Final Office Action dated Oct. 20, 2017”, 20 pgs.
“U.S. Appl. No. 14/798,809, Advisory Action dated Feb. 28, 2018”, 3 pgs.
“U.S. Appl. No. 14/798,809, Final Office Action dated Dec. 29, 2017”, 4 pgs.
“U.S. Appl. No. 14/798,809, Response filed Feb. 21, 2018 to Final Office Action dated Dec. 29, 2017”, 7 pgs.
“U.S. Appl. No. 14/798,809, Response Filed Mar. 29, 2018 to Advisory Action dated Feb. 28, 2018”, 8 pgs.
“U.S. Appl. No. 14/865,762, Final Office Action dated Mar. 8, 2018”, 14 pgs.
“U.S. Appl. No. 15/008,528, Response filed Dec. 7, 2017 to Restriction Requirement dated Oct. 12, 2017”, 7 pgs.
“U.S. Appl. No. 15/008,528, Restriction Requirement dated Oct. 12, 2017”, 6 pgs.
“U.S. Appl. No. 15/130,414, Response filed Apr. 2, 2018 to Restriction Requirement dated Feb. 6, 2018”, 7 pgs.
“U.S. Appl. No. 15/130,414, Response filed Nov. 6, 2017 to Restriction Requirement dated Sep. 20, 2017”, 8 pgs.
“U.S. Appl. No. 15/130,414, Restriction Requirement dated Feb. 6, 2018”, 8 pgs.
“U.S. Appl. No. 15/224,741, Restriction Requirement dated Mar. 15, 2018”, 7 pgs.
“U.S. Appl. No. 15/267,714, Notice of Allowance dated Oct. 10, 2017”, 13 pgs.
“U.S. Appl. No. 15/495,432, Response filed Apr. 4, 2018 to Restriction Requirement dated Feb. 9, 2018”, 10 pgs.
“U.S. Appl. No. 15/495,432, Restriction Requirement dated Feb. 9, 2018”, 8 pgs.
“U.S. Appl. No. 15/618,331, Notice of Allowance dated Jan. 10, 2018”, 10 pgs.
“U.S. Appl. No. 15/712,679, Preliminary Amendment filed Oct. 12, 2017”, 7 pgs.
“U.S. Appl. No. 15/863,421, Preliminary Amendment Filed Mar. 13, 2018”, 9 pgs.
“U.S. Appl. No. 15/875,204, Preliminary Amendment filed Mar. 8, 2018”, 9 pgs.
“U.S. Appl. No. 15/878,984, Preliminary Amendment Filed Mar. 9, 2018”, 8 pgs.
“European Application Serial No. 16179349.2, Response filed Oct. 19, 2017 to Extended European Search Report dated Mar. 22, 2017”, 17 pgs.
“European Application Serial No. 16179569.5, Response filed Feb. 7, 2018 to Extended European Search Report dated Jul. 7, 2017”, 14 pgs.
“German Application Serial No. 1120111008104, Office Action dated Oct. 18, 2017”, (W/ English translation of claims), 7 pgs.
“German Application Serial No. 1120111008104, Response filed Feb. 23, 2018 to Office Action dated Oct. 18, 2017”, (W/ English translation of claims), 8 pgs.
Kwon, Oh-Ryong, et al., “The Effect of Femoral Cutting Guide Design Improvements for Patient-Specific Instruments”, BioMed Research International, vol. 2015, Article ID 978686; https://www.hindawi.com/journals/bmri/2015/978686/, (Apr. 20, 2015), 9 pgs.
Macdessi, S., et al., “Patient-specific cutting guides for total knee arthroplasty”, Cochrane Database of Systematic Reviews, Issue 3. Art. No. CD012589; http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD012589/full, (Mar. 13, 2017), 16 pgs.
“3D-Implantatplanung und StereolithographieImplantatbohrschablonen”, Stomatologie 101.3, (2004), 55-59.
“AGC 3000 Intramedullary”,—Surgical Technique Using PMMA Fixation—Biomet, Inc., (1987), 32 pgs.
“AGC Distal Fem Cutter for Dr. Hardy”, Biomet, Inc., (Jun. 22, 1989), 4 pgs.
“AGC Total Knee System, Intramedullary Without Distractor Surgical Technique”, Biomet, Inc., (1989), 35 pgs.
“AGC Total Knee System, Unicondylar Surgical Overview”, Biomet, Inc., (Jan. 31, 1989), 5 pgs.
“AGC Traditional Surgical Overview”, Biomet Orthopedics, Inc., (2001), 8 pgs.
“AGC-S Total Knee System, Surgical Technique for the AGC-S Total Knee System”, Biomet, Inc., (1992), 22 pgs.
“Anatomic Axial Alignment Instrumentation”, Biomet, Inc., (1994), 24 pgs.
“U.S. Appl. No. 09/861,859, 312 Amendment filed Sep. 27, 2011”, 3 pgs.
“U.S. Appl. No. 09/861,859, Final Office Action dated Aug. 5, 2011”, 10 pgs.
“U.S. Appl. No. 09/861,859, Non Final Office Action dated Mar. 3, 2011”, 9 pgs.
“U.S. Appl. No. 09/861,859, Notice of Allowance dated Sep. 8, 2011”, 5 pgs.
“U.S. Appl. No. 09/861,859, Notice of Non Compliant Amendment dated Nov. 18, 2010”, 3 pgs.
“U.S. Appl. No. 09/861,859, PTO Response to Rule 312 Communication dated Oct. 7, 2011”, 2 pgs.
“U.S. Appl. No. 09/861,859, Response filed May 12, 2011 to Non-Final Office Action dated Mar. 3, 2011”, 13 pgs.
“U.S. Appl. No. 09/861,859, Response filed Aug. 22, 2011 to Non Final Office Action dated Aug. 5, 2011”, 9 pgs .
“U.S. Appl. No. 09/861,859, Response filed Oct. 28, 2010 to Restriction Requirement dated Sep. 29, 2010”, 1 pg.
“U.S. Appl. No. 09/861,859, Response filed Nov. 29, 2010 to Notice of Non Compliant Amendment dated Nov. 18, 2010”, 8 pgs.
“U.S. Appl. No. 09/861,859, Restriction Requirement dated Sep. 29, 2010”, 7 pgs.
“U.S. Appl. No. 11/363,548, Advisory Action dated Aug. 5, 2009”, 2 pgs.
“U.S. Appl. No. 11/363,548, Appeal Brief filed Jun. 19, 2009”, 52 pgs.
“U.S. Appl. No. 11/363,548, Final Office Action dated Jan. 22, 2009”, 12 pgs.
“U.S. Appl. No. 11/363,548, Non Final Office Action dated Jul. 9, 2008”, 11 pgs.
“U.S. Appl. No. 11/363,548, Notice of Allowance dated Apr. 9, 2010”, 5 pgs.
“U.S. Appl. No. 11/363,548, Response filed Jun. 19, 2009 to Final Office Action dated Jan. 22, 2009”, 9 pgs.
“U.S. Appl. No. 11/363,548, Response filed Oct. 8, 2008 to Non Final Office Action dated Jul. 9, 2008”, 18 pgs.
“U.S. Appl. No. 11/971,390, Non Final Office Action dated Mar. 3, 2011”, 7 pgs.
“U.S. Appl. No. 11/971,390, Notice of Allowance dated Jul. 26, 2011”, 8 pgs.
“U.S. Appl. No. 11/971,390, Preliminary Amendment filed Jan. 14, 2011”, 8 pgs.
“U.S. Appl. No. 11/971,390, Response filed May 12, 2011 to Non Final Office Action dated Mar. 3, 2011”, 12 pgs.
“U.S. Appl. No. 11/971,390, Response filed Dec. 23, 2010 to Restriction Requirement dated Nov. 23, 2010”, 1 pgs.
“U.S. Appl. No. 11/971,390, Restriction Requirement dated Nov. 23, 2010”, 6 pgs.
“U.S. Appl. No. 12/039,849, Final Office Action dated Apr. 8, 2012”, 7 pgs.
“U.S. Appl. No. 12/039,849, Non Final Office Action dated Mar. 8, 2012”, 11 pgs.
“U.S. Appl. No. 12/039,849, Notice of Allowance dated Jun. 6, 2012”, 7 pgs.
“U.S. Appl. No. 12/039,849, Response filed Apr. 3, 2012 to Non Final Office Action dated Mar. 8, 2012”, 19 pgs.
“U.S. Appl. No. 12/039,849, Response filed May 14, 2012 to Final Office Action dated Apr. 8, 2012”, 7 pgs.
“U.S. Appl. No. 12/039,849, Response filed Aug. 30, 2011 to Restriction Requirement dated Aug. 16, 2011”, 11 pgs.
“U.S. Appl. No. 12/039,849, Restriction Requirement dated Aug. 16, 2011”, 6 pgs.
“U.S. Appl. No. 12/103,824, Examiner Interview Summary dated Jan. 12, 2012”, 2 pgs.
“U.S. Appl. No. 12/103,824, Examiner Interview Summary dated Sep. 19, 2011”, 3 pgs.
“U.S. Appl. No. 12/103,824, Final Office Action dated Apr. 26, 2012”, 19 pgs.
“U.S. Appl. No. 12/103,824, Final Office Action dated Dec. 6, 2011”, 20 pgs.
“U.S. Appl. No. 12/103,824, Non Final Office Action dated Aug. 17, 2011”, 17 pgs.
“U.S. Appl. No. 12/103,824, Response filed Sep. 15, 2011 to Non Final Office Action dated Aug. 17, 2011”, 16 pgs.
“U.S. Appl. No. 12/103,834 , Final Office Action dated Dec. 8, 2010”, 11 pgs.
“U.S. Appl. No. 12/103,834 , Non Final Office Action dated Jun. 22, 2010”, 9 pgs.
“U.S. Appl. No. 12/103,834 , Response filed Feb. 3, 2011 to Final Office Action dated Dec. 8, 2010”, 5 pgs.
“U.S. Appl. No. 12/103,834 , Response filed Sep. 21, 2010 to Non Final Office Action dated Jun. 22, 2010”, 11 pgs.
“U.S. Appl. No. 12/103,834, Notice of Allowance dated Feb. 23, 2011”, 9 ogs.
“U.S. Appl. No. 12/103,834, Response filed Mar. 18, 2010 to Restriction Requirement dated Feb. 18, 2010”, 9 pgs.
“U.S. Appl. No. 12/103,834, Restriction Requirement dated Feb. 18, 2010”, 9 pgs.
“U.S. Appl. No. 12/211,407, Examiner Interview Summary dated Jan. 13, 2012”, 3 pgs.
“U.S. Appl. No. 12/211,407, Examiner Interview Summary dated Dec. 5, 2013”, 3 pgs.
“U.S. Appl. No. 12/211,407, Final Office Action dated Nov. 25, 2011”, 14 pgs.
“U.S. Appl. No. 12/211,407, Non Final Office Action dated Aug. 17, 2011”, 15 pgs.
“U.S. Appl. No. 12/211,407, Notice of Allowance dated Aug. 7, 2013”, 12 pgs.
“U.S. Appl. No. 12/211,407, Response filed Jan. 16, 2012 to Final Office Action dated Nov. 25, 2011”, 18 pgs.
“U.S. Appl. No. 12/211,407, Response filed Aug. 29, 2011 to Non Final Office Action dated Aug. 17, 2011”, 19 pgs.
“U.S. Appl. No. 12/255,945, Advisory Action dated Feb. 5, 2014”, 3 pgs.
“U.S. Appl. No. 12/255,945, Advisory Action dated Feb. 10, 2012”, 3 pgs.
“U.S. Appl. No. 12/255,945, Advisory Action dated Mar. 27, 2014”, 3 pgs.
“U.S. Appl. No. 12/255,945, Appeal Brief filed Mar. 26, 2014”, 29 pgs.
“U.S. Appl. No. 12/255,945, Appeal Brief filed Oct. 13, 2014”, 30 pgs.
“U.S. Appl. No. 12/255,945, Examiner Interview Summary dated Aug. 13, 2013”, 3 pgs.
“U.S. Appl. No. 12/255,945, Examiner Interview Summary dated Sep. 22, 2011”, 3 pgs.
“U.S. Appl. No. 12/255,945, Examiner's Answer dated Feb. 12, 2015”, 26 pgs.
“U.S. Appl. No. 12/255,945, Final Office Action dated Sep. 30, 2013”, 21 pgs.
“U.S. Appl. No. 12/255,945, Final Office Action dated Nov. 28, 2011”, 14 pgs.
“U.S. Appl. No. 12/255,945, Non Final Office Action dated May 7, 2013”, 23 pgs.
“U.S. Appl. No. 12/255,945, Non Final Office Action dated Jul. 24, 2014”, 26 pgs.
“U.S. Appl. No. 12/255,945, Non Final Office Action dated Aug. 4, 2011”, 12 pgs.
“U.S. Appl. No. 12/255,945, Reply Brief filed Apr. 13, 2015”, 4 pgs.
“U.S. Appl. No. 12/255,945, Response filed Jan. 17, 2012 to Final Office Action dated Nov. 28, 2011”, 11 pgs.
“U.S. Appl. No. 12/255,945, Response filed Jan. 28, 2014 to Final Office Action dated Sep. 30, 2013”, 13 pgs.
“U.S. Appl. No. 12/255,945, Response filed Feb. 28, 2012 to Advisory Action dated Feb. 10, 2012”, 13 pgs.
“U.S. Appl. No. 12/255,945, Response filed Jul. 7, 2011 to Restriction Requirement dated Jun. 7, 2011”, 8 pgs.
“U.S. Appl. No. 12/255,945, Response filed Aug. 8, 2013 to Non Final Office Action dated May 7, 2013”, 13 pgs.
“U.S. Appl. No. 12/255,945, Response filed Nov. 4, 2011 to Non Final Office Action dated Aug. 4, 2011”, 14 pgs.
“U.S. Appl. No. 12/255,945, Restriction Requirement dated Jun. 7, 2011”, 8 pgs.
“U.S. Appl. No. 12/255,945, Supplemental Amendment filed Mar. 5, 2014”, 13 pgs.
“U.S. Appl. No. 12/371,096, Examiner Interview Summary dated Jan. 13, 2012”, 3 pgs.
“U.S. Appl. No. 12/371,096, Examiner Iinterview Summary dated Dec. 5, 2013”, 3 pgs.
“U.S. Appl. No. 12/371,096, Final Office Action dated Jul. 6, 2011”, 23 pgs.
“U.S. Appl. No. 12/371,096, Final Office Action dated Nov. 25, 2011”, 14 pgs.
“U.S. Appl. No. 12/371,096, Non Final Office Action dated Mar. 30, 2011”, 19 pgs.
“U.S. Appl. No. 12/371,096, Non Final Office Action dated Apr. 17, 2014”, 23 pgs.
“U.S. Appl. No. 12/371,096, Non Final Office Action dated Aug. 17, 2011”, 15 pgs.
“U.S. Appl. No. 12/371,096, Non Final Office Action dated Aug. 28, 2014”, 21 pgs.
“U.S. Appl. No. 12/371,096, Notice of Allowance dated Aug. 7, 2013”, 12 pgs.
“U.S. Appl. No. 12/371,096, Notice of Allowance dated Nov. 5, 2013”, 2 pgs.
“U.S. Appl. No. 12/371,096, Notice of Allowance dated Nov. 15, 2013”, 2 pgs.
“U.S. Appl. No. 12/371,096, Response filed Jan. 16, 2012 to Final Office Action dated Nov. 25, 2011”, 15 pgs.
“U.S. Appl. No. 12/371,096, Response filed Aug. 29, 2011 to Non Final Office Action dated Aug. 17, 2011”, 19 pgs.
“U.S. Appl. No. 12/389,901, Applicant's Summary of Examiner Interview filed Nov. 28, 2011”, 1 pg.
“U.S. Appl. No. 12/389,901, Examiner Interview Summary dated Nov. 1, 2011”, 3 pgs.
“U.S. Appl. No. 12/389,901, Non Final Office Action dated May 12, 2011”, 6 pgs.
“U.S. Appl. No. 12/389,901, Notice of Allowance dated Sep. 30, 2011”, 12 pgs.
“U.S. Appl. No. 12/389,901, Notice of Allowance dated Dec. 7, 2011”, 9 pgs.
“U.S. Appl. No. 12/389,901, Response filed Mar. 17, 2011 to Restriction Requirement dated Mar. 2, 2011”, 8 pgs.
“U.S. Appl. No. 12/389,901, Response filed Jun. 28, 2011 to Non Final Office Action dated May 12, 2011”, 11 pgs.
“U.S. Appl. No. 12/389,901, Restriction Requirement dated Mar. 2, 2011”, 6 pgs.
“U.S. Appl. No. 12/483,807 , Advisory Action dated Jan. 3, 2012”, 2 pgs.
“U.S. Appl. No. 12/483,807, Applicant's Summary of Examiner Interview filed Jan. 19, 2012”, 3 pgs.
“U.S. Appl. No. 12/483,807, Applicant's Summary of Examiner Interview filed Dec. 21, 2011”. 3 pgs.
“U.S. Appl. No. 12/483,807, Non Final Office Action dated Oct. 3, 2011”, 18 pgs.
“U.S. Appl. No. 12/483,807, Notice of Allowance dated Feb. 21, 2013”, 9 pgs.
“U.S. Appl. No. 12/483,807, Response filed Jan. 16, 2012 to Advisory Action dated Jan. 3, 2012”, 14 pgs.
“U.S. Appl. No. 12/483,807, Response filed Oct. 24, 2011 to Non Final Office Action dated Oct. 3, 2011”, 16 pgs.
“U.S. Appl. No. 12/483,807, Response filed Dec. 19, 2011 to Final Office Action dated Nov. 4, 2011”, 7 pgs.
“U.S. Appl. No. 12/486,992, Examiner Interview Summary dated Jan. 9, 2012”, 3 pgs.
“U.S. Appl. No. 12/486,992, Examiner Interview Summary dated Mar. 9, 2012”, 4 pgs.
“U.S. Appl. No. 12/486,992, Final Office Action dated Feb. 21, 2012”, 8 pgs.
“U.S. Appl. No. 12/486,992, Non Final Office Action dated Nov. 21, 2011”, 9 pgs.
“U.S. Appl. No. 12/486,992, Notice of Allowance dated Jun. 12, 2014”, 11 pgs.
“U.S. Appl. No. 12/486,992, Preliminary Amendment filed Mar. 9, 2010”, 3 pgs.
“U.S. Appl. No. 12/486,992, Response filed Jan. 17, 2012 to Non Final Office Action dated Nov. 21, 2011”, 13 pgs.
“U.S. Appl. No. 12/486,992, Response filed Mar. 12, 2012 to Final Office Action dated Feb. 21, 2012”, 10 pgs.
“U.S. Appl. No. 12/486,992, Response filed Oct. 24, 2011 to Restriction Requirement dated Sep. 30, 2011”, 7 pgs.
“U.S. Appl. No. 12/486,992, Restriction Requirement dated Sep. 30, 2011”, 6 pgs.
“U.S. Appl. No. 12/571,969, Advisory Action dated Oct. 21, 2013”, 3 pgs.
“U.S. Appl. No. 12/571,969, Examiner Interview Summary dated Feb. 26, 2015”, 3 pgs.
“U.S. Appl. No. 12/571,969, Examiner Interview Summary dated Mar. 11, 2013”, 3 pgs.
“U.S. Appl. No. 12/571,969, Final Office Action dated Jan. 15, 2015”, 9 pgs.
“U.S. Appl. No. 12/571,969, Final Office Action dated Jul. 31, 2013”, 8 pgs.
“U.S. Appl. No. 12/571,969, Non Final Office Action dated Jun. 26, 2014”, 8 pgs.
“U.S. Appl. No. 12/571,969, Non Final Office Action dated Dec. 19, 2012”, 7 pgs.
“U.S. Appl. No. 12/571,969, Notice of Allowance dated Jun. 23, 2015”, 8 pgs.
“U.S. Appl. No. 12/571,969, Preliminary Amendment filed Mar. 16, 2010”, 3 pgs.
“U.S. Appl. No. 12/571,969, Response filed Mar. 6, 2013 to Non Final Office Action dated Dec. 19, 2012”, 10 pgs.
“U.S. Appl. No. 12/571,969, Response filed May 15, 2015 to Final Office Action dated Jan. 15, 2015”, 16 pgs.
“U.S. Appl. No. 12/571,969, Response filed Jun. 4, 2012 to Restriction Requirement dated May 9, 2012”, 9 pgs.
“U.S. Appl. No. 12/571,969, Response filed Sep. 26, 2014 to Non Final Office Action dated Jun. 26, 2014”, 12 pgs.
“U.S. Appl. No. 12/571,969, Response filed Sep. 30, 2013 to Final Office Action dated Jul. 31, 2013”, 13 pgs.
“U.S. Appl. No. 12/571,969, Restriction Requirement dated May 9, 2012”, 9 pgs.
“U.S. Appl. No. 12/714,023, Non Final Office Action dated Jan. 26, 2012”, 15 pgs.
“U.S. Appl. No. 12/714,023, Notice of Allowance dated Apr. 9, 2012”, 10 pgs.
“U.S. Appl. No. 12/714,023, Response filed Jan. 3, 2012 to Restriction Requirement dated Dec. 12, 2011”, 9 pgs.
“U.S. Appl. No. 12/714,023, Response filed Feb. 14, 2012 to Non Final Office Action dated Jan. 26, 2012”, 15 pgs.
“U.S. Appl. No. 12/714,023, Restriction Requirement dated Dec. 12, 2011”, 5 pgs.
“U.S. Appl. No. 12/872,663, Non Final Office Action dated Jun. 20, 2012”, 11 pgs.
“U.S. Appl. No. 12/872,663, Notice of Allowance dated Nov. 15, 2012”, 9 pgs.
“U.S. Appl. No. 12/872,663, Response filed May 21, 2012 to Restriction Requirement dated Apr. 27, 2012”, 7 pgs.
“U.S. Appl. No. 12/872,663, Restriction Requirement dated Apr. 27, 2012”, 6 pgs.
“U.S. Appl. No. 12/872,663, Supplemental Amendment filed Nov. 8, 2012”, 8 pgs.
“U.S. Appl. No. 12/888,005, Non Final Office Action dated Jun. 1, 2012”, 11 pgs.
“U.S. Appl. No. 12/888,005, Notice of Allowance dated Sep. 27, 2012”, 6 pgs.
“U.S. Appl. No. 12/888,005, Response filed May 15, 2012 to Restriction Requirement dated Apr. 27, 2012”, 7 pgs.
“U.S. Appl. No. 12/888,005, Response filed Jul. 11, 2012 to Non Final Office Action dated Jun. 1, 2012”, 12 pgs.
“U.S. Appl. No. 12/888,005, Restriction Requirement dated Apr. 27, 2012”, 7 pgs.
“U.S. Appl. No. 12/893,306, Examiner Interview Summary dated Dec. 18, 2014”, 3 pgs.
“U.S. Appl. No. 12/893,306, Final Office Action dated Sep. 11, 2014” 8 pgs.
“U.S. Appl. No. 12/893,306, Non Final Office Action dated Feb. 26, 2014”, 9 pgs.
“U.S. Appl. No. 12/893,306, Notice of Allowability dated Jul. 29, 2015”, 2 pgs.
“U.S. Appl. No. 12/893,306, Notice of Allowance dated Apr. 14, 2015”, 5 pgs.
“U.S. Appl. No. 12/893,306, Response filed Jan. 12, 2015 to Final Office Action dated Sep. 11, 2014”, 14 pgs.
“U.S. Appl. No. 12/893,306, Response filed May 22, 2014 to Non Final Office Action dated Feb. 26, 2014”, 8 pgs.
“U.S. Appl. No. 12/893,306, Response filed Nov. 4, 2013 to Restriction Requirement dated Oct. 4, 2013”, 11 pgs.
“U.S. Appl. No. 12/893,306, Restriction Requirement dated Oct. 4, 2013”, 11 pgs.
“U.S. Appl. No. 12/938,905, Advisory Action dated Feb. 4, 2013”, 3 pgs.
“U.S. Appl. No. 12/938,905, Appeal Brief filed Feb. 28, 2013”, 1 pg.
“U.S. Appl. No. 12/938,905, Appeal Brief filed Apr. 29, 2013”, 26 pgs.
“U.S. Appl. No. 12/938,905, Appeal Decision dated Dec. 14, 2015”, 18 pgs.
“U.S. Appl. No. 12/938,905, Examiner Interview Summary dated Jan. 30, 2013”, 3 pgs.
“U.S. Appl. No. 12/938,905, Examiner Interview Summary dated Jul. 13, 2012”, 3 pgs.
“U.S. Appl. No. 12/938,905, Examiner's Answer to Appeal Brief dated Jun. 24, 2013”, 8 pgs.
“U.S. Appl. No. 12/938,905, Final Office Action dated Nov. 28, 2012”, 11 pgs.
“U.S. Appl. No. 12/938,905, Non Final Office Action dated Jun. 4, 2012”, 11 pgs.
“U.S. Appl. No. 12/938,905, Reply Brief filed Aug. 26, 2013”, 12 pgs.
“U.S. Appl. No. 12/938,905, Response filed Jan. 28, 2013 to Final Office Action dated Nov. 28, 2012”, 19 pgs.
“U.S. Appl. No. 12/938,905, Response filed May 14, 2012 to Restriction Requirement dated Apr. 17, 2012”, 7 pgs.
“U.S. Appl. No. 12/938,905, Response filed Jul. 19, 2012 to Non Final Office Action dated Jun. 4, 2012”, 20 pgs.
“U.S. Appl. No. 12/938,905, Response filed Oct. 8, 2012 to Restriction Requirement dated Sep. 14, 2012”, 8 pgs.
“U.S. Appl. No. 12/938,905, Restriction Requirement dated Apr. 17, 2012”, 8 pgs.
“U.S. Appl. No. 12/938,905, Restriction Requirement dated Sep. 14, 2012”, 6 pgs.
“U.S. Appl. No. 12/938,913, Advisory Action dated Jan. 15, 2015”, 3 pgs.
“U.S. Appl. No. 12/938,913, Examiner Interview Summary dated Dec. 18, 2014”, 3 pgs.
“U.S. Appl. No. 12/938,913, Final Office Action dated Oct. 1, 2014”, 9 pgs.
“U.S. Appl. No. 12/938,913, Non Final Office Action dated Mar. 11, 2014”, 10 pgs.
“U.S. Appl. No. 12/938,913, Non Final Office Action dated Apr. 9, 2015”, 8 pgs.
“U.S. Appl. No. 12/938,913, Notice of Allowance dated Nov. 12, 2015”, 5 pgs.
“U.S. Appl. No. 12/938,913, Response filed Jan. 2, 2015 to Final Office Action dated Oct. 1, 2014”, 10 pgs.
“U.S. Appl. No. 12/938,913, Response filed Feb. 2, 2015 to Advisory Action dated Jan. 15, 2015”, 14 pgs.
“U.S. Appl. No. 12/938,913, Response filed Jun. 11, 2014 to Non Final Office Action dated Mar. 11, 2014”, 9 pgs.
“U.S. Appl. No. 12/938,913, Response filed Jul. 7, 2015 to Non Final Office Action dated Apr. 9, 2015”, 11 pgs.
“U.S. Appl. No. 12/938,913, Response filed Nov. 6, 2013 to Restriction Requirement dated Oct. 7, 2013”, 1 pg.
“U.S. Appl. No. 12/938,913, Restriction Requirement dated Oct. 7, 2013”, 7 pgs.
“U.S. Appl. No. 12/955,361 , Non Final Office Action dated Mar. 27, 2013”, 23 pgs.
“U.S. Appl. No. 12/955,361 , Response filed Jun. 27, 2013 to Non Final Office Action dated Mar 27, 2013”, 12 pgs.
“U.S. Appl. No. 12/955,361, Notice of Allowance dated Jul. 18, 2013”, 9 pgs.
“U.S. Appl. No. 12/955,361, Notice of Allowance dated Oct. 1, 2013”, 4 pgs.
“U.S. Appl. No. 12/955,361, Notice of Allowance dated Oct. 24, 2013”, 4 pgs.
“U.S. Appl. No. 12/955,361, Response filed Jan. 14, 2013 to Restriction Requirement dated Dec. 14, 2012”, 13 pgs.
“U.S. Appl. No. 12/955,361, Restriction Requirement dated Dec. 14, 2012”, 9 pgs.
“U.S. Appl. No. 12/973,214 , Response filed Feb. 21, 2014 to Final Office Action dated Nov. 21, 2013”, 16 pgs.
“U.S. Appl. No. 12/973,214, Examiner Interview Summary dated Jan. 24, 2014”, 3 pgs.
“U.S. Appl. No. 12/973,214, Final Office Action dated Sep. 9, 2015”, 10 pgs.
“U.S. Appl. No. 12/973,214, Final Office Action dated Nov. 21, 2013”, 14 pgs.
“U.S. Appl. No. 12/973,214, Non Final Office Action dated Feb. 3, 2015”, 14 pgs.
“U.S. Appl. No. 12/973,214, Non Final Office Action dated May 22, 2013”, 11 pgs.
“U.S. Appl. No. 12/973,214, Notice of Allowance dated Jan. 11, 2016”, 8 pgs.
“U.S. Appl. No. 12/973,214, Response filed Apr. 12, 2013 to Restriction Requirement dated Mar. 13, 2013”, 9 pgs.
“U.S. Appl. No. 12/973,214, Response filed Jun. 3, 2015 to Non Final Office Action dated Feb. 3, 2015”, 13 pgs.
“U.S. Appl. No. 12/973,214, Response filed Aug. 22, 2013 to Non Final Office Action dated May 22, 2013”, 12 pgs.
“U.S. Appl. No. 12/973,214, Response filed Nov. 6, 2015 to Final Office Action dated Sep. 9, 2015”, 14 pgs.
“U.S. Appl. No. 12/973,214, Restriction Requirement dated Mar. 13, 2013”, 8 pgs.
“U.S. Appl. No. 12/978,069, Advisory Action dated Jun. 12, 2013”, 3 pgs.
“U.S. Appl. No. 12/978,069, Examiner Interview Summary dated May 28, 2013”, 3 pgs.
“U.S. Appl. No. 12/978,069, Final Office Action dated Mar. 25, 2013”, 11 pgs.
“U.S. Appl. No. 12/978,069, Non Final Office Action dated Sep. 11, 2012”, 11 pgs.
“U.S. Appl. No. 12/978,069, Notice of Allowance dated Jun. 21, 2013”, 13 pgs.
“U.S. Appl. No. 12/978,069, Response filed May 23, 2013 to Final Office Action dated Mar. 25, 2013”, 17 pgs.
“U.S. Appl. No. 12/978,069, Response filed Aug. 27, 2012 to Restriction Requirement dated Aug. 10, 2012”, 8 pgs.
“U.S. Appl. No. 12/978,069, Response filed Dec. 10, 2012 to Non Final Office Action dated Sep. 11, 2012”, 15 pgs.
“U.S. Appl. No. 12/978,069, Restriction Requirement dated Aug. 10, 2012”, 11 pgs.
“U.S. Appl. No. 12/978,069, Supplemental Notice of Allowance dated Aug. 9, 2013”, 3 pgs.
“U.S. Appl. No. 12/978,069, Supplemental Notice of Allowance dated Sep. 17, 2013”, 2 pgs.
“U.S. Appl. No. 13/041,469, Non Final Office Action dated Mar. 22, 2013”, 12 pgs.
“U.S. Appl. No. 13/041,469, Notice of Allowance dated Aug. 8, 2013”, 6 pgs.
“U.S. Appl. No. 13/041,469, Notice of Allowance dated Oct. 3, 2013”, 2 pgs.
“U.S. Appl. No. 13/041,469, Notice of Allowance dated Nov. 19, 2013”, 2 pgs.
“U.S. Appl. No. 13/041,469, Response filed Jun. 18, 2013 to Non Final Office Action dated Mar. 22, 2013”, 15 pgs.
“U.S. Appl. No. 13/041,469, Response filed Oct. 25, 2012 to Restriction Requirement dated Sep. 25, 2012”, 1 pg.
“U.S. Appl. No. 13/041,469, Restriction Requirement dated Sep. 25, 2012”, 5 pgs.
“U.S. Appl. No. 13/041,495, Appeal Brief filed Oct. 4, 2013”, 39 pgs.
“U.S. Appl. No. 13/041,495, Examiner Interview Summary dated Feb. 20, 2013”, 3 pgs.
“U.S. Appl. No. 13/041,495, Examiner Interview Summary dated Aug. 6, 2013”, 3 pgs.
“U.S. Appl. No. 13/041,495, Final Office Action dated Jun. 18, 2013”, 14 pgs.
“U.S. Appl. No. 13/041,495, Non Final Office Action dated Nov. 2, 2012”, 10 pgs.
“U.S. Appl. No. 13/041,495, Non Final Office Action dated Dec. 31, 2013”, 11 pgs.
“U.S. Appl. No. 13/041,495, Notice of Allowance dated Jun. 11, 2014”, 5 pgs.
“U.S. Appl. No. 13/041,495, Response filed Jan. 31, 2013 to Non Final Office Action dated Nov. 2, 2012”, 13 pgs.
“U.S. Appl. No. 13/041,495, Response filed Mar. 31, 2014 to Non Final Office Action dated Dec. 31, 2013”, 12 pgs.
“U.S. Appl. No. 13/041,495, Response filed Oct. 8, 2012 to Restriction Requirement dated Sep. 25, 2012”, 8 pgs.
“U.S. Appl. No. 13/041,495, Restriction Requirement dated Sep. 25, 2012”, 7 pgs.
“U.S. Appl. No. 13/041,495, Supplemental Amendment filed Feb. 20, 2013”, 15 pgs.
“U.S. Appl. No. 13/041,665, Examiner Interview Summary dated Apr. 30, 2013”, 3 pgs.
“U.S. Appl. No. 13/041,665, Final Office Action dated Mar. 5, 2013”, 10 pgs.
“U.S. Appl. No. 13/041,665, Non Final Office Action dated Sep. 27, 2012”, 10 pgs.
“U.S. Appl. No. 13/041,665, Notice of Allowance dated May 16, 2013”, 7 pgs.
“U.S. Appl. No. 13/041,665, Response filed May 3, 2013 to Final Office Action dated Mar. 5, 2013”, 13 pgs.
“U.S. Appl. No. 13/041,665, Response filed Sep. 17, 2012 to Restriction Requirement dated Aug. 20, 2012”, 6 pgs.
“U.S. Appl. No. 13/041,665, Response filed Dec. 27, 2012 to Non Final Office Action dated Sep. 27, 2012”, 16 pgs.
“U.S. Appl. No. 13/041,665, Restriction Requirement dated Aug. 20, 2012”, 9 pgs.
“U.S. Appl. No. 13/041,883, Advisory Action dated May 18, 2016”, 3 pgs.
“U.S. Appl. No. 13/041,883, Appeal Brief filed Jul. 25, 2016”, 26 pgs.
“U.S. Appl. No. 13/041,883, Examiner Interview Summary dated Oct. 27, 2014”, 3 pgs.
“U.S. Appl. No. 13/041,883, Final Office Action dated Jan. 15, 2015”, 10 pgs.
“U.S. Appl. No. 13/041,883, Final Office Action dated Feb. 11, 2016”, 9 pgs.
“U.S. Appl. No. 13/041,883, Non Final Office Action dated Jun. 26, 2014”, 8 pgs.
“U.S. Appl. No. 13/041,883, Non Final Office Action dated Aug. 13, 2015”, 10 pgs.
“U.S. Appl. No. 13/041,883, Response filed Feb. 17, 2014 to Restriction Requirement dated Jan. 15, 2014”, 3 pgs.
“U.S. Appl. No. 13/041,883, Response filed Apr. 7, 2016 to Final Office Action dated Feb. 11, 2016”, 17 pgs.
“U.S. Appl. No. 13/041,883, Response filed May 15, 2015 to Final Office Action dated Jan. 15, 2015”, 13 pgs.
“U.S. Appl. No. 13/041,883, Response filed Sep. 26, 2014 to Non Final Office Action Jun. 26, 2014”, 12 pgs.
“U.S. Appl. No. 13/041,883, Response filed Nov. 6, 2015 to Non Final Office Action dated Aug. 13, 2015”, 16 pgs.
“U.S. Appl. No. 13/041,883, Restriction Requirement dated Jan. 15, 2014”, 9 pgs.
“U.S. Appl. No. 13/045,169, Applicant's Summary of Examiner Interview filed Sep. 21, 2015”, 2 pgs.
“U.S. Appl. No. 13/045,169, Examiner Interview Summary dated Sep. 10, 2015”, 3 pgs.
“U.S. Appl. No. 13/045,169, Final Office Action dated Dec. 3, 2015”, 8 pgs.
“U.S. Appl. No. 13/045,169, Non Final Office Action dated Jun. 4, 2015”, 8 pgs.
“U.S. Appl. No. 13/045,169, Non Final Office Action dated Sep. 24, 2014”, 9 pgs.
“U.S. Appl. No. 13/045,169, Response filed May 15, 2014 to Restriction Requirement dated Mar. 14, 2014”, 10 pgs.
“U.S. Appl. No. 13/045,169, Response filed Aug. 31, 2015 to Non Final Office Action dated Jun. 4, 2015”, 14 pgs.
“U.S. Appl. No. 13/045,169, Response filed Dec. 23, 2014 to Non Final Office Action dated Sep. 24, 2014”, 10 pgs.
“U.S. Appl. No. 13/045,169, Restriction Requirement dated Mar. 14, 2014”, 10 pgs.
“U.S. Appl. No. 13/047,924, Examiner Interview Summary dated Jan. 21, 2015”, 3 pgs.
“U.S. Appl. No. 13/047,924, Examiner Interview Summary dated Jan. 25, 2013”, 3 pgs.
“U.S. Appl. No. 13/047,924, Examiner Interview Summary dated Sep. 5, 2013”, 3 pgs.
“U.S. Appl. No. 13/047,924, Examiner Interview Summary dated Sep. 18, 2012”, 3 pgs.
“U.S. Appl. No. 13/047,924, Final Office Action dated Apr. 3, 2015”, 16 pgs.
“U.S. Appl. No. 13/047,924, Final Office Action dated Jul. 18, 2013”, 14 pgs.
“U.S. Appl. No. 13/047,924, Non Final Office Action dated Sep. 21, 2012”, 11 pgs.
“U.S. Appl. No. 13/047,924, Non Final Office Action dated Nov. 3, 2014”, 14 pgs.
“U.S. Appl. No. 13/047,924, Response filed Feb. 3, 2015 to Non Final Office Action dated Nov. 3, 2014”, 16 pgs.
“U.S. Appl. No. 13/047,924, Response filed May 1, 2013 to Restriction Requirement dated Apr. 1, 2013”, 11 pgs.
“U.S. Appl. No. 13/047,924, Response filed Sep. 17, 2012 to Restriction Requirement dated Aug. 20, 2012”, 9 pgs.
“U.S. Appl. No. 13/047,924, Response filed Oct. 18, 2013 to Final Office Action dated Jul. 18, 2013”, 18 pgs.
“U.S. Appl. No. 13/047,924, Response filed Dec. 20, 2012 to Non Final Office Action dated Sep. 21, 2012”, 19 pgs.
“U.S. Appl. No. 13/047,924, Restriction Requirement dated Apr. 1, 2013”, 7 pgs.
“U.S. Appl. No. 13/047,924, Restriction Requirement dated Aug. 20, 2012”, 8 pgs.
“U.S. Appl. No. 13/081,618, Examiner Interview Summary dated Feb. 5, 2013”, 3 pgs.
“U.S. Appl. No. 13/081,618, Examiner Interview Summary dated Aug. 31, 2012”.
“U.S. Appl. No. 13/081,618, Final Office Action dated Nov. 19, 2012”, 8 pgs.
“U.S. Appl. No. 13/081,618, Non Final Office Action dated Jul. 25, 2012”, 7 pgs.
“U.S. Appl. No. 13/081,618, Notice of Allowance dated Feb. 26, 2013”, 9 pgs.
“U.S. Appl. No. 13/081,618, Response filed Feb. 15, 2013 to Final Office Action dated Nov. 19, 2012”, 12 pgs.
“U.S. Appl. No. 13/081,618, Response filed Aug. 23, 2012 to Non Final Office Action dated Jul. 25, 2012”, 10 pgs.
“U.S. Appl. No. 13/081,618, Supplemental Notice of Allowability dated Jun. 21, 2013”, 2 pgs.
“U.S. Appl. No. 13/088,787, Final Office Action dated May 20, 2015”, 11 pgs.
“U.S. Appl. No. 13/088,787, Non Final Office Action dated Sep. 11, 2014”, 8 pgs.
“U.S. Appl. No. 13/088,787, Restriction Requirement dated Mar. 12, 2014”, 9 pgs.
“U.S. Appl. No. 13/106,295, Non Final Office Action dated Jan. 24, 2013”, 14 pgs.
“U.S. Appl. No. 13/106,295, Notice of Allowance dated Aug. 1, 2013”, 9 pgs.
“U.S. Appl. No. 13/106,295, Response filed Apr. 16, 2013 to Non Final Office Action dated Jan. 24, 2013”, 10 pgs.
“U.S. Appl. No. 13/106,295, Response filed Dec. 20, 2012 to Restriction Requirement dated Nov. 23, 2012”, 1 pg.
“U.S. Appl. No. 13/106,295, Restriction Requirement dated Nov. 23, 2012”, 5 pgs.
“U.S. Appl. No. 13/111,007, Non Final Office Action dated Mar. 25, 2013”, 10 pgs.
“U.S. Appl. No. 13/111,007, Notice of Allowance dated Aug. 1, 2013”, 8 pgs.
“U.S. Appl. No. 13/111,007, Notice of Allowance dated Oct. 4, 2013”, 2 pgs.
“U.S. Appl. No. 13/111,007, Notice of Allowance dated Nov. 7, 2013”, 2 pgs.
“U.S. Appl. No. 13/111,007, Response filed Jun. 20, 2013 to Non Final Office Action dated Mar. 25, 2013”, 12 pgs.
“U.S. Appl. No. 13/111,007, Response filed Nov. 26, 2012 to Restriction Requirement dated Sep. 24, 2012”, 13 pgs.
“U.S. Appl. No. 13/111,007, Restriction Requirement dated Sep. 24, 2012”, 7 pgs.
“U.S. Appl. No. 13/303,546, Notice of Allowance dated Jun. 29, 2012”, 12 pgs.
“U.S. Appl. No. 13/303,546, Notice of Allowance dated Nov. 6, 2012”, 10 pgs.
“U.S. Appl. No. 13/303,546, Response filed Jun. 14, 2012 to Restriction Requirement dated May 30, 2012”, 7 pgs.
“U.S. Appl. No. 13/303,546, Response filed Aug. 16, 2012 to Non Final Office Action dated Jun. 29, 2012”, 11 pgs.
“U.S. Appl. No. 13/303,546, Restriction Requirement dated May 30, 2012”, 6 pgs.
“U.S. Appl. No. 13/303,546, Supplemental Notice of Allowance dated Jan. 8, 2013”, 4 pgs.
“U.S. Appl. No. 13/303,546, Supplemental Notice of Allowance dated Feb. 13, 2013”, 4 pgs.
“U.S. Appl. No. 13/343,957, Non Final Office Action dated Feb. 20, 2014”, 14 pgs.
“U.S. Appl. No. 13/343,957, Notice of Allowance dated Jul. 24, 2014”, 7 pgs.
“U.S. Appl. No. 13/343,957, Response filed May 20, 2014 to Non Final Office Action dated Feb. 20, 2014”, 14 pgs.
“U.S. Appl. No. 13/400,652, Corrected Notice of Allowance dated Feb. 1, 2016”, 2 pgs.
“U.S. Appl. No. 13/400,652, Non Final Office Action dated Jun. 17, 2015”, 7 pgs.
“U.S. Appl. No. 13/400,652, Notice of Allowance dated Jan. 11, 2016”, 7 pgs.
“U.S. Appl. No. 13/400,652, Response filed Jan. 28, 2015 to Restriction Requirement dated Nov. 28, 2014”, 17 pgs.
“U.S. Appl. No. 13/400,652, Response filed Apr. 13, 2015 to Restriction Requirement dated Feb. 13, 2015”, 16 pgs.
“U.S. Appl. No. 13/400,652, Response filed Aug. 13, 2014 to Restriction Requirement dated Jun. 13, 2014”, 19 pgs.
“U.S. Appl. No. 13/400,652, Response filed Sep. 16, 2015 to Non Final Office Action dated Jun. 17, 2015”, 12 pgs.
“U.S. Appl. No. 13/400,652, Restriction Requirement dated Feb. 13, 2015”, 8 pgs.
“U.S. Appl. No. 13/400,652, Restriction Requirement dated Jun. 13, 2014”, 9 pgs.
“U.S. Appl. No. 13/400,652, Restriction Requirement dated Nov. 28, 2014”, 7 pgs.
“U.S. Appl. No. 13/527,981, Advisory Action dated Jan. 20, 2016”, 3 pgs.
“U.S. Appl. No. 13/527,981, Final Office Action dated Feb. 5, 2015”, 22 pgs.
“U.S. Appl. No. 13/527,981, Final Office Action dated Nov. 6, 2015”, 13 pgs.
“U.S. Appl. No. 13/527,981, Non Final Office Action dated Feb. 26, 2015”, 10 pgs.
“U.S. Appl. No. 13/527,981, Non Final Office Action dated Jul. 28, 2016”, 11 pgs.
“U.S. Appl. No. 13/527,981, Non Final Office Action dated Sep. 15, 2014”, 19 pgs.
“U.S. Appl. No. 13/527,981, Response filed Jan. 6, 2016 to Final Office Action dated Nov. 6, 2015”, 14 pgs.
“U.S. Appl. No. 13/527,981, Response filed May 27, 2014 to Restriction Requirement dated Mar. 27, 2014”, 11 pgs.
“U.S. Appl. No. 13/527,981, Response filed Jul. 27, 2015 to Non-Final Office Action dated Feb. 26, 2015”, 25 pgs.
“U.S. Appl. No. 13/527,981, Response Filed Oct. 28, 2016 to Non-Final Office Action dated Jul. 28, 2016”, 15 pgs.
“U.S. Appl. No. 13/527,981, Restriction Requirement dated Mar. 27, 2014”, 7 pgs.
“U.S. Appl. No. 13/572,895, Non Final Office Action dated Nov. 7, 2013”, 5 pgs.
“U.S. Appl. No. 13/572,895, Notice of Allowance dated Apr. 29, 2014”, 7 pgs.
“U.S. Appl. No. 13/572,895, Response filed Feb. 7, 2014 to Non Final Office Action dated Nov. 7, 2013”, 13 pgs.
“U.S. Appl. No. 13/674,531, Final Office Action dated Apr. 29, 2015”, 8 pgs.
“U.S. Appl. No. 13/674,531, Response filed Jul. 29, 2015 to Final Office Action dated Apr. 29, 2015”, 12 pgs.
“U.S. Appl. No. 13/674,531, Restriction Requirement dated Sep. 24, 2014”, 7 pgs.
“U.S. Appl. No. 13/713,710, Notice of Allowance dated Sep. 15, 2015”, 10 pgs.
“U.S. Appl. No. 13/713,710, Response filed Aug. 25, 2015 to Restriction Requirement dated Jul. 2, 2015”, 7 pgs.
“U.S. Appl. No. 13/713,710, Restriction Requirement dated Jul. 2, 2015”, 6 pgs.
“U.S. Appl. No. 13/744,022, Advisory Action dated Oct. 27, 2014”, 3 pgs.
“U.S. Appl. No. 13/744,022, Final Office Action dated Jul. 14, 2014”, 9 pgs.
“U.S. Appl. No. 13/744,022, Non Final Office Action dated Jan. 30, 2014”, 20 pgs.
“U.S. Appl. No. 13/744,022, Notice of Allowance dated Nov. 28, 2014”, 9 pgs.
“U.S. Appl. No. 13/744,022, Response filed Apr. 25, 2014 to Non Final Office Action dated Jan. 30, 2014”, 16 pgs.
“U.S. Appl. No. 13/744,022, Response filed Oct. 8, 2014 to Final Office Action dated Jul. 14, 2014”, 15 pgs.
“U.S. Appl. No. 13/766,419, Advisory Action dated May 18, 2015”, 2 pgs.
“U.S. Appl. No. 13/766,419, Final Office Action dated Jan. 13, 2015” 16 pgs.
“U.S. Appl. No. 13/766,419, Non Final Office Action dated Sep. 5, 2014”, 14 pgs.
“U.S. Appl. No. 13/766,419, Response filed May 12, 2015 to Final Office Action dated Jan. 13, 2015”. 13 pgs.
“U.S. Appl. No. 13/766,419, Response filed Dec. 5, 2014 to Non Final Office Action dated Sep. 5, 2014”, 12 pgs.
“U.S. Appl. No. 13/800,334, Examiner Interview Summary dated Jan. 29, 2015”, 4 pgs.
“U.S. Appl. No. 13/800,334, Final Office Action dated Feb. 12, 2015”, 11 pgs.
“U.S. Appl. No. 13/800,334, Non Final Office Action dated Sep. 24, 2015”, 14 pgs.
“U.S. Appl. No. 13/800,334, Non Final Office Action dated Oct. 22, 2014”, 11 pgs.
“U.S. Appl. No. 13/800,334, Non Final Office Action dated Dec. 15, 2016”, 26 pgs.
“U.S. Appl. No. 13/800,334, Response filed Jan. 21, 2015 to Non Final Office Action dated Oct. 22, 2014”, 12 pgs.
“U.S. Appl. No. 13/800,334, Response filed Jun. 24, 2016 to Final Office Action dated Apr. 7, 2016”, 19 pgs.
“U.S. Appl. No. 13/800,334, Response filed Jul. 10, 2015 to Final Office Action dated Feb. 12, 2015”, 8 pgs.
“U.S. Appl. No. 13/800,334, Response filed Dec. 16, 2015 to Non Final Office Action dated Sep. 24, 2015”, 16 pgs.
“U.S. Appl. No. 13/923,827, Advisory Action dated Oct. 9, 2014”, 3 pgs.
“U.S. Appl. No. 13/923,827, Examiner Interview Summary dated Sep. 29, 2014”, 3 pgs.
“U.S. Appl. No. 13/923,827, Final Office Action dated Jul. 28, 2014”, 11 pgs.
“U.S. Appl. No. 13/923,827, Non Final Office Action dated Apr. 10, 2014”, 9 pgs.
“U.S. Appl. No. 13/923,827, Notice of Allowance dated Oct. 29, 2014”, 11 pgs.
“U.S. Appl. No. 13/923,827, Response filed Jul. 10, 2014 to Non Final Office Action dated Apr. 10, 2014”, 13 pgs.
“U.S. Appl. No. 13/923,827, Response filed Sep. 29, 2014 to Final Office Action dated Jul. 28, 2014” 11 pgs.
“U.S. Appl. No. 13/923,827, Supplemental Notice of Allowance dated Feb. 11, 2015”, 2 pgs.
“U.S. Appl. No. 13/923,827, Supplemental Notice of Allowance dated Dec. 19, 2014”, 3 pgs.
“U.S. Appl. No. 14/027,340, Advisory Action dated Sep. 17, 2015”, 3 pgs.
“U.S. Appl. No. 14/027,340, Final Office Action dated Jul. 8, 2015”, 10 pgs.
“U.S. Appl. No. 14/027,340, Non Final Office Action dated Jan. 22, 2015”, 11 pgs.
“U.S. Appl. No. 14/027,340, Non Final Office Action dated Dec. 9, 2015”, 10 pgs.
“U.S. Appl. No. 14/027,340, Notice of Allowance dated May 12, 2016”, 7 pgs.
“U.S. Appl. No. 14/027,340, Response filed Feb. 19, 2016 to Non Final Office Action dated Dec. 9, 2015”, 13 pgs.
“U.S. Appl. No. 14/027,340, Response filed May 21, 2015 to Non Final Office Action dated Jan. 22, 2015”, 14 pgs.
“U.S. Appl. No. 14/027,340, Response filed Sep. 9, 2015 to Final Office Action dated Jul. 8, 2015”, 15 pgs.
“U.S. Appl. No. 14/064,970, Advisory Action dated Jan. 4, 2016”, 3 pgs.
“U.S. Appl. No. 14/064,970, Final Office Action dated Oct. 19, 2015”, 10 pgs.
“U.S. Appl. No. 14/064,970, Non Final Office Action dated Mar. 12, 2015”, 11 pgs.
“U.S. Appl. No. 14/064,970, Non Final Office Action dated Jul. 26, 2016”, 12 pgs.
“U.S. Appl. No. 14/064,970, Response filed Jul. 8, 2015 to Non Final Office Action dated Mar. 12, 2015”, 8 pgs.
“U.S. Appl. No. 14/064,970, Response filed Oct. 26, 2016 to Non Final Office Action dated Jul. 26, 2016”, 14 pgs.
“U.S. Appl. No. 14/064,970, Response filed Dec. 9, 2014 to Restriction Requirement dated Oct. 9, 2014”, 11 pgs.
“U.S. Appl. No. 14/064,970, Response filed Dec. 15, 2015 to Final Office Action dated Oct. 19, 2015”, 11 pgs.
“U.S. Appl. No. 14/064,970, Restriction Requirement dated Oct. 9, 2014”, 9 pgs.
“U.S. Appl. No. 14/086,447, Notice of Allowance dated Aug. 12, 2016”, 9 pgs.
“U.S. Appl. No. 14/086,447, Preliminary Amendment filed Jul. 29, 2016”, 4 pgs.
“U.S. Appl. No. 14/086,447, Response filed May 4, 2016 to Restriction Requirement dated Apr. 6, 2016”, 7 pgs.
“U.S. Appl. No. 14/086,447, Restriction Requirement dated Apr. 6, 2016”, 7 pgs.
“U.S. Appl. No. 14/100,134 Response Filed Apr. 14, 2016 to Restriction Requirement dated Feb. 24, 2016”, 7 pgs.
“U.S. Appl. No. 14/100,134, Notice of Allowance dated Jun. 16, 2016”, 14 pgs.
“U.S. Appl. No. 14/100,134, Restriction Requirement dated Feb. 24, 2016”, 5 pgs.
“U.S. Appl. No. 14/105,669, Non Final Office Action dated Jan. 11, 2016”, 11 pgs.
“U.S. Appl. No. 14/105,669, Non Final Office Action dated Aug. 11, 2016”, 5 pgs.
“U.S. Appl. No. 14/105,669, Response filed Oct. 13, 2015 to Restriction Requirement dated Sep. 8, 2015”, 7 pgs.
“U.S. Appl. No. 14/105,669, Response filed Oct. 31, 2016 to Non Final Office Action dated Aug. 11, 2016”, 8 pgs.
“U.S. Appl. No. 14/105,669, Restriction Requirement dated Sep. 8, 2015”, 6 pgs.
“U.S. Appl. No. 14/106,669, Response filed Apr. 11, 2016 to Non Final Office Action dated Jan. 11, 2016”, 11 pgs.
“U.S. Appl. No. 14/107,316, Corrected Notice of Allowance dated Jul. 11, 2016”, 2 pgs.
“U.S. Appl. No. 14/107,316, Examiner Interview Summary dated Jun. 10, 2016”, 3 pgs.
“U.S. Appl. No. 14/107,316, Non Final Office Action dated Mar. 24, 2016”, 16 pgs.
“U.S. Appl. No. 14/107,316, Notice of Allowance dated Jun. 28, 2016”, 11 pgs.
“U.S. Appl. No. 14/107,316, Notice of Non-Compliant Amendment dated Dec. 30, 2015”, 3 pgs.
“U.S. Appl. No. 14/107,316, Response filed Jan. 18. 2016 to Notice of Non-Compliant Amendment dated Dec. 30, 2015”, 8 pgs.
“U.S. Appl. No. 14/107,316, Response filed Jun. 13, 2016 to Non Final Office Action dated Mar. 24, 2016”, 13 pgs.
“U.S. Appl. No. 14/107,316, Response filed Dec. 16, 2015 to Restriction Requirement dated Oct. 29, 2015”, 8 pgs.
“U.S. Appl. No. 14/107,316, Restriction Requirement dated Oct. 29, 2015”, 8 pgs.
“U.S. Appl. No. 14/159,071, Final Office Action dated May 14, 2015”, 7 pgs.
“U.S. Appl. No. 14/159,071, Non Final Office Action dated Dec. 8, 2014”, 14 pgs.
“U.S. Appl. No. 14/483,214, Final Office Action dated Dec. 16, 2015”, 9 pgs.
“U.S. Appl. No. 14/483,214, Non Final Office Action dated Jun. 5, 2015”, 8 pgs.
“U.S. Appl. No. 14/483,214, Non Final Office Action dated Oct. 6, 2016”, 12 pgs.
“U.S. Appl. No. 14/483,214, Response filed Jan. 6, 2017 to Non Final Office Action dated Oct. 6, 2016”, 16 pgs.
“U.S. Appl. No. 14/483,214, Response filed Mar. 14, 2016 to Final Office Action dated Dec. 16, 2015”, 15 pgs.
“U.S. Appl. No. 14/483,214, Response filed May 15, 2015 to Restriction Requirement dated Mar. 25, 2015”, 2 pgs.
“U.S. Appl. No. 14/483,214, Response filed Sep. 2, 2015 to Non Final Office Action dated Jun. 5, 2015”, 13 pgs.
“U.S. Appl. No. 14/483,214, Restriction Requirement dated Mar. 25, 2015”, 6 pgs.
“U.S. Appl. No. 14/658,429, Final Office Action dated Aug. 29, 2016”, 9 pgs.
“U.S. Appl. No. 14/658,429, Non Final Office Action dated Mar. 24, 2016”, 7 pgs.
“U.S. Appl. No. 14/658,429, Response filed Nov. 21, 2016 to Final Office Action dated Aug. 29, 2016”, 14 pgs.
“U.S. Appl. No. 14/658,429, Response Filed Jun. 20, 2016 to Non-Final Office Action dated Mar. 24, 2016”, 12 pgs.
“U.S. Appl. No. 14/684,936, Corrected Notice of Allowance dated Sep. 22, 2016”, 4 pgs.
“U.S. Appl. No. 14/684,936, Non Final Office Action dated Mar. 22, 2016”, 7 pgs.
“U.S. Appl. No. 14/684,936, Notice of Allowance dated Aug. 30, 2016”, 6 pgs.
“U.S. Appl. No. 14/684,936, Response filed Jun. 9, 2016 to Non Final Office Action dated Mar. 22, 2016”, 8 pgs.
“U.S. Appl. No. 14/798,809, Preliminary Amendment filed Oct. 29, 2015”, 7 pgs.
“U.S. Appl. No. 14/798,809, Restriction Requirement dated Jan. 4, 2017”, 10 pgs.
“U.S. Appl. No. 14/812,583, Preliminary Amendment filed Jul. 29, 2015”, 6 pgs.
“U.S. Appl. No. 14/865,762, Preliminary Amendment filed Oct. 14, 2015”, 6 pgs.
“U.S. Appl. No. 14/973,057, Non Final Office Action dated Oct. 18, 2016”, 6 pgs.
“U.S. Appl. No. 14/973,057, Preliminary Amendment filed Dec. 18, 2015”, 7 pgs.
“U.S. Appl. No. 14/973,057, Response filed Sep. 21, 2016 to Restriction Requirement dated Jul. 29, 2016”, 5 pgs.
“U.S. Appl. No. 14/973,057, Restriction Requirement dated Jul. 29, 2016”, 8 pgs.
“U.S. Appl. No. 15/008,528, Preliminary Amendment dated Jan. 29, 2016”, 8 pgs.
“U.S. Appl. No. 15/093,384, Preliminary Amendment filed Apr. 28, 2016”, 5 pgs.
“U.S. Appl. No. 15/224,741, Preliminary Amendment filed Sep. 12, 2016”, 8 pgs.
“U.S. Appl. No. 15/267,714, Preliminary Amendment filed Oct. 6, 2016”, 7 pgs.
“U.S. Appl. No. 15/267,714, Restriction Requirement dated Jan. 5, 2017”, 5 pgs.
“U.S. Appl. No. 12/025,414, Applicant's Summary of Examiner Interview filed Apr. 9, 2012”, 4 pgs.
“U.S. Appl. No. 12/025,414, Final Office Action dated Mar. 14, 2012”, 6 pgs.
“U.S. Appl. No. 12/025,414, Final Office Action dated May 1, 2012”, 10 pgs.
“U.S. Appl. No. 12/025,414, Non Final Office Action dated Oct. 25, 2011”, 10 pgs.
“U.S. Appl. No. 12/025,414, Notice of Allowance dated Jun. 13, 2012”, 7 pgs.
“U.S. Appl. No. 12/025,414, Response filed Apr. 9, 2012 to Final Office Action dated Mar. 14, 2012”, 15 pgs.
“U.S. Appl. No. 12/025,414, Response filed May 21, 2012 to Final Office Action dated May 1, 2012”, 6 pgs.
“U.S. Appl. No. 12/025,414, Response filed Jul. 26, 2011 to Restriction Requirement dated Jul. 19, 2011”, 8 pgs.
“U.S. Appl. No. 12/025,414, Response filed Dec. 22, 2011 to Non Final Office Action dated Oct. 25, 2011”, 13 pgs.
“U.S. Appl. No. 12/025,414, Restriction Requirement dated Jul. 19, 2011”, 5 pgs.
“U.S. Appl. No. 12/483,807, Final Office Action dated Nov. 4, 2011”, 20 pgs.
“U.S. Appl. No. 12/872,663, Response filed Sep. 13, 2012 to Non Final Office Action dated Jun. 20, 2012”, 9 pgs.
“U.S. Appl. No. 13/800,334, Final Office Action dated Apr. 6, 2016”, 19 pgs.
“Australian Application Serial No. 2013222609, Response filed Sep. 17, 2015 to First Examiner Report dated Feb. 16, 2015”, 17 pgs.
“DURALOC® Cementless Acetabular Reconstruction”, Surgical Technique brochure, DePuy International Ltd., (2007), 10 pgs.
“European Application Serial 13710642.3, Communication Pursuant to Article 94(3) EPC dated Nov. 6, 2015”, 3 pgs.
“European Application Serial 13710642.3, Intention to grant dated Jun. 17, 2016”, 7 pgs.
“European Application Serial 13710642.3, Response filed Mar. 16, 2016 to Communication Pursuant to Article 94(3) EPC dated Nov. 6, 2015”, 8 pgs.
“European Application Serial No. 07809326.7, Office Action dated Jan. 28, 2009”, 2 pgs.
“European Application Serial No. 07809326.7, Office Action dated Dec. 2, 2011”, 1 pg.
“European Application Serial No. 07809326.7, Response filed Jun. 6, 2012 to Extended European Search Report dated Nov. 15, 2011”, 6 pgs.
“European Application Serial No. 07809326.7, Response filed Jul. 31, 2015 to Examination Notification Art. 94(3) dated Jan. 22, 2015”, 10 pgs.
“European Application Serial No. 09731923.0, Communication Pursuant to Article 94(3) EPC dated Nov. 29, 2016”, 5 pgs.
“European Application Serial No. 09731923.0, Office Action dated Feb. 3, 2011”, 2 pgs.
“European Application Serial No. 09731923.0, Response filed Aug. 20, 2015 to Examination Notification Art. 94(3) dated Feb. 10, 2015”, 11 pgs.
“European Application Serial No. 09732174.9, Communication Pursuant to Article 94(3) EPC dated Mar. 3, 2016”, 4 pgs.
“European Application Serial No. 09732174.9, Communication Pursuant to Article 94(3) EPC dated Oct. 17, 2016”, 4 pgs.
“European Application Serial No. 09732174.9, Examination Notification Art. 94(3) dated Mar. 7, 2014”, 5 pgs.
“European Application Serial No. 09732174.9, Office Action dated Feb. 3, 2011”, 2 pgs.
“European Application Serial No. 09732174.9, Response filed Jul. 13, 2016 to Communication Pursuant to Article 94(3) EPC dated Mar. 3, 2016”, 12 pgs.
“European Application Serial No. 09732174.9, Response filed Jul. 14, 2014 to Examination Notification Art. 94(3) dated Mar. 7, 2014”, 6 pgs.
“European Application Serial No. 09792468.2, Communication Pursuant to Article 94(3) EPC dated Jun. 7, 2016”, 4 pgs.
“European Application Serial No. 09792468.2, Examination Notification Art. 94(3) dated Jan. 29, 2015”, 5 pgs.
“European Application Serial No. 09792468.2, Office Action dated Jul. 8, 2011”, 2 pgs.
“European Application Serial No. 09792468.2, Response filed Jan. 9, 2012 to Office Action dated Jul. 8, 2011”, 11 pgs.
“European Application Serial No. 09792468.2, Response filed May 29, 2015 to Examination Notification Art. 94(3) dated Jan. 29, 2015”, 8 pgs.
“European Application Serial No. 09792468.2, Response filed Sep. 28, 2016 to Communication Pursuant to Article 94(3) EPC dated Jun. 7, 2016”, 21 pgs.
“European Application Serial No. 10705064.3, Communication Pursuant to Article 94(3) dated Dec. 8, 2015”, 4 pgs.
“European Application Serial No. 10705064.3, Office Action dated Nov. 22, 2011”, 2 pgs.
“European Application Serial No. 10705064.3, Response filed Apr. 18, 2016 to Communication Pursuant to Article 94(3) EPC dated Dec. 8, 2015”, 8 pgs.
“European Application Serial No. 10705064.3, Response filed Aug. 14, 2015 to Examination Notification Art. 94(3) dated Feb. 4, 2015”, 9 pgs.
“European Application Serial No. 10705951.1, Communication Pursuant to Article 94(3) EPC dated Jan. 22, 2013”, 7 pgs.
“European Application Serial No. 10705951.1, Office Action dated Oct. 7, 2011”, 2 pgs.
“European Application Serial No. 10705951.1, Response filed May 23, 2013 to Communication Pursuant to Article 94(3) EPC dated Jan. 22, 2013”, 8 pgs.
“European Application Serial No. 12156937.0, Decision of Grant dated May 4, 2015”, 2 pgs.
“European Application Serial No. 12156937.0, Examination Notification Art. 94(3) dated Dec. 11, 2013”, 5 pgs.
“European Application Serial No. 12156937.0, Extended European Search Report dated Sep. 6, 2012”, 9 pgs.
“European Application Serial No. 12156937.0, Response filed Apr. 16, 2013 to Extended European Search Report dated Sep. 6, 2012”, 9 pgs.
“European Application Serial No. 12156937.0, Response filed Apr. 17, 2014 to Examination Notification Art. 94(3) dated Dec. 11, 2013”, 15 pgs.
“European Application Serial No. 12724475.4, Communication Pursuant to Article 94(3) EPC dated Aug. 31, 2016”, 5 pgs.
“European Application Serial No. 12724475.4, Office Action dated Jan. 21, 2014”, 2 pgs.
“European Application Serial No. 12724475.4, Response filed Apr. 15, 2015 to Examination Notification Art. 94(3) dated Nov. 24, 2014”, 9 pgs.
“European Application Serial No. 13710642.3, Amendment dated Sep. 1, 2014”, 7 pgs.
“European Application Serial No. 13710642.3, Office Action dated Oct. 10, 2014”, 2 pgs.
“Hand Instruments”, High Performance, Precision Series brochure by Arthrotek, copyright, (2000), 3 pgs.
“International Application Serial No. PCT/GB2007/003737, International on Preliminary Report on Patentability dated Apr. 7, 209”, 8 pgs.
“International Application Serial No. PCT/GB2007/003737, Written Opinion dated Jan. 25, 2008”, 7 pgs.
“International Application Serial No. PCT/US2009/061434, International Preliminary Report on Patentability dated May 5, 2011”, 6 pgs.
“International Application Serial No. PCT/US2009/061434, International Search Report dated Feb. 2, 2010”, 4 pgs.
“International Application Serial No. PCT/US2009/061434, Written Opinion dated Feb. 2, 2010”, 4 pgs.
“International Application Serial No. PCT/US2011/026412, International Preliminary Report on Patentability dated Sep. 30, 2012”, 8 pgs.
“International Application Serial No. PCT/US2011/057300 , International Preliminary Report on Patentability dated May 16, 2013”, 11 pgs.
“International Application Seriai No. PCT/US2011/057300, Written Opinion dated Mar. 5, 2012”, 9 pgs.
“International Application Serial No. PCT/US2012/038351 , International Search Report dated Jul. 6, 2012”, 6 pgs.
“International Application Serial No. PCT/US2012/038351, Written Opinion dated Jul. 6, 2012”, 8 pgs.
“International Application Serial No. PCT/US2013/074288, International Preliminary Report on Patentability dated Jun. 25, 2015”, 13 pgs.
“International Application Serial No. PCT/US2014/068131, International Search Report dated May 8, 2015”, 5 pgs.
“International Application Serial No. PCT/US2014/068131, Written Opinion dated May 8, 2015”, 9 pgs.
“International Application Serial No. PCT/US2015/039561 , International Search Report dated Sep. 14, 2015”, 5 pgs.
“International Application Serial No. PCT/US2015/039561, Written Opinion dated Sep. 14, 2015”, 6 pgs.
“Japanese Application Serial No. 2011-505080, Appeal Decision dated Jun. 24, 2015”, (W/ English Translation), 3 pgs.
“Japanese Application Serial No. 2011-505080, Decision of Refusal dated Nov. 27, 2013”, (W/ English Translation), 4 pgs.
“Japanese Application Serial No. 2011-505080, Office Action dated Feb. 25, 2015”, (W/ English Translation), 2 pgs.
“Japanese Application Serial No. 2011-505080, Office Action dated Apr. 3, 2013”, (W/ English Translation), 6 pgs.
“Japanese Application Serial No. 2011-505080, Response filed Mar. 27, 2014 to Decision of Refusal dated Nov. 27, 2013”, (W/ English Translation), 12 pgs.
“Japanese Application Serial No. 2011-505080, Response filed May 25, 2015 to Office Action dated Feb. 25, 2015”, No English Translation, 6 pgs.
“Japanese Application Serial No. 2011-505080, Response filed Jul. 3, 2013 to Office Action dated Apr. 3, 2013”, (W/ English Translation), 11 pgs.
“Japanese Application Serial No. 2011-527885, Office Action dated Aug. 27, 2013”, (English Translation), 8 pgs.
“Japanese Application Serial No. 2011-527885, Response filed Nov. 26, 2013 to Office Action mailed Aug. 27, 2013”, (W/ English Translation of Claims), 9 pgs.
“Japanese Application Serial No. 2013-537691, Office Action dated Feb. 10, 2015”, No English Translation, 3 pgs.
“Japanese Application Serial No. 2013-537691, Office Action dated Apr. 15, 2014”, (W/ English Translation), 2 pgs.
“Japanese Application Serial No. 2013-537691, Office Action dated Aug. 19, 2014”, (W/ English Translation), 4 pgs.
“Japanese Application Serial No. 2013-537691, Response filed Jul. 5, 2014 to Office Action dated Apr. 15, 2014”, No English Translation, 7 pgs.
“Japanese Application Serial No. 2013-537691, Response filed Dec. 19, 2014 to Office Action dated Aug. 19, 2014”, No English Translation, 8 pgs.
“Japanese Application Serial No. 2014-257600, Examiners Decision of Final Refusal dated Dec. 20, 2016”, (W/ English Translation), 2 pgs.
“Japanese Application Serial No. 2014-257600, Office Action dated May 24, 2016”, (W/ English Translation), 5 pgs.
“Japanese Application Serial No. 2014-257600, Office Action dated Oct. 27, 2015”, (W/ English Translation), 6 pgs.
“Japanese Application Serial No. 2014-257600, Response filed Jan. 20, 2016 to Office Action dated Oct. 27, 2015”, (W/ English Translation of Claims), 5 pgs.
“Japanese Application Serial No. 2014-257600, Voluntary Amendment filed Dec. 19, 2014”, No English Translation, 16 pgs.
“Japanese Application Serial No. 2014-511538, Office Action dated Apr. 7, 2015”, (W/ English Translation), 5 pgs.
“Japanese Application Serial No. 2014-511538, Office Action dated Nov. 17, 2015”, W/ English Translation, 5 pgs.
“Japanese Application Serial No. 2014-511538, Response filed Feb. 17, 2016 to Office Action dated Nov. 17, 2015”, (W/ English Translation of Claims), 9 pgs.
“Japanese Application Serial No. 2014-511538, Response filed Jul. 6, 2015 to Office Action dated Apr. 7, 2015”, No English Translation, 6 pgs.
“Japanese Application Serial No. 2014-558800, Office Action dated Sep. 1, 2015”, (W/ English Translation), 8 pgs.
“Japanese Application Serial No. 2014-558800, Response filed Dec. 1, 2015 to Office Action dated Sep. 1, 2015”, (W/ English Translation), 9 pgs.
“Insall/Burstein II Modular Knee System”, Zimmer, Inc., (1989), 20 pgs.
“Magnum™, M2a-Magnum™ Operative Technique”, brochure. Biomet UK Ltd., (2008), 14 pgs.
“MAX-Ti™ Modular Protrusio Cage”, Surgical Technique brochure. Biomet Orthopedics, Inc., (2003), 10 pgs.
“MAX-Ti™ Modular Protrusio Cage”, Surgical Technique brochure. Biomet Orthopedics, Inc., (2006), 12 pgs.
“Minimally Invasive Solution Technique—Instrumentation”, The M/G Unicompartmental Knee, (2001), 4 pgs.
“MIS Minimally Invasive Solution, The M/G Unicompartmental Knee Minimally Invasive Surgical Technique”, Zimmer, Inc. Nexgen Complete Knee Solution, 97-5791-02, (Aug. 14, 2008), 27 pgs.
“Nex Gen Complete Knee Solution-Intramedually Instrumentation Surgical Technique”, NexGen Cruciate Reatining & Legacy Posterior Stablized Knee, (1994), 37 pgs.
“Nexgen Complete Knee Solution”, Extramedullary/intramedullary Tibial Resector: Surgical Technique, Zimmer, Inc. 97-5997-02 Rev 1, (2000), 26 pgs.
“NexGen Complete Knee Solution-Multi-Reference 4-in-1 Femoral Instrumentation-Anterior Reference Surgical Technique”, (Aug. 1, 2001), 17 pgs.
“NexGen System Complete Knee Solution—Design Rationale”, 26 pgs.
“Orthopaedic Salvage System Femoral/Tibial Augmentation”, Biomet Orthopedics, Inc., Product Brochure, (2003, 2004), 12 pgs.
“PAR 5™ Protrusio Acetabular Reconstruction System”, Biomet Orthopedics, Inc., (2006), 12 pgs.
“Proximal Tibial Replacement (MOST)”, Zimmer MOST Options System Surgical Technique, (2005), 84 pgs.
“Scorpio Single Axis Total Knee System—Passport Total Knee Instruments”, Suri:iical TechniQue by Srvker Howmedica Osteonics, (2000), 54 pgs.
“Simple Instruments Surgical Technique for the Knee”, Biomet, Inc., (2000), 4 pgs.
“Surgical Navigation for Total Knee Arthroplasty—Belived to have been presented at the American Academy of Orthopedic Surgeons”, (Feb. 2001), 24 pgs.
“Surgical Technique for the Maxim®, Ascent™ and Vanguard™ Total Knee Systems”, Microplast™ minimally invasive knee instruments brochure, (Feb. 29, 2004), 15 pgs.
“Surgical Technique—Nexgen Complete Knee Solution for the Legacy Knee LPS-Flex Fixed Bearing Knee”, Zimmer, Inc., (2004, 2007), 12 pgs.
“Taperloc Complete Hip System Surgical Technique”, Biomet: Brochure 2012 REV061512, (2011), 12 pgS.
“The AGC Revision Knee System Surgical Technique”, Biomet, Inc., (1997), 14 pgs.
“The Fudger™—The Ultimate Weapon in the Femoral Referencing War”, Biomet, Inc., 2 pgs.
“United Kingdom Application Serial No. 0619534.1, Search Report dated Dec. 18, 2006”, (dated Dec. 8, 2006), 1 pg.
“United Kingdom Application Serial No. 1116054.6, Office Action dated Aug. 12, 2016”, 2 pgs.
“United Kingdom Application Serial No. 1116054.6, Response filed Oct. 11, 2016 to Office Action dated Aug. 12, 2016”, 12 pgs.
“United Kingdom Application Serial No. 11160546, First Examination Report dated Jun. 6, 2016”, 4 pgs.
“United Kingdom Application Serial No. 1207103.1, Amendment filed Apr. 13, 2012”, 9 pgs.
“United Kingdom Application Serial No. 1207103.1, Office Action dated May 14, 2015”, 3 pgs.
“United Kingdom Application Serial No. 1207103.1, Office Action dated Oct. 6, 2015”, 2 pgs.
“United Kingdom Application Serial No. 1207103.1, Response filed Sep. 14, 2015 to Office Action dated May 14, 2015”, 22 pgs.
“United Kingdom Application Serial No. 1216577.5, Office Action dated Oct. 20, 2016”, 4 pgs.
“United Kingdom Application Serial No. 1216577.5, Office Action dated Oct. 29, 2015”, 4 pgs.
“United Kingdom Application Serial No. 1216577.5, Response filed Feb. 24, 216 to Office Action dated Oct. 29, 2015”, 27 pgs.
“United Kingdom Application Serial No. 1216577.5, Response filed Oct. 25, 2016 to Office Action dated Oct. 20, 2016”, 24 pgs.
“United Kingdom Application Serial No. 1308746.5, Office Action dated Oct. 14, 2016”, 5 pgs.
“United Kingdom Application Serial No. 1516672.1, Combined Search and Examination Report dated Oct. 22, 2015”, 5 pgs.
“United Kingdom Application Serial No. 1516672.1, Office Action dated Mar. 7, 2016”, 3 pgs.
“United Kingdom Application Serial No. 1516672.1, Response filed Feb. 22, 2016 to Combined Search and Examination Report dated Oct. 22, 2015”, (English Translation of Claims), 37 pgs.
“United Kingdom Application Serial No. 1516672.1, Response filed Apr. 13, 2016 to Office Action dated Mar. 7, 2016”, 13 pgs.
“Zimmer MIS Multi-Reference 4-in-1 Femoral Instrumentation Surgical Technique”, Zimmer, Inc., (2003, 2008, 2009), 48 pgs.
Biomet, “The Oxford® Partial Knee System Surgical Technique”, Biomet: Manual of the Surgical Technique, (Feb. 2010), 44 pgs.
Clohisy, John C, et al., “Periacetabular Osteotomy in the Treatment of Severe Acetabular Dysplasia”, The Journal of Bone & Joint Surgery, vol. 87-A ⋅ No. 2, (2005), 7 pgs.
Hitt, Kirby, et al., “Anthropometric Measurements of the Human Knee: Correlation to the Sizing of Current Knee Arthroplasty Systems”, The Journal of Bone & Joint Surgery, (2003), 114-122.
Keys, Graham W., “Reduced Invasive Approach for Oxford II Medial Unicompartmental Knee Replacement—a Preliminary Study”, The Knee, (1999), 193-196.
Masatoshi, Naito, et al., “Curved Periacetabular Osteotomy for Treatment of Dysplastic Hip”, Clinical Orthopaedics and Related Research, (Apr. 2005), 129-135.
Miller, et al., “Unicompartmental Knee System”, The Miller/Galante Advantage; Zimmer, 11 pgs.
Miller, Nancy H, et al., “Long-term Results of the Dial Osteotomy in the Treatment of High-grade Acetabular Dysplasia”, Clinical Orthopaedics and Related Research, (2005), 115-123.
Yasunaga, Yuji, et al., “Rotational Acetabular Osteotomy for Advanced Osteoarthritis Secondary to Dysplasia of the Hip. Surgical Technique”, The Journal of Bone & Joint Surgery, (2007), 11 pgs.
“U.S. Appl. No. 12/371,096, Appeal Decision dated Jun. 23, 17”, 10 pgs.
“U.S. Appl. No. 13/527,981, Response filed Sep. 21, 2017 to Non Final Office Action dated Jun. 22, 2017”, 11 pgs.
“U.S. Appl. No. 13/800,334, Notice of Allowance dated Aug. 31, 2017”, 8 pgs.
“U.S. Appl. No. 14/327,234, Notice of Allowance dated Jun. 22, 2017”, 12 pgs.
“U.S. Appl. No. 14/483,214, Response filed Jul. 31, 2017 to Non Final Office Action dated May 2, 2017”, 12 pgs.
“U.S. Appl. No. 14/658,429, Advisory Action dated Sep. 12, 2017”, 3 pgs.
“U.S. Appl. No. 14/658,429, Examiner Interview Summary dated Aug. 17, 2017”, 2 pgs.
“U.S. Appl. No. 14/658,429, Response filed Aug. 11, 2017 to Final Office Action dated Jun. 15, 2017”, 21 pgs.
“U.S. Appl. No. 14/658,429, Supplemental Response Filed Sep. 21, 2017 to Final Office Action dated Jun. 15, 2017 and Advisory Action dated Sep. 12, 2017”, 25 pgs.
“U.S. Appl. No. 14/798,809, Examiner Interview Summary dated Sep. 14, 2017”, 3 pgs.
“U.S. Appl. No. 14/798,809, Non Final Office Action dated Jun. 28, 2017”, 7 pgs.
“U.S. Appl. No. 14/798,809, Response filed Sep. 26, 2017 to Non Final Office Action dated Jun. 28, 2017”, 9 pgs.
“U.S. Appl. No. 14/865,762, Response filed Sep. 13, 2017 to Non Final Office Action dated Jun. 13, 2017”, 17 pgs.
“U.S. Appl. No. 15/130,414, Restriction Requirement dated Sep. 20, 2017”, 7 pgs.
“U.S. Appl. No. 15/267,714, Response filed Aug. 4, 2017 to Non Final Office Action dated May 10, 2017”, 21 pgs.
“U.S. Appl. No. 15/618,331, Preliminary Amendment filed Jun. 28, 2017”, 6 pgs.
“U.S. Appl. No. 15/650,035, Preliminary Amendment filed Jul. 20, 2017”, 6 pgs.
“U.S. Appl. No. 15/672,724, Preliminary Amendment Filed Aug. 9, 2017”, 4 pgs.
“U.S. Appl. No. 15/672,724, Supplemental Preliminary Amendment filed Aug. 23, 2017”, 7 pgs.
“U.S. Appl. No. 13/800,334, Response filed Aug. 10, 2017 to Final Office Action dated Jun. 15, 2017”, 9 pgs.
“European Application Serial No. 15739458.6, Response filed Sep. 4, 2017 to Communication pursuant to Rules 161(1) and 162 EPC dated Feb. 21, 2017”, 9 pgs.
“European Application Serial No. 16179569.5, Extended European Search Report dated Jul. 7, 2017”, 8 pgs.
“U.S. Appl. No. 15/130,414, Non Final Office Action dated Jul. 27, 2018”, 7 pgs.
Related Publications (1)
Number Date Country
20150351778 A1 Dec 2015 US
Provisional Applications (1)
Number Date Country
61310752 Mar 2010 US
Divisions (1)
Number Date Country
Parent 12872663 Aug 2010 US
Child 13766419 US
Continuations (1)
Number Date Country
Parent 13766419 Feb 2013 US
Child 14739160 US